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Ca2+ signals determine smooth muscle contraction and the switch from a contractile 
to a migratory-proliferative phenotype(s), which requires changes in gene expression. 
However, the mechanism by which different Ca2+ signals are selective for these 
processes is enigmatic. In the thesis, I built on the “panjunctional sarcoplasmic 
reticulum” hypothesis, and described the evidence in support of the view that a variety 
of Ca2+ pumps and release channels, with different kinetics and affinities for Ca2+, are 
strategically positioned within the cytoplasmic nanocourses of pulmonary arterial 
smooth muscle cells (PASMCs), and they serve to demarcate different Ca2+ signalling. 
Nanocourses of the SR are formed in the perinuclear, extraperinuclear, 
subplasmalemmal regions and the nucleus. Different subtypes of ryanodine receptors 
(RyRs) are targeted to those nanocourses. Immunocytochemistry results suggest that 
RyR1s was preferentially targeted to the subplasmalemmal and nuclear nanocourses 
of PASMCs, they gave rise to a spatially restricted Ca2+ signal within the nanocourses 
upon stimulation, without affecting global Ca2+ concentration. The Ca2+ signals in the 
subplasmalemmal nanocourses were shown to induce arterial smooth muscle cell 
relaxation. On the other hand, the RyR2 and 3 were shown to target to the perinuclear 
and extraperinuclear nanocourses. Upon stimulation, they generate propagating Ca2+ 
waves in the cytoplasmic nanocourses, which trigger arterial smooth muscle cell 
contraction. However, during this process, no Ca2+ transient was observed within the 
subplasmalemmal nanocourses, suggesting that the regulation of both contraction 
and relaxation of smooth muscle cells are achieved by spatially restricted Ca2+ signals 
within different nanocourses.  
Invaginations of the nucleoplasmic reticulum in arterial myocytes form trans-nuclear 
networks of cytoplasmic nanospaces, generate Ca2+ signals by strategically 
positioned Ca2+ pumps (SERCA1) and release channels (RyR1). Within a 
subpopulation of nuclear invaginations, evoked Ca2+ signals via ryanodine receptors 
exhibited spatial and temporal separation from adjacent Ca2+ signals within a single 
“activated” nuclear invagination, and also from those Ca2+ signals arising within 
different nuclear invaginations. Moreover, nuclear invaginations provide sites for 
transcriptional suppression, because lamin A and/or emerin line the entire surface of 
their inner nuclear membranes and co-localise with nesprin-1 positive puncta. More 
intriguing still, a subpopulation of these nuclear invaginations harboured punctate 
regions of colocalisation between lamin A and the suppressive heterochromatin mark 
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H3K9me2, while emerin-positive invaginations harboured puncta of BAF (Barrior to 
autointegration factor) co-localisation and thus an alternative pathway to the 
regulation of gene expression. I propose that nuclear invaginations form cytoplasmic 
nanotubes within which nano-patterning of Ca2+ signals may support stochastic 
modulation of transcriptional suppressors.   
Together, the cytoplasmic nanocourses form a cell-wide web for Ca2+ signalling and 
the regulation of various arterial smooth muscle functions, ranging from the regulation 



























Ca2+ signals determine smooth muscle functions. However, the mechanism by which 
different Ca2+ signals select for various processes is enigmatic. It was generally 
accepted that the bulk cytoplasm serves as a container of diverse ions that can diffuse 
freely across the entire cytoplasm. In this thesis, this understanding is challenged. 
The Ca2+ releasing channels are targeted to the membrane of the intracellular Ca2+ 
storage organelles where they serve to transport the Ca2+ from the Ca2+ store to the 
cytoplasm. My data suggest that instead of diffusing across the cytoplasm, the 
released Ca2+ is restricted within nanospaces defined by the membrane of Ca2+ stores. 
These nanospaces were named as cytoplasmic nanocourses, and these cytoplasmic 
nanocourses extend from the cell periphery to the nucleus, forming a cell-wide web. 
Within the nanocourses, unique Ca2+ signals are generated for the regulation of 
smooth muscle functions. Due to the fact that the Ca2+ signals are retained within the 
nanocourses, global Ca2+ concentration remains unaffected. Moreover, Ca2+ 
receptors that target to different nanocourses seem to show distinct properties, this 
determined that the Ca2+ signals generated within different nanocourses exhibit 
distinct characteristics. As the result, varied Ca2+ signals are formed, and they are 
proposed to modulate different smooth muscle functions. To summarize, the 
formation of the cell-wide web of cytoplasmic nanocourses allowed precise and 
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Chapter 1: General Introduction 
 
1.1 Smooth muscle physiology 
The blood pressure is regulated by the constriction and dilation of blood vessels, 
because the blood vessels are built with smooth muscle cells that can contract or 
relax in response to biological cues. The walls of blood vessels are composed of, from 
outside to inside, loose connective tissues, layers of smooth muscle cells with elastic 
lamina, basal lamina and a thin sheet of endothelial cells (Alberts, 2002). Among 
these, smooth muscle cells count for the vast majority. Moreover, it has been reported 
that vascular smooth musle cell contraction can produce a change in blood pressure 
(Crowley et al., 2005, Brozovich et al., 2016), which puts smooth muscle cells in an 
important position when discussing hypentension and health. 
Vascular smooth muscle contraction is regulated by intracellular Ca2+ signalling. Local 
increase in Ca2+ concentration would saturate the four Ca2+ binding sites on camodulin, 
which activates myosin light chain kinase. The kinase would phosphorylate the light 
chains of myosin which generate the force that drives smooth mucle contraction 
(Wilson et al., 2002). On the other hand, smooth muscle relaxation is driven by the 
net loss of intracellular Ca2+ level which opposes contraction. The increase of Ca2+ 
concentration near the plasma membrane could activate the BKca channels (Ca2+ 
activated big potassium channels), causing memebrane hyperpolarization and 
consequencial closing of voltage gated Ca2+ channels at the plasma membrane, while 
favouring Ca2+ extrution via the Na+/Ca2+ exchangers (Boittin et al., 2003, Nelson et 
al., 1995, Khalil et al., 2017). To understand smooth muscle physiology, one must 
start with intracellular Ca2+ signalling. 
 
1.2 Intracellular Ca2+ signalling 
Ca2+ is a chemical messenger that serves to convey information for the regulation of 
a variety of cellular processes including gene expression, muscle contraction and 
relaxation, neurosecretion and programmed cell death. To understand the concept of 
Ca2+ signalling, one must bear in mind that Ca2+ causes protein and nucleic acid 
aggregation, which breaks lipid membranes and leads to the precipitation of 
phosphates (Case et al., 2007, Tsien and Barrett, 2005). Consequently, high 
intracellular Ca2+ concentration hampers the cells. Therefore, Ca2+ must be stowed 
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away, and a Ca2+ homeostatic system must be developed to maintain the intracellular 
Ca2+ concentration at a low level. This in turn makes Ca2+ a favourable signalling 
molecule, because the intracellular Ca2+ concentration is maintained at around 100 
nM whereas the extracellular Ca2+ concentration is significantly higher (Case et al., 
2007). As the result, it was postulated that a small influx of Ca2+ from the extracellular 
space could effectively raise the intracellular Ca2+ concentration to a level that induces 
significant changes (Tsien and Barrett, 2005).  
 
Due to the cytotoxicity of high intracellular Ca2+ concentration, it now becomes clear 
that the intracellular Ca2+ handling is not a simple case of modulating the Ca2+ 
concentration within the “bulk” cytoplasm, the intracellular Ca2+ signals must be 
spatially restricted (Case et al., 2007).   However, to reach the cell interior, the Ca2+ 
flux originating from the extracellular space must travel a long distance. To overcome 
the problem and to maintain intracellular Ca2+ homeostasis, intracellular Ca2+ stores 
were developed. For example, the endoplasmic reticulum (ER) is an intracellular Ca2+ 
store which exhibits high luminal free Ca2+ concentration. The total ER Ca2+ 
concentration within its lumen is around 200 µM or more (Mogami et al., 1998), which 
is 2000 times greater than the intracellular free Ca2+ concentration. The ER forms a 
wide-spread network within the cell, with Ca2+ releasing channels and Ca2+ 
transporters targeted to the ER membranes (Mekahli et al., 2011). This allows for the 
control of the site of action by dictating local Ca2+ release from the intracellular Ca2+ 
stores. On the other hand, rapid closing of the Ca2+ releasing channels leads to the 
dissipation of the signals by diffusion and local buffering (i.e. moving the Ca2+ back to 
the ER by the Ca2+ transporters)(Cardenas et al., 2010, Case et al., 2007, Mekahli et 
al., 2011). Therefore, intracellular Ca2+ stores facilitate the generation of spatially and 
temporally restricted Ca2+ signals whilst avoiding the detrimental effect of universal 
and prolonged rises in Ca2+.  Furthermore, it is the spatial and temporal characteristics 
of the Ca2+ signals that encode the messages, allowing a single ion to regulate a wide 
variety of physiological processes (i.e. from muscle contraction to gene 
expression)(Evans et al., 2016). 
 
The means by which Ca2+ coordinates various physiological processes are far more 
complicated than the simple sketch depicted above, and the investigation of this must 
build on top of the understanding of how Ca2+ is sequestered and released from the 
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intracellular Ca2+ stores, and how the Ca2+signals are restricted once they are 
released from the Ca2+ stores. 
 
1.3 The endoplasmic/sarcoplasmic reticulum serves as the largest 
mobilisable intracellular Ca2+ store 
The endoplasmic reticulum (ER) is the largest organelle in most of the mammalian 
cells (Tagaya and Simmen), this dynamic structure is essentially an interconnected 
network formed by tubules and rough sheets. The sizes of the ER sheets varies, but 
the luminal spaces of the sheets are generally around 50 nm (Bernales et al., 2006). 
The sheets appear in a stacked conformation and are connected through regions of 
twisted membranes with helical edges (Terasaki et al., 2013). A large number of 
ribosomes can be identified on the cytoplasmic surface of the ER sheets, and these 
represent the main sites of protein synthesis, folding and post-translational 
modifications. In contrast, fewer ribosomes can be identified on the cytosolic surface 
of ER tubules. The ER tubules are smooth and curvy, forming a dynamic network that 
is constantly reconfigured. The primary function of the ER includes protein synthesis, 
folding and modification, lipid biogenesis and translocation (Schwarz and Blower, 
2016). More importantly, the ER serves as the major intracellular Ca2+ store, and this 





Figure 1.1 Structure of the endoplastic reticulum. 
(A) Location of the ER in relation to the nuclear envelope (red arrow).  
(B) ER morphology.  
(C) Morphology of ER sheets and tubules,  
(D) ER sheets containing ribosomes (red arrow). Scale bar is 10 mM. Figure adapted 
from “The endoplasmic reticulum: structure, function and response to cellular 




The function of the ER is tightly related to its structure (Schwarz and Blower, 2016). 
The ER can be sub-divided into the rough ER and the smooth ER. The rough ER is 
characterized by the large number of membrane bound ribosomes found on the ER 
surface, and is majorly involved in protein synthesis and secretion. The smooth ER, 
on the other hand, lacks the membrane bound ribosomes, provides the primary 
releasable Ca2+ store and also supports the synthesis of lipids and steroids. In muscle 
cells, a form of specialized smooth ER is present, and it is referred to as the 
sarcoplasmic reticulum (SR). Electron microscopy of smooth muscle showed that the 
SR forms a network of membranes (Figure 1.1) composed of tubules and sacs. The 
SR network is wide-spread across the cell, the peripheral SR is close to the plasma 
membrane and caveolae, whereas the central SR projects deeper into the cell, forms 
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close associations with the mitochondria and is continuous with the outer nuclear 
membrane (ONM; see review (Pozzan et al., 1994)).  
 
Figure 1.2 Ultrastructure of the sarcoplasmic reticulum under electron 
microscopy. 
The sarcoplasmic reticulum in a smooth muscle cell from guinea pig portal vein. 
Peripheral sarcoplasmic reticulum is indicated by arrows. Figure adapted from 
“Release and recycling of Ca2+ by the sarcoplasmic reticulum in guinea-pig portal vein 




The function of the SR in smooth muscle cells has been extensively studied. One 
early investigation used strontium as the surrogate for Ca2+, and showed that the 
strontium was accumulated in the SR of aorta and pulmonary arterial smooth muscle 
cells. It was postulated that Ca2+ is stored in the SR and it may serve as the activator 
for contraction (Somlyo and Somlyo, 1971). More direct evidence came from the 
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electron-probe X-ray microanalysis which showed that the Ca2+ concentration within 
the SR decreased upon agonist stimulation, and that Ca2+ is released from and 
recycled back to the SR during muscle contraction and relaxation (Kowarski et al., 
1985, Bond et al., 1984). This release and recycling of Ca2+ to and from the SR proved 
that the SR is a mobilisable intracellular Ca2+ store which harbours Ca2+ transporters, 
Ca2+ storage proteins and Ca2+ releasing channels. 
 
1.3.1   Sequestration of Ca2+ by the sarcoplasmic/endoplasmic reticulum 
Ca2+ATPase 
Intracellular Ca2+ can be sequestrated into the sarcoplasmic /endoplasmic reticulum 
(S/ER) by the sarcoplasmic/endoplasmic reticulum Ca2+ ATPases (SERCAs). SERCA 
proteins are encoded by ATP2A1, 2 and 3 genes located on 3 chromosomes, and by 
alternative splicing they transcribe into more than 14 SERCA mRNAs that can be 
further translated to species and tissue specific SERCA isoforms (Lipskaia et al., 2014, 
Chemaly et al., 2017). For example, the APT2A1 gene encodes for adult SERCA1a 
and neonatal SERCA1b, both of them were identified in skeletal muscle. APT2A 2 
gene encodes for SERCA2a and SERCA2b, SERCA2a is the dominant isoform found 
in cardiac muscle whereas both of them were identified in smooth muscles. APT2A 
encodes for SERCA3a-f, that have been found co-expressed with SERCA2b in many 
cell types including endothelial cells of the intestine, salivary glands and cerebellar 
purkinje neurons (see review (Chemaly et al., 2017)).  
 
The SERCAs are referred to as Ca2+ pumps due to the fact that they bring the cytosolic 
free Ca2+ into the lumen of S/ER and other Ca2+ stores, maintaining Ca2+ homeostasis 
in the cytoplasm. To “pump” the Ca2+ to the S/ER store, the SERCAs undergo a 
catalytic cycle as Figure 1.2 demonstrates. The cycle is the transformation between 
two conformational states, namely the E1 and E2. The major difference between the 
E1 and E2 conformation is that E1 shows two Ca2+ binding sites with high affinity for 
Ca2+, when they are facing the cytoplasm; whereas in E2 the Ca2+ binding sites exhibit 
a low affinity for Ca2+ when they are facing the lumen of the S/ER. Upon binding to 
Ca2+, the SERCA is in the 2Ca2+-E1-ATP form, which is then phosphorylated to yield 
2Ca2+-E1-P. In this high-energy phospho-intermediate, the two bound Ca2+ ions are 
occluded. Next, it is converted to the low-energy form 2Ca2+-E2-P, during which the 
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Ca2+ binding sites are oriented towards the S/ER lumen and the affinity for Ca2+ is 
decreased. Finally, the Ca2+ is released to the S/ER lumen, and the SERCA in E2 
state is transformed back to the E1 state (Wuytack et al., 2002). The sequestration of 
Ca2+ is achieved by SERCAs, but the refilling of the SR is a far more complicated 
process that involves multiple proteins and intracellular structures, and the subject will 
be discussed in detail in relation to the PM-SR nanojunction in section 1.6.3.1. 
 
Figure 1.3 Scheme of the E1/E2 model of the SERCA catalytic cycle. 
Basic steps of the SERCA catalysis cycle is shown, with E1 and E2 representing the 
2 conformational states of SERCAs. Figure adapted from “Molecular physiology of 





The SERCA isoforms share structural similarities. However, they display functional 
variations by exhibiting diverse affinities for Ca2+ and speeds of action.  One early 
experiment reported that SERCA2b has a higher affinity for Ca2+ (K0.5 0.17±0.01μM) 
compared to SERCA2a (K0.5 0.31±0.02μM) (Verboomen et al., 1992). SERCA1 
exhibits a similar affinity for Ca2+ to SERCA2a, whereas SERCA3 displays 3 to 4-fold 
lower affinity for Ca2+. Moreover, SERCA2b and SERCA3 display lower turnover rates 
and lower Vmax compared to SERCA2a and SERCA1 (Verboomen et al., 1994, 
Lytton et al., 1992).  
 
The inhibition of SERCA can be achieved by endogenous proteins or small molecules. 
For example, phospholamban (PLN) and sarcolipin (SLN) are two SR membrane 
proteins that could effectively inhibit SERCA activity. PLN is a 6080 Da 
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transmembrane protein that is found in the S/ER of muscle cells, it serves as a 
reversible inhibitor of SERCA by decreasing SERCA’s affinity for Ca2+ while having 
no effect on its Vmax (Simmerman and Jones, 1998). The inhibition can be reversed 
by phosphorylating the PLN at Ser16 by PKA and/or Thr17 by CaMKll (Wuytack et al., 
2002, Sharma et al., 2001). Similarly, SLN is a 3733 Da transmembrane protein that 
can be found in the S/ER. It was reported to increase the Km for Ca2+ thus to decrease 
the affinity of SERCAs (Odermatt et al., 1998). Similar to PLN, the inhibitory effect of 
SLN on SERCAs can be reversed by phosphorylation at Ser4 and Thr5 by serine 
threonine kinase (Gramolini et al., 2004). Moreover, SERCAs can be inhibited by 
either thapsigargin or cyclopiazonic acid (Lytton et al., 1991, Martinez-Azorin, 2004), 
blocking SERCAs with thapsigargin was shown to deplete the S/ER Ca2+ store (Du et 
al., 1994). 
 
In terms of post-translational modifications, the activity of SERCA2a can be 
modulated by sumoylation. In the cardiomyocytes of heart failure patients, restoring 
sumoylation increased SERCA2a activity and prolonged the lifetime of the cell (Kho 
et al., 2011). Moreover, glutathionylation of SERCA at cysteine 674 residue activates 
SERCA and was shown to increase Ca2+ uptake (Adachi et al., 2004). 
 
The activation of SERCAs can be achieved by the interaction with small molecules or 
transmembrane micropeptides.  For example, CDN1163 was shown to be an 
allosteric activator of SERCA2, increasing SERCA2b activity in liver cells (Kang et al., 
2016). 6-gingerol was also shown to be a novel cardiotonic agent that activates 
SERCAs in skeletal and cardiac SR (Kobayashi et al., 1987). On the other hand, 
DWORF, a transmembrane micropeptide, was shown to increase SR Ca2+ load by 
enhancing the activity of SERCA2a. It effectively competes with SERCA inhibitors (i.e. 
phospholamban) for binding to SERCA2a (Nelson et al., 2016).  
 
1.3.2 Ca2+ release by the sarcoplasmic / endoplasmic reticulum  
Two families of Ca2+ releasing channels are targeted to the S/ER, they are the 
ryanodine receptors (RyRs) and Inositol 1,4,5-trisphosphate receptors (IP3Rs) (Curtis 
et al., 2004, Jaggar et al., 1998, Smith and Parker, 2009, Dickinson et al., 2012, 
Mekahli et al., 2011). 
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1.3.2.1 Ca2+ release from the RyRs 
In mammalian cells, 3 isoforms of RyRs have been identified. RyR1 was first isolated 
from skeletal muscles (Takeshima et al., 1989) whereas RyR2 was widely expressed 
in cardiac muscles (Otsu et al., 1990), RyR3 was found originally in the brain 
(Hakamata et al., 1992). Each of the three isoforms of RyRs can be selectively 
expressed in certain cell types, as described above. However, they can also co-exist 
in a single cell type. For example, RyR1, RyR2 and RyR3 were found in the SR of 
pulmonary arterial smooth muscle cells (Clark et al., 2010a, Yang et al., 2005).  
 
The RyRs are the largest ion channels discovered to date (Lanner et al., 2010). The 
structure of the receptor has been extensively studied. All three subtypes are similar, 
sharing ~65% sequence homology. RyRs form homotetramers in the shape of a 
square prism. They are composed of cytoplasmic domains and transmembrane 
domains. The carboxy terminus of the protein forms the transmembrane domain, 
where the ion-conducting pore is formed. The cytoplasmic domains are also referred 
to as the “foot”, which is an area full of cavities and microstructures that constitutes 
the binding sites for small molecules and modulator proteins. The cytoplasmic 
domains are subdivided into 15 subdomains including the clamps, handle, central rim 
and column. Notably, the clamps undergo major conformational changes during the 
opening and closing of the channel, and they are possibly the sites for modulation by 
regulatory molecules (Lanner et al., 2010). 
 
 
Figure 1.4 Structure of RyR1 
(A) Structure of RyR1 in relation to the SR membrane indicated by black lines.  
(B) As for (A), but showing the schematic model. Figure adapted from “Structure of a 




As the name indicates RyRs can be activated by ryanodine, but only at the nanomolar 
range. When exposing to ryanodine at 10-100 micromolar or more, RyRs are inhibited 
(Meissner, 1986). Ca2+ opens RyRs, which allows further Ca2+ release from the SR. 
This signal amplification process is called Ca2+ induced Ca2+ release (CICR). However, 
Ca2+ can also trigger the closing of RyRs. This dual-role of Ca2+ is supported by 
different binding sites on RyRs, each exhibiting different affinities for Ca2+. The 
resultant relationship between RyR open probability (P0) and Ca2+ concentration is 
bell-shaped (Meissner et al., 1986). Moreover, it should be noted that although all the 
RyR subtypes have similar thresholds for activation by Ca2+ when cytoplasmic Ca2+ 
concentration is higher than 100 nM, each RyR subtypes display different half 
maximal activation by Ca2+ (EC50) and threshold for inactivation by Ca2+ (Chen et al., 
1997, Li and Chen, 2001).  
 
RyRs can also be modulated by multiple intracellular proteins. Calmodulin is a protein 
containing 4 EF-hand Ca2+ motifs, it was reported that a single calmodulin bind to a 
single RyR monomer in a Ca2+ independent manner (Balshaw et al., 2001). However, 
other studies showed that it binds to RyRs in the absence or presence of Ca2+ for the 
regulation of Ca2+ release from the SR (Song et al., 2011). Calmodulin decreases the 
open probability of RyR2 in the presence of Ca2+ in the micromolar range (Balshaw et 
al., 2001). Moreover, calmodulin was reported to increase the duration of closing time 
and decrease the frequency of opening of RyRs, leading to the cessation of Ca2+ 
release (Xu and Meissner, 2004). Intriguingly, when calmodulin binds to RyR1, it 
appears to inhibit RyR1 activity in the presence of micromolar Ca2+ concentrations, 
while activating RyR1 at nanomolar Ca2+ concentrations (Balshaw et al., 2001, Buratti 
et al., 1995). This biphasic regulation of RyR activity by calmodulin suggests that the 
paradox might be more complicated than people manage to understand. 
 
RyRs are also subject to phosphorylation and dephosphorylation by kinases and 
phosphatases. It was reported that the PPA, PP2A and PKA bind to RyR2 through 
their adaptor proteins spinophilin, PR130 and Makap. The PKA/Makap, 
PPA/spinophilin and PP2A/PR130 complexes target the RyRs via the LZ motifs 
between the adaptor proteins and the RyRs (Marx et al., 2001). Moreover, 3 
phosphorylation sites on the RyRs have been identified. Ser2080 in RyR2 and 
Ser2843 in RyR1 can be phosphorylated by PKA and CaMKII; Ser2814 in RyR2 can 
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be phosphorylated by CaMKII; and Ser2030 of RyR2 can be phosphorylated by PKA 
as reviewed by Song et al (Song et al., 2011). The phosphorylation state of RyRs is 
determined by the interplay between the phosphatases and the kinases, the impact 
of the phosphorylation is controversial and thus will require further investigation before 
any conclusion can be made. 
 
In relation to my thesis, it is important to note that the activity of RyRs can also be 
regulated by exogenous application of calcins (Xiao et al., 2016), the membrane 
traversing proteins derived from scorpion venom, and can be blocked by tetracaine 
(Laver and van Helden, 2011, Xu et al., 1993). Maurocalcine is a RyR1 agonist, it 
selectively activates RyR1, locking it in a long-lasting subconductance which results 
in sustained Ca2+ release from the S/ER (Chen et al., 2003). The selectivity of 
maurocalcine is supported by the fact that while it is able to bind to RyR2 but the 
binding fails to open the channel (Altafaj et al., 2007). In contrast, tetracaine is a non-
selective antagonist of RyRs, it was shown to block all three types of RyRs (Laver and 
van Helden, 2011). 
 
1.3.2.2 Ca2+release from the IP3Rs 
IP3Rs also mediate Ca2+ release from the S/ER. In the case of IP3Rs, the most 
common understanding is that the IP3 binds to and gates IP3Rs on the S/ER, resulting 
in Ca2+ release from the S/ER into the cytoplasm (Berridge et al., 2000).  Three IP3R 
subtypes have been identified in mammalian cells (Blondel et al., 1993), namely IP3R1, 
2 and 3. The expression of IP3Rs subtypes exhibits tissue specificity. IP3R1 is the 
predominantly expressed subtype in arterial smooth muscle, with little co-expression 
of IP3R2 and IP3R3 (Grayson et al., 2004).  By contrast, rat portal vein myocytes 
mainly express IP3R1 and IP3R2, while urethral myocytes express IP3R1 and IP3R3 
(Wojcikiewicz, 1995, Morel et al., 2003, Wray and Burdyga, 2010). 
 
Similar to the RyR subtypes, the 3 IP3R subtypes also display different characteristics 
in relation to their function.  It was reported that each subtype exhibits different 
sensitivities to IP3: IP3R1 has an EC50 of 4.7M; IP3R2 has an EC50 of 0.35 M 
whereas IP3R3 has an EC50 of 18.6 M (Miyakawa et al., 1999).  However, the activity 
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of the receptor is modulated not only by IP3 but also by the cytoplasmic concentration 
of Ca2+. Ca2+ concentrations below 300 nM activates IP3R1 whereas increases on 
Ca2+ concentration above 300 nM inhibit this receptor. However, similar 
concentration-dependent regulation is not reported with the other two subtypes (Patel 
et al., 1999). The direct binding of Ca2+ to the receptors may trigger CICR from the 
S/ER. The diverse affinities and sensitivities for ligands displayed by the different 
subtypes of IP3Rs and RyRs suggest that those S/ER membrane bound Ca2+ 
receptors may target to distinct subcellular compartments that give rise to different 
Ca2+ signals within the local microenvironments, and the features of the subtypes are 
optimal for regulating the Ca2+ homeostasis within those microenvironments. 
 
1.3.3  Ca2+ buffering proteins of the sarcoplasmic / endoplasmic reticulum 
The S/ER contains Ca2+ buffering proteins that ensure the free Ca2+ concentration 
within the lumen is maintained near or below 1 mM (MacLennan et al., 2002). The 
Ca2+ buffering proteins exhibit high capacity and low affinity for Ca2+, allowing the 
S/ER to effectively store Ca2+ (Volpe et al., 1994).  Calsequestrin (CSQ) and 
calreticulin are the two extensively studied Ca2+ buffering proteins found in the S/ER. 
 
CSQ has been shown to present in multiple cell types, and two isoforms of the protein 
have been identified, namely the fast-twitch skeletal form and the cardiac form (Volpe 
et al., 1994, Beard et al., 2004). The skeletal muscle form of CSQ has a low affinity 
for Ca2+ (Kd 0.8 mM) and binds 40-50 Ca2+ ions per CSQ molecule. The cardiac form 
of CSQ binds around 20 Ca2+ ions with a binding constant of 0.5 mM (Volpe et al., 
1994, MacLennan et al., 2002).  It was reported that both forms of CSQ are present 
in the smooth muscle cells (Volpe et al., 1994). In terms of the mode of action, CSQs 
display a high negative charge and are thought to bind Ca2+ via pairs of acidic residues 
(Wang et al., 1998).  Moreover, CSQ was reported to associate with other S/ER 
proteins including triadin and junction, which results in a physical association with 
RyRs; (Guo and Campbell, 1995). CSQ is also found in the vicinity of IP3Rs. Together 
these proteins form S/ER complexes that facilitate the Ca2+ handling within the S/ER 
and effective Ca2+ release via the RyRs and IP3Rs. 
 
Calreticulin is another Ca2+ buffering protein that is identified in the ER/SR of many 
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cell types (Michalak et al., 1992).  It is also expressed in other organelles and may 
thus affect cell adhesion, antithrombotic activity, long-term memory and development 
as reviewed (Johnson et al., 2001). However, here I only focus on its function of 
buffering Ca2+ in the S/ER lumen. Calreticulin has a low affinity (Kd 2 mM) Ca2+ binding 
domain with high capacity for Ca2+ binding (18 mol of Ca2+/mol of protein) in the C-
terminal domain, where the high Ca2+ binding capacity is determined by a region rich 
in acidic amino acid residues (Michalak et al., 1999, Baksh and Michalak, 1991).   
Moreover, calreticulin may bind to the luminal tail of SERCAb and decrease its activity 
when the SR Ca2+ concentration is high (Michalak et al., 1999). Like CSQ, calreticulin 
buffers Ca2+ in the S/ER lumen, allowing the rapid release of Ca2+ upon activation of 
Ca2+ release channels within the ER/SR, via, for example, IP3Rs and RyRs. 
 
1.4  Acidic lysosomal Ca2+ stores  
Considering that Ca2+ is such a versatile signalling ion, it is not surprising that more 
than one organelle serves as the intracellular Ca2+ store. Among these, the 
endosomes and lysosomes represent a releasable acidic Ca2+ store, identifiable by 
their high luminal H+ concentration.  
 
Studies on the role of lysosomes as an intracellular Ca2+ store were inspired by the 
finding that nicotinic acid adenine dinucleotide phosphate (NAADP) evoked Ca2+ 
release from acidic organelles  that are called reserve granules in sea urchin eggs 
(Churchill et al., 2002).  Boittin et al demonstrated in mammalian cells that NAADP 
mobilised Ca2+ from an intracellular Ca2+ store other than the SR (Boittin et al., 2002), 
which has been shown to be an acidic, lysosome-related store (Kinnear et al., 2004). 
 
Subsequently, NAADP-sensitive channels were identified on liver lysosomes (Zhang 
and Li, 2007), cementing the view that lysosomes may serve as the Ca2+ store that 
supports NAADP-induced Ca2+ release. Indeed, it was observed that lysosomes 
contain a high luminal Ca2+ concentration, which is around 0.4 to 0.6 mM (Christensen 
et al., 2002, Yagodin et al., 1999, Lloyd-Evans et al., 2008). More direct evidence 
came from studies that utilised glycyl-phenylamine 2-naphthylamide (GPN).  GPN is 
membrane permable, therefore it can diffuse into the lysosomes, where it is cleaved 
by cathepsin C, an exopeptidase found exclusively within lysosomes, into its 
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constituent amino acids upon entering the lysosomes.  The resulting amino acids are 
unable to pass through the lysosomal membrane and therefore they are accumulated 
within the lysosomal lumen, causing high osmotic pressure and eventually lyse the 
lysosomes. (Berg et al., 1994, Jadot et al., 1984).  Addition of GPN, which causes the 
rupture of lysosomes and the release of the lysosomal content, resulted in an increase 
in the intracellular Ca2+ concentration in both mammalian and non-mammalian cells 
(Yagodin et al., 1999, Churchill et al., 2002, Haller et al., 1996, Srinivas et al., 2002).  
Moreover, NAADP induced Ca2+ release was inhibited by the addition of GPN in 
myometrial cells (Soares et al., 2007). Given the above, it was concluded that the 
lysosomes can serve as a releasable Ca2+ store.  
 
1.4.1 Sequestration of Ca2+ by lysosomes 
The process by which lysosomes sequester Ca2+ remains unclear. However, it is 
generally accepted that lysosomes take up Ca2+ from the cytosol in a pH dependent 
manner, given that the intracellular Ca2+ concentration of the lysosome decreased 
upon the increase of luminal pH (Christensen et al., 2002).  Experiment in mouse 
macrophages showed that 3 compounds (FCCP, nigecerin and NH3) that can disrupt 
the lysosomal proton gradient inhibited Ca2+ uptake into lysosome-related organelles 
(Churchill et al., 2002). Moreover, the vacuolar proton pump (V-H+-ATPase) inhibitor 
bafilomycin A1 inhibited Ca2+ uptake into lysosomes (Christensen et al., 2002).  This 
led to the proposal that lysosomal Ca2+ stores contain a V-H+-ATPase that can 
generate a proton gradient, which perhaps favours the H+/Ca2+ exchanger in the mode 
that accumulates Ca2+ (Churchill et al., 2002, Christensen et al., 2002). Two Ca2+ 
transporters that pump Ca2+ into the vacuole (lysosome equivalent in plants) have 
been identified in plants, one is a homolog of the mammalian plasma membrane Ca2+-
ATPases that consumes ATP, the other is a Ca2+/H+ exchanger that removes H+ in 
exchange of Ca2+ (Hirschi et al., 1996, Geisler et al., 2000). However, no such 
homologs have been found in mammalian cells. 
 
1.4.2 Ca2+ release channels in lysosomes 
1.4.2.1 TRPMLs 
TRPML1 (Transient Receptor Potencial Mucolipin channel 1) belongs to the mucolipin 
family of proteins which consists of the cation channels TRPML1,2 and 3. TRPML1 is 
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majorly targeted to the lysosomes whereas TRPML2 is mostly found in the 
endosomes. TRPML3 can be found both in lysosomes and on the plasma membrane 
(see review (Xiong and Zhu, 2016)). The lysosome dominant subtype is TRPML1, 
which can be activated by PI(3,5)P2 and mediates Ca2+release from the lysosomes. 
TRPML1 is proven to play a part in endocytic vesicle trafficking, lysosome exocytosis 
and vesicle fusion. 
 
1.4.2.2 Two pore channels 
In 2009, it was shown that NAADP evoked Ca2+ release form endo/lysosomes, which 
was supported by two pore channels (TPCs)(Calcraft et al., 2009). TPCs are voltage-
gated ion channels that are localised to acidic organelles including vacuoles in plants 
and endolysosomes in mammals. In mammalian cells, 3 subtypes of TPCs have been 
identified. TPC1 and TPC2 are expressed in all animals whereas TPC3 is expressed 
in vertebrates apart from human and rodents (see review (Xiong and Zhu, 2016). In 
terms of subcellular localisation, TPC2 is targeted to lysosomes whereas TPC1 is 
found within the endolysosomal system, ER and plasma membrane.  
 
1.5 Ca2+ handling by mitochondria 
Mitochondria are not generally considered as a releasable Ca2+ store, but they have 
been proposed to act as spatial Ca2+ buffer that sequesters Ca2+ (Duchen, 2000). 
The mitochondrial Ca2+ uptake is essential to the mitochondrial functions, including 
mitochondrial metabolism, coopering oxidative stress and regulation of cell death. 
The mitochondria have been shown to accumulate Ca2+ via uniporters or the Na+-
Ca2+ exchanger as reviewed (Duchen, 2000). The Ca2+ uniporters facilitate 
mitochondrial Ca2+ uptake from the cytoplasm. Upon mitochondrial respiration, large 
potential gradients are established across the mitochondrial outer membrane which 
results in a mitochondrial membrane potential of 150-200 mV (negative to the 
cytosol).  Together with the low mitochondrial Ca2+ concentration, this promotes 
mitochondrial Ca2+ uptake. The voltage-dependent anion channels (VDACs) on the 
outer mitochondrial membrane allow Ca2+ diffusion across the outer membrane 
(Rapizzi et al., 2002, Rizzuto et al., 1993), following which Ca2+ is transported into 
the mitochondrial matrix by Ca2+ uniporters (Michels et al., 2009). Once the 
mitochondria are loaded with Ca2+, the unloading process would be activated by 
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favouring Ca2+ extrusion via 3Na+/Ca2+-exchanger, which may in part facilitate SR 
re-loading (Malli et al., 2003). It was also proposed that mitochondrial Ca2+ uptake 
can be achieved by the mitochondrial Na+-Ca2+ exchanger in the mode that favours 
Ca2+ entry. It was reported that mitochondria in rat cardiomyocytes may become Ca2+ 
loaded by the reversal of the Na+-Ca2+ exchanger during hypoxia (Griffiths et al., 
1998).  
 
1.6 Nucleoplasmic reticulum can serve as a Ca2+ store 
The primary role of the nuclear envelope (NE) is to isolate the nucleoplasm from the 
cytoplasm. However, the nucleoplasmic reticulum (NR) is continuous with the S/ER, 
and estimation of the Ca2+ concentration within its lumen using a low affinity 
fluorescent probe indicated that the NE holds Ca2+ at 250-350 μM (Petersen et al., 
1998). Therefore, it is now generally accepted that the NR can serve as a releasable 
Ca2+ pool (Papp et al., 2003). Several studies have confirmed that the NR can serve 
as a perinuclear Ca2+ store that supports the  generation of highly localised Ca2+ 
signals in order to modulate gene expression (see review (Bootman et al., 2009)).  
 
On the membrane of NE, Ca2+ releasing channels including IP3Rs and RyRs have 
been identified, which may direct Ca2+ release from NR into the nucleoplasm. For 
example, IP3 has been shown to induce intranuclear Ca2+ elevations in isolated acinar 
pancreatic nuclei (Gerasimenko et al., 2003). Moreover, RyRs have been visualized 
on the NE of pancreatic cells with BODIPY-Ry (Gerasimenko et al., 2003), and on the 
NE and NR of myoblastic cells by immunolabelling (Marius et al., 2006). Both RyRs 
and IP3Rs have the capacity to generate nuclear Ca2+ signals, and they were 
proposed to cooperate for the maintenance of nuclear Ca2+ homeostasis.   
 
To summarize, multiple intracellular Ca2+ stores are identified including the S/ER, 
endo-lysosomes, mitochondria and nucleus. They harbour Ca2+ releasing channels 
and transporters for intracellular Ca2+ handling. Most importantly, as Figure 1.3 shows, 
these Ca2+stores are actively interacting, with evidence from a variety of studies 
showing that Ca2+ can be transferred between the SR and all the other Ca2+ handling 




Figure 1.5 Schematic image shows the overview of intracellular Ca2+ handling. 
Intracellular Ca2+ influx and efflux between organelles,  and Ca2+ channels and 
transpoters involved in the processes . Abbreviation used are as follow: IP3R, 
inositol1,4,5-trisphosphate (IP3) receptor; NCX, Na+/Ca2+ exchanger; RyR, 
Ryanodine Receptor; MCU, mitochondrial Ca2+ uniporter; LTCC, L-type Ca2+ channel; 
SERCA, Sarco/Endoplasmic Reticulum Ca2+ ATPase; TPC2, two-pore channel 2; 
TRPC, transient receptor potential canonical; STIM1, Stromal interaction molecule 1; 
VDAC, voltage-dependent anion channel. Figure adapted from “SERCA control of cell 
death and survival”, by Chemaly et al (Chemaly et al., 2017). 
 
1.7 From contraction and dilation to gene expression: Do nanojunctions 
of the sarcoplasmic reticulum support site- and function-specific Ca2+ 
signals necessary for the coordination of cell function?  
As stated at the beginning of this chapter, sustained increases in cytoplasmic Ca2+ 
concentration are cytotoxic to cells. Therefore, Ca2+ must be stored in the intracellular 
organelles and released in the form of transient Ca2+ signals, causing the increase in 
local Ca2+ concentration. For example, for the induction of CICR via RyRs, the 
cytoplasmic Ca2+ concentration must rise to the micromolar range (Kim et al., 1983), 
which is evidently higher than the cytoplasmic Ca2+ concentration at rest (~100 nM). 
However, cell-wide increases in Ca2+ concentration within the micromolar range would 
require a very large influx of Ca2+ that might be expected to compromise the cell. The 
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optimal solution to this is to build a narrow cytoplasmic space between the target 
membrane and releasable Ca2+ stores such as the SR. Within these cytoplasmic 
spaces, increases in Ca2+ concentration can be readily achieved by a relatively small 
Ca2+ flux, with released Ca2+ quickly recycled back into cellular Ca2+ stores or extruded 
from the cell. In this instance, Ca2+ signals would be restricted within the narrow space 
therefore the global Ca2+ concentration remains unaffected. In fact, such delicately 
designed structures have already been discovered within cells, and the dimensions 
of these functionally segregated compartments appear to be on the nanoscale. For 
example, the regulation of excitation-contraction coupling observed in all types of 
muscles is accomplished by the interactions between Ca2+ release channels in the 
sarcoplasmic reticulum (SR) and voltage-gated Ca2+ channels (VGCCs) on the 
plasma membrane or membrane invaginations including T-tubules and caveolae. The 
underpinning mechanisms require strategic positioning of cellular Ca2+ release 
channels and Ca2+ transporters to the membrane-membrane junctions that are 
separated by less than 50 nm across (van Breemen et al., 2013). These narrow 
junctional spaces are widely distributed across cells, and they have been referred to 
as nanojunctions. 
 
1.7.1  Intercellular nanojunctions: the neuromuscular junction 
The first membrane-membrane junction that was identified with a clear functional 
significance in terms of signalling was the neuromuscular junction, which is the 
synapse located between motor neurons and skeletal muscle fibers (Del Castillo and 
Katz, 1956). This intercellular junction is formed between the presynaptic motor axon 
and the plasma membrane of post-synaptic skeletal muscle fibers. It coordinates the 
control of skeletal muscle contraction by the central nervous system. The motor nerve 
terminal harbours synaptic vesicles that contain a neurotransmitter, acetylcholine, 
whereas the post synaptic membrane of skeletal muscle fibers displays deep folds 
with the crests of folds carrying acetylcholine receptors. Upon the transmission of 
impulses, nerve action potentials trigger Ca2+ influx within the motor nerve terminal, 
which leads to the fusion of synaptic vesicles with the terminal membrane at the active 
zones. As a result, acetylcholine is released into the synaptic clefts, which typically 
have junctional widths ~20 nm (Siksou et al., 2007). This is narrow enough to ensure 
rapid (within 1ms) neurotransmitter diffusion and binding to acetylcholine receptors 
on the plasma membrane of muscle fiber. Acetylcholine receptor activation elicits 
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inward currents into the muscle fiber, which results in depolarization of the endplate 
potential that is more than sufficient to breach the threshold for the generation of an 
action potential in the muscle fiber. 
 
In this event, three morphological and physiological properties of the neuromuscular 
junction contribute to its proper function. First, the width of the synaptic cleft is around 
20 nm, the narrow separation is required for fast diffusion of the neurotransmitter, 
which facilitates rapid post-junctional actions; the importance of such junctional 
complexes is relevant not only here at the NMJ but also at synapses across the 
peripheral and central nervous system. Second, the length of a neuromuscular 
junction ranges from 200 to 500 nm (Siksou et al., 2007, Schikorski and Stevens, 
1997). Considering the average diameter of a synaptic vesicle (35-50 nm), this length 
ensures efficient acetylcholine can be released into the junctional space per unit time. 
Third, acetylcholine receptors are targeted to the membrane that defines the 
neuromuscular junction, which is crucial for signal transmission (Siksou et al., 2007).  
 
Figure 1.6 Structure of the neuromuscular junction. 
The structure of the neuromuscular junction is revealed under electron microscope. 
The key components are indicated by black arrows. Figure adapted from 




1.7.2 Intracellular nanojunctions 
Although little attention has thus far been paid to intracellular nanojunctions, it is 
evident that such structures exist and share similar morphological and physiological 
properties with the neuromuscular junction. Among these, one intracellular 
nanojunction has received significant attention, which is the junction formed between 
the terminal cisternae of the sarcoplasmic reticulum (SR) and T-tubes of the 
sarcolemma in skeletal and cardiac muscle cells (Figure 1.4). This junctional complex 
exhibits clear similarities when compared to the NMJ, which is perhaps not surprising 
given that both structures play key roles in the process of excitation-contraction 
coupling by directing transmitter/ion flux across the junctional space. In both cases 
the junctional membrane pairs are separated by less than 20 nm (Franziniarmstrong, 
1964, Franzini-Armstrong, 1970, Langer and Peskoff, 1996, Franzini-Armstrong et al., 
1999). However, the mechanisms through which excitation-contraction coupling is 
elaborated within triads and diads of skeletal and cardiac muscle is slightly different, 
and tailored to the requirements of each cell.  
 
The triads in skeletal muscles are formed by positioning a T-tubule between two 
terminal cisternae of the SR, the membranes of terminal cisternae and the 
membranes of the opposing T-tubules are so closely aligned that they enclose 
junctional gaps that are separated by 9-20 nm (Franziniarmstrong, 1964, Franzini-
Armstrong, 1970). Ryanodine receptor type 1 (RyR1) is targeted to the membrane of 
the SR, and the cytoplasmic domain of the RyRs are referred as the junctional feet 
that span the junctional space. On the membrane of the T-tubules, clusters of 
dihydropyridine receptors (DHPRs), namely the tetrads, were observed, and the 
position of tetrads mirrors that of the junctional feet. Upon excitation-contraction 
coupling, an action potential passes along the surface of T-tubules that form an 
extensive network, and the resulting depolarization is detected by the DHPRs. The 
DHPRs serve as voltage sensors. The voltage-dependent movements of electrical 
charge in the skeletal DHPRs are coupled to the opening of RyR1 on the opposing 
membrane of SR. The DHPRs directly interact with RyR1 to achieve an efficient fast 
control over Ca2+ release which subsequently causes vigorous muscle contraction, 
and is ceased when the Ca2+ release is stopped. This termination of signal occurs 




Figure 1.7 Electron micrographs and schematic model showing triads and 
diads. 
(A) Triads formed betweenone T-tubule and two SR cisternae in adult toadfish 
swimbladder muscle.  
(B) Dyadse formed between one SR vesicle and  the surface membrane or a T-tubule 
in a BC3H1 cell. 
(C) As for B, but showing dyad in canine heart 
Figure adapted from“Structural interaction between RYRs and DHPRs in Ca2+ 






Diads are junctions defined by the membrane of terminal cisternae of the 
sarcoplasmic reticulum (SR) and the membrane T-tubules of the sarcolemma in 
cardiac muscles (Langer and Peskoff, 1996). Again, these junctions are separated by 
around 5-15 nm with clusters of  RyR2 targeted to the SR membrane juxtaposed to 
the T-tubule membrane that is lined by DHPRs (Langer and Peskoff, 1996, Franzini-
Armstrong et al., 1999). However, in cardiac muscle cells, both the dominant subtype 
of RyRs and DHPRs are different from the subtypes found in skeletal muscle cells. 
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Notably, the distribution of DHPR clusters is irregular and it does not match the 
disposition of the junctional feet. When action potentials pass through the surface 
membrane of cardiac T-tubules, it activates the DHPRs that allow influx of 
extracellular Ca2+ into the cytoplasm. The Ca2+ binds and opens RyR2 on the SR 
membrane, resulting in further Ca2+ release from the SR by CICR via RyR2. 
Importantly, this Ca2+ efflux then triggers Ca2+ release from other adjacent clusters of 
RyR2. Rapid and accurate control of contraction in cardiac muscle is possible 
because fast control of RyRs on the adjacent SR can be achieved due to the short 
distances of communication conferred by the nanojunctions. 
 
At this stage it is important to highlight that in each case the nanojunction between 
the sarcolemma and the T-tubule is less than 20 nm across, with receptors and Ca2+ 
release channels targeted to the junctional membranes in order to coordinate 
signalling across each junctional space. Furthermore, it is evident that in triads and 
diads similar physiological outcomes are achieved by different subtypes of a given 
protein, through their very distinct coupling mechanisms that were underpinned by the 
differential positioning of the receptors and channels. 
 
1.7.3 The PM-SR nanojunction of smooth muscles  
The PM-SR junction of smooth muscle was first identified in the early 1970s and was 
described as a narrow cytoplasmic space located between the PM and superficial SR 
(Gabella, 1971, Devine et al., 1972). It was found majorly in the vicinity of caveolae, 
from which it was inferred that the PM-SR junction might be associated with smooth 
muscle activation. A few years later it was proposed that the PM-SR junction could 
restrict ion diffusion, and thus allow the superficial SR to modulate Ca2+ flux from the 
plasma membrane to the myofilaments, hence regulating smooth muscle contractility 
(Van Breemen, 1977). Interestingly, further studies revealed a more complicated 
model through which smooth muscle contraction was manipulated. It was shown that 
a depolarization-activated net Ca2+ uptake would trigger fast large force development 
when the Ca2+ entered rapidly. In contrast, if the same Ca2+ uptake entered slowly but 
with longer durations of flux, a small and slow contraction would be stimulated instead 
(van Breemen and Saida, 1989). From these facts, the authors postulated that a Ca2+ 
pump of the SR (SERCAs) must determine outcomes. Importantly, the SERCA pump 
37 
 
near the plasma membrane was found to have a limited Vmax, and it was saturated 
when fast Ca2+ flux was delivered through the voltage-gated Ca2+ channels (VGCC) 
to the cytoplasm. However, when encountering a slow and sustained Ca2+ flux, the 
SERCA of the superficial SR could remove the cytoplasmic Ca2+ efficiently and pump 
it into the SR. These studies led to the “superficial buffer barrier” hypothesis, which 
states that the narrow cytoplasmic spaces formed between the PM and SR could 
effectively restrict Ca2+ diffusion, which facilitates SR Ca2+ intake from the junctional 
space, and this would serve as the buffer barrier to attenuate Ca2+ flux from the PM 
to the deep myoplasm (van Breemen et al., 1995, Van Breemen, 1977). The theory 
has since been confirmed by several research groups (Rembold and Chen, 1998, 
Shmigol et al., 1999, Yoshikawa et al., 1996). 
 
When considered alongside the NMJ, triads and diads, the PM-SR junctions highlight 
one question that has yet to be answered. Why is the junctional gap always 
maintained at 20 nm or less？ To answer this question, computational models have 
been developed to simulate Ca2+ flux across the PM-SR junction in smooth muscle 
cells. The results suggest that the junctional membrane pairs cannot be separated by 
more than 50 nm without compromising the integrity of the junction. Junctional 
integrity is therefore required for the compartmentalized Ca2+ signalling within the 
junctional space, and these signals will be progressively lost to random diffusion once 







Figure 1.8. PM-SR junction formed between the superficial SR and plasma 
membrane. 
The PM-SR junction formed between the superficial SR (white arrowheads) and the 
PM (black arrowheadsin smooth muscle cells. Scale bar=400 nm. Figure adapted 
from “Organellar junctions promote targeted Ca2+ signalling in smooth muscle: why 






Apart from muscle contraction, it was also proposed that the superficial SR was 
involved in a variety of physiological processes, for example, vasodilation triggered 
by vasodilators. In arterial smooth muscles, cADPR activates RyRs located on the 
superficial SR that are in close contact with the plasma membrane. Here evoked Ca2+ 
release causes membrane hyperpolarization which eventually leads to vasodilation 
(Boittin et al., 2003). Moreover, it is evident that the superficial SR may be able to 
behave bidirectionally: when extracellular Ca2+ is removed, Ca2+ release from the 
superficial SR to the cytoplasm is triggered (Nazer and van Breemen, 1998); when 
the store is depleted, Ca2+ influx across the PM-SR junction may be triggered in order 
to refill the SR (Spinelli and Trebak, 2016). 
 
1.7.3.1 Refilling of the SR 
The SR store in smooth muscles is replenished through receptor-operated channels 
acting in association with the Na+/Ca2+ exchanger in its reverse mode (Lemos et al., 
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2007, Poburko et al., 2007), or store depletion activated Ca2+ entry via the stromal 
interaction molecule (STIM)/Orai system (Soboloff et al., 2012). Moreover, Ca2+ influx 
via L-type voltage dependent channels in part fills the store (Flores-Soto, Reyes-
Garcia, Sommer, & Montano, 2013). Interestingly, PM-SR nanojunctions are involved 
in all the pathways above and may be either formed or enhanced at the PM-SR 
interface, thus restricting the distances of Ca2+ diffusion for SERCA Ca2+ intake and 
store refilling. 
 
SR store refilling by Ca2+ influx via L-type voltage dependent channels requires Ca2+ 
influx into PM-SR junctions, which is pumped into the superficial SR by SERCAs. It 
was proposed that the Ca2+ near sarcolemma acts as a messenger to convey 
information on functional SR content by regulating Ca2+ –activated potassium 
channels (BKCa channels). Depletion of SR store results in reduced activity of BKCa 
channels, which causes membrane deperpolarization and thus Ca2+ entry via L-type 
Ca2+ channels from the extracellular space (Flores-Soto et al., 2013, Wu et al., 2002). 
Consistent with the “superficial buffer barrier” theory, it was proposed that the Ca2+ 
flux from the L-type Ca2+ channel was restricted in the PM-SR junction, which was 
pumped into the superficial SR by SERCAs for store refilling. In this way, the store 
refilling is independent of changes in bulk sarcoplasmic Ca2+ level. 
 
The initiation of SR loading via receptor-operated Ca2+ entry pathways requires the 
activation of those non-selective cation-permeable receptor-operated receptors on 
the cell membrane. For example, the transient receptor potential canonical channel 6 
(TRPC6). It has been shown that localised, transient elevations in sodium 
concentration were dependent on TRPC6 (Poburko et al., 2007). The elevated local 
sodium concentration and the resulting membrane depolarization favour the reversal 
mode of Na+/ Ca2+ exchanger that facilitates Ca2+ entry into the “local cytoplasm”, or 
to be specific, the cytoplasmic nanodomain demarcated by PM-SR junctions. Early 
studies stated that elevation of the sodium concentration within the junctional space 
was sufficient to generate sodium concentrations required to mediate reversal of NCX 
and thus NCX-mediated Ca2+ entry (Dai et al., 2005). Moreover, it is evident that the 
junctional clustering of Ca2+ and Na+ transporters would support the NCX-mediated 
Ca2+ entry (Poburko et al., 2007). On the basis of these facts it was proposed that the 
geometry of PM-SR junctions facilitates the elevation of local Na+ concentration via 
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TRPC6, which then enhances Ca2+ entry through the NCX in its reverse mode (Lemos 
et al., 2007). Again, as the superficial buffer barrier theory stated, the junctional Ca2+ 
would be pumped into the superficial SR by SERCAs, hence the SR store is 
replenished (Poburko et al., 2008).  
 
PM-SR nanojunctions can also be formed upon STIM/Orai complex formation, which 
ensures that the extracellular Ca2+ can be fed directly into the SR through the trams-
membrane complex (Soboloff et al., 2012, Trebak, 2012). The depletion of the stores 
is able to activate dimerization of stromal interaction molecules (STIMs), which act as 
SR Ca2+ sensors (Liou et al., 2005). STIM1, for example, is a transmembrane protein 
that contains an N-terminal EF-hand motif with low Ca2+ affinity, and it serves to sense 
luminal Ca2+ changes within the SR/ER. STIM1 loses associated Ca2+ upon the 
depletion of the Ca2+ store, which leads to the interactions between the EF-hand-SAM 
domains within STIM1, and this causes the formation of an extended configuration 
that exposes the STIM-Orai activating region (SOAR).  The STIM dimmers further 
oligomerize and migrate to the PM-SR/ER junctions, where STIMs were anchored to 
the plasma membrane to fully expose the SOAR. It was observed that the SOAR 
interacts with the C- and N- termini of Orai, which is a store-operated Ca2+ channel 
(SOC) (Park et al., 2009). Orais are tethered together by STIMs to form tetramers that 
mediate Ca2+ release-activated Ca2+ current (CRAC), which allows Ca2+ entry to the 
SR store. Furthermore, STIM1 might recruit POST (partner of STIM1), an adaptor 
protein that could further recruit SERCAs to the junctional space to assist ER/SR Ca2+ 
loading (Krapivinsky et al., 2011). Following SR store depletion, POST binds and 
moves STIM1 to shorten PM-SR/ER junctional distances. Moreover, the POST 
mediated organization of SERCA pumps within the STIM/Orai junction, effectively 




Figure 1.9  PM-SR junction in SR refill. 
The SR can be refilled by different mechanisms facilated by the PM-SR junction, for 
example, the receptor-operated refill (B), the store-operated refill (C) and through the 
Na+/Ca2+ exchanger in the reverse mode. Figure adapted from “Vascular  
pharmacology: smooth muscle, Chapter one”, by Khalil et al and A. M. Evans (Khalil 
et al., 2017). 
 
It is important to note that all three mechanisms for SR refilling can be observed in a 
single type of smooth muscle cell (Tang et al., 2010, Ogawa et al., 2012, Kato et al., 
2013). It still remains unclear how these different SR refilling mechanisms contribute 
to the coordination of store refilling within smooth muscle cells, but there is no doubt 




1.7.3.2 Emptying of the SR and vasodilation 
When the smooth muscle cells are at rest, the NCX in the PM function in the forward 
mode which allows SR unloading via the PM-SR junctions, and this contributes 
partially to the maintenance of cellular Ca2+ homeostasis (Lee et al., 2002). Moreover, 
muscle relaxation may also be promoted by vasodilator-induced unloading of SR Ca2+ 
into PM-SR junctions (Boittin et al., 2003).  The intracellular Ca2+- and voltage-
activated K channels, BKCa, located on the plasma membrane, drive membrane 
hyperpolarization that underpins vasodilation (Brayden, 1990). Hyperpolarization of 
plasma membrane closes voltage-dependent Ca2+ channels, which serves as a 
feedback mechanism to decrease global Ca2+. In 1995, it was shown that activation 
of BKCa channels is coordinated by the release of highly localised Ca2+ sparks 
delivered by RyR clusters positioned on the superficial SR adjacent to BKCa channels 
in the PM (Nelson et al., 1995), confirming the original proposal of Benham and Bolton 
(Benham and Bolton, 1986). As described above, this ultimately leads to vasodilation 
and extrusion of Ca2+ released by the SR via NCX (Brayden and Nelson, 1992, Knot 
et al., 1998).  
 
Later studies indicated that in pulmonary arterial myocytes, Ca2+ sparks were possibly 
released through RyR1 by showing that only RyR1 was preferentially targeted to the 
subplasmalemmal region, which is adjacent to the plasma membrane (Clark et al., 
2010a); although in cerebral arterial myocytes it has been suggested that RyR2 might 
support this process (Nelson et al., 1995). The study by Clark et al (Clark et al., 2010a) 
also pointed out that SERCA2b was strategically targeted to the subplasmalemmal 
region of pulmonary arterial myocytes, i.e. to the superficial SR. Together, SERCA2b 
and RyR1 appear to line PM-SR junctions and may serve to coordinate superficial SR 
unloading and refilling. Accordingly, blocking peripheral SERCA with cyclopiazonic 
acid or blocking RyRs with the high concentrations of ryanodine markedly inhibited 
vasodilation in response to beta-adrenoceptor activation (Boittin et al., 2003).  
 
1.7.4 Lysosome-SR nanojunction  
Lysosome-SR (L-SR) nanojunctions, as the name indicates, are the narrow 
junctional spaces demarcated by juxtaposed membranes of lysosomes and 
perinuclear SR. Little attention had been paid to the L-SR junctions until 2004, when 
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one study proposed that the L-SR junctions form a trigger zone for Ca2+ signalling 
by NAADP (Kinnear et al., 2004). The study suggested that lysosome clusters and 
a subpopulation of RyRs, which was later confirmed to be RyR3(Kinnear et al., 2008), 
colocalised within L-SR junctional complexes. Within this trigger zone, it was 
proposed that NAADP induced Ca2+ release from acidic, lysosomal Ca2+ stores may 
trigger Ca2+-induced Ca2+ release (CICR) from the RyR3s and give rise to a global 
Ca2+ wave. In  2014, standard 2D transmission electron microscopy and tomography 
revealed for the first time the ultrastructure of the L-SR junctions (Fameli et al., 2014). 
The membrane pairs that define L-SR junctions were separated by 30 nm or less, 
and were around 300 nm in extension. The existence of L-SR junctions was also 
confirmed in cardiac ventricular myocytes (Aston et al., 2017), where the junctional 
width was also less than 30 nm, and they were 200-400 in extension.  
 
Notably, the formation of Ca2+ trigger zone by the L-SR junction heavily relies on the 
close opposition of the junctional membrane pairs. To illustrate this, a 3D stochastic 
Monte Carlo model of Ca2+ transport in L-SR junction was built based on its 
characteristics. Both Ca2+ releasing channels (TPC2, RyR2) and Ca2+ transporters 
(SERCA2a) as well as their features (thresholds, kinetics) were included (Fameli et 
al., 2014). Computational simulations with the model suggested that the narrow 
junctional space restricted free Ca2+ diffusion, which guaranteed that the junctional 
Ca2+ transient from TPC2 could easily breach the threshold for CICR via RyR3. If the 
junctional space was separated by 50 nm or more, junctional integrity was disrupted 
and the NAAPD induced Ca2+ burst from TPC2 failed to trigger CICR from RyR3. 
This explains why the global Ca2+ waves were observed in an all-or-none manner. 
This example emphasized again that the nanoscale-geometry is required for tight 







Figure 1.10 Lysosome-SR junction in smooth muscle cells 
Lysosomes (L), SR cisterns and examples of L-SR junctions in pulmonary arterial 
smooth muscle cells are indicated by arrows. Scale bars: 500 nm. Adapted from 
“Cytoplasmic nanojunctions between lysosomes and sarcoplasmic reticulum are 
required for specific Ca2+ signalling”, by N. Fameli et al (Fameli et al., 2014). 
 
 
1.7.4.1 Ca2+ release channels in L-SR junction 
Based on the proposal that L-SR junction forms a trigger zone for Ca2+ signalling, 
immunocytochemistry was conducted to identify the RyR subtype that was 
responsible for the observed CICR (Kinnear et al., 2008). A lysosome specific protein 
alphalgP120 was used to identify lysosome clusters, and it was reported that the 
lysosomes were clustered majorly within the perinuclear region, where RyR3 was 
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also primarily localised. Furthermore, colocalisation between alphalgP120 and RyRs 
significantly declined outside the perinuclear region. Taking into account that NAADP 
induced Ca2+ bursts failed to induce global Ca2+ waves when RyR3 and RyR1 were 
selectively blocked, it was concluded that L-SR junction was formed primarily in the 
perinuclear region, and it forms a trigger zone that gives rise to global Ca2+ waves by 
CICR via RyR3. 
 
Early studies conducted on pulmonary arterial smooth muscle showed that IP3 
induced Ca2+ waves were unaffected when the acidic Ca2+ stores were depleted with 
bafilomycin, or the RyRs were inhibited with ryanodine in a high concentration 
(Boittin et al., 2002, Kinnear et al., 2004). Additionally, NAADP induced global Ca2+ 
waves were not blocked by the IP3R blocker Xestospongin C. Together these facts 
indicated that IP3 induces Ca2+ waves through a pathway that is independent of 
NAADP and RyRs, and that NAADP-evoked Ca2+ waves are mediated via RyRs but 
not IP3Rs.  Conversely, in other cell types, for example oligodendrocyte progenitor 
cells (Haak et al., 2001) or smooth muscle cells isolated from portal vein (Gordienko 
and Bolton, 2002), crosstalk between RyRs and IP3Rs were observed, which 
suggest that the lysosome-SR coupling might involve IP3R in these cell types. 
 
It was proposed that NAADP-evoked Ca2+ bursts from lysosomes are likely 
supported by two-pore segmented channels (TPCs) targeted to the endolysosomes 
(Calcraft et al., 2009). This study suggested that TPCs represent a family of NAADP 
receptors. In recombinant HEK293 where human TPC2 was restricted to the 
lysosome membrane, NAADP triggered Ca2+ release from lysosome-related Ca2+ 
stores via TPC2, which is amplified by CICR via IP3Rs in this cell type. Consistent 
with this view, it was reported that although NAADP could induce Ca2+ release from 
TPC1, 2 and 3 in recombinant HEK293, only the Ca2+ bursts through lysosome 
targeted TPC2 and endosome targeted TPC3 displayed the magnitude that was 
required to couple with the ER for CICR (Ogunbayo et al., 2015). Here it can be 
concluded that within the L-SR junction, NAADP would induce Ca2+ release from the 
lysosome via membrane targeted TPC2s, which will be amplified by CICR from the 




1.7.4.2 Ca2+ transporters in L-SR junction 
When discussing Ca2+ handling, the Ca2+ transporters cannot be neglected. 
Considering the L-SR junction was localised to the perinuclear region, it can be 
inferred that SERCA2a would serve as the Ca2+ transporter to supply the perinuclear 
SR for the CICR (Clark et al., 2010a). On the lysosomal membrane, Ca+-Mg2+ 
ATPase was discovered in rat liver cells, which may supply Ca2+ to the lysosome 
(Ezaki et al., 1992). In plant vacuoles, the Ca2+/H+ exchanger was considered as the 
key to Ca2+ supplement in conjugated with the vATPase that dominate H+ influx 
(Hirschi et al., 1996).  
 
1.8  Aims and hypotheses 
The aim of the study is to investigate the intracellular Ca2+ signalling supported by 
the nanospaces in pulmonary arterial smooth muscle cells. By exploring how the 
cytoplasmic nanospaces demarcate site- and function- specific Ca2+ signalling, I wish 
to learn how they modulate multiple smooth muscle functions as an integrity. In 
particular, the function of one type of intracellular nanotube, the nuclear 
invaginations, remains controversial over decades. Hence, I envisage to study the 
function of nuclear invaginations. By investigating how Ca2+ signals were modulated 
within nuclear invaginations, I wish to investigate whether this local Ca2+ signal may 
direct gene expression. 
 
I hypothesize that the intracellular nanospaces in pulmonary arterial smooth muscle 
cells demarcate Ca2+ signalling (Figure 1.11), their capacity for Ca2+ handling is 
conferred by Ca2+ releasing channels and transporters targeted to the membranes. 
Nuclear invaginations, as an intracellular nanospace, give rise to independent local 




Figure 1.11 Skematic figure showing nanospaces in smooth muscle cells 
Nanospaces for restricted Ca2+ signalling are predicted to form between the ER/SR 















































Chapter 2: Materials and methods 
2.1 Dissection and identification of intrapulmonary arteries 
All experiments were performed under the United Kingdom Animals (Scientific 
Procedures) Act 1986. Adult male Sprague Dawley rats (≈300 g) were sacrificed by 
cervical dislocation. Heart and lungs were removed and placed on ice in physiological 
salt solution (PSS) of the following composition (mmol/L): 130 NaCl, 5.2 KCl, 1 MgCl2, 
1.7 CaCl2, 10 glucose, and 10 HEPES, pH 7.4. 
 
The dissection of intrapulmonary arteries was conducted under a dissection 
microscope (model PZM, World Precision Instruments, Sarasota FL, USA) with 
dissection forceps and spring bow scissors (Duckworth & Kent, England, UK). During 
the process, lung lobes were bathed in ice cold PPS, one individual lobe was pinned 
onto a Sylgard coated dissection dish with the cut of the trachea facing up. The airway 
was cut open along the length of it from where the trachea entered the lobe, and the 
artery was identified as the parallel semi-translucent tube that was running below the 
trachea. To expose the artery, the parenchyma and the connective tissues on both 
sides of the artery and the trachea need to be fully removed. The artery was extracted 
with care to guarantee minimal damage, and the connective tissues attached to the 
artery was carefully cleaned before the artery was cut open and immersed in ice cold 
PPS for further experimental procedures.  
 
2.2 Dissociation of pulmonary arterial smooth muscle cells 
Primary, secondary and tertiary order branches of the pulmonary arteries were 
dissected out using the method described in section 2.1, and single pulmonary arterial 
smooth muscle cells were dissociated by either of the two protocols described below. 
2.2.1 Acute isolation of pulmonary arterial smooth muscle cells 
Overnight digestion protocol for pulmonary arterial smooth muscle cell 
dissociation  
As described in Clark et al (Clark et al., 2010a), arteries were placed in low Ca2+ 
solution of the following composition (mM): 110 NaCl, 5 KCl, 2 MgCl2, 0.5 NaH2PO4, 
5 KH2PO, 15 NaHCO3, 0.16 CaCl2, 0.5 EDTA, 10 glucose, 10 taurine and 10 HEPES, 
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pH 7.4. After 10 minutes the arteries were placed in the same solution containing 0.5 
mg/ml papain and 1 mg/ml bovine serum albumin and kept at 4 oC overnight. Papain 
is a cysteine protease that cleaves peptide bonds of basic amino acids, leucine or 
glycin. It exhibits broad specificity and will digest most protein substrates, and it also 
hydrolyses esters and amides. Papain was widely used in cell isolation, notably, it 
was able to isolate rat vascular smooth muscle cells with good viability without 
compromising the sensitivity of the cells to stimuli (Bolzon and Cheung, 1989). The 
overnight treatment allowed papain to penetrate the tissue. The following day 0.2 
mmol/L 1,4-dithio-DL-threitol (DTT) was added to the solution, and the preparation 
was incubated for 1 hour at room temperature (22 oC). The proteolytic activity of 
papain requires a free sulfhydryl group, and DTT is able to maintain the sulfhydryl 
group in a reduced state, as the result papain would be activated. The tissue was then 
washed 3 times in fresh low Ca2+ solution without enzymes, and single smooth muscle 
cells were isolated by gentle trituration with a fire-polished Pasteur pipette. Cells were 
stored in suspension at 4 oC until required. 
Fast digestion protocol for pulmonary arterial smooth muscle cells dissociation  
Arteries were immersed in Ca2+ free solution of following composition (mM): 130 NaCl, 
5.2 KCl, 2.5 MgCl2, 10 glucose, 10 Hepes, pH 7.4. The dissociation solution was 
prepared by adding 1mg/ml papain, 0.8 mg/ml DTT and 0.7mg/ml bovine serum 
albumin into the Ca2+ free solution. Arteries were placed in the dissociation solution 
for 15 minutes at 37 oC, which was followed by 3 times of wash in fresh Ca2+ free 
solution. Single smooth muscle cells were isolated by gentle trituration with a fire-
polished Pasteur pipette, and cells were stored in suspension at 4 oC until required. 
Compared to the overnight digestion protocol, the fast digestion protocol allows the 
isolation to be done within an hour and the cells can be used for experiments on the 
day of artery dissection, which improved cell viability. However, the protocol does not 
provide a very long time for papain to penetrate the tissue, which compromises the 
efficiency of isolation.  




2.3 Cell culture and sample fixation 
2.3.1 Culture of pulmonary arterial smooth muscle cells. 
Freshly isolated pulmonary arterial smooth muscle cells were suspended in low Ca2+ 
solution or Ca2+ free solution depending on the isolation method used, with the density 
of 105 -2x105 cells per ml. 100 μl, 90 μl, 50 μl or 25 μl of cell suspension was added 
to each Fluorodish (WPI, USA) and cultured for 1, 2, 4 or 7 days. If culture for 
immunocytochemistry, the same amount of cell suspension was added to a 13 mm 
circular coverslip sat in a 12-well plate. The cells were allowed to attach for 45 min at 
room temperature in a cell culture hood, 2 ml of culture medium of following 
composition (44.5% Waymouth’s Medium, 44.5% Ham’s F12 Nutrient Mixture, 10% 
foetal bovine serum, 1% Penicillin-Streptomycin) was added to each Fluorodish or 
each well of the 12-well plate, and the cells were incubated at 37 o C with 5% CO2. 
Foetal bovine serum contains multiple growth factors that enhance cell growth as well 
as cell proliferation (Franke et al., 2014), whereas antibiotics were added to reduce 
the chance of infection. The culture medium was replaced every 3 days for the best 
outcomes. 
 
2.3.2 Acutely isolated cell fixation with methanol 
Freshly isolated pulmonary arterial smooth muscle cells were suspended in low Ca2+ 
solution or Ca2+ free solution depending on the isolation method with the cell density 
of 105 -2x105 cells per ml. 100 μl cell suspension was added to a 13 mm circular cover 
glass that sat in a 12-well plate, and the cells were allowed to attach for 45 minutes 
at room temperature. 2 ml of ice-cold methanol was added into each well, and the 12-
well plate was sealed with parafilm and stored at -20 o C for 10 minutes or longer. 
Alcohol fixatives act by denaturing proteins through the removal of water, it is a very 
fast fixation process, but it will result in tissue shrinkage because of dehydration 
(Howat and Wilson, 2014). Generally, it was considered as a less toxic alternative to 
formaldehyde for studies of membrane bound proteins.  
 
2.3.3 Cultured cell fixation with methanol  
Cultured pulmonary arterial smooth muscle cells were taken out of the incubator and 
were washed 3 times with PPS that was pre-warmed to 37 oC. 2 ml of ice-cold 
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methanol was added into each well, and the 12-well plate sealed with parafilm and 
stored at -20 o C for at least 10 minutes. 
 
2.3.4 Sample fixation with paraformaldehyde 
Acutely isolated or cultured pulmonary arterial smooth muscle cells were prepared as 
described in section 2.2 or 2.3.1. Instead of adding methanol, 1ml of 4% 
paraformaldehyde was added to each well of the 12-well plate and the cells were 
incubated at 37 o C for 20 minutes. 4% paraformaldehyde was prepared by dissolving 
paraformaldehyde in phosphate buffer which contains 650 mM Na2HPO4 · 2H2O and 
174 mM NaH2PO4 · 2H2O with pH adjusted to 7.4. Following the fixation, cells were 
permeabilized by incubating with 0.2% Triton X-100 (prepared with PPS) for 10 
minutes at room temperature. Paraformaldehyde is polymerized formaldehyde, and 
formaldehyde fixatives act by cross-linking side chain amino groups of lysine without 
affecting the secondary and tertiary structures of proteins (Howat and Wilson, 2014), 
it was used instead of methanol when the secondary and tertiary structures of proteins 
need to be retained. 
 
2.4 Immunocytochemistry 
2.4.1 Primary and secondary antibodies for immunocytochemistry 












Table  2.1 Primary antibodies used in immunocytochemistry and information on 
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Samples fixed by either method described in section 2.3 were washed three times 
with Tris-buffered saline containing 140 mM NaCl, 25 mM Tris-base, 1.3 mM KCl (PH 
7.4), followed by a 30 minutes incubation with blocking buffer of the following 
composition: 1% bovine serum albumin, 1% goat serum, 10% donkey serum, 10% 
foetal bovine serum and 0.1% Tween-20 in phosphate-buffered saline, pH 7.4. The 
blocking buffer contains serum and bovine serum albumin to prevent any unspecific 
labelling of the primary antibodies, and this improves the signal to noise ratio of the 
imaging taken from the labelled sample. After blocking, primary antibodies that were 
diluted in blocking buffer based on the dilution factors described in Table 2.1 were 
applied to the samples and the samples were incubated overnight at 4 oC in dark. The 
following day, samples were washed 3 x 10 minutes with Tris-buffered saline 
containing 0.1% Tween-20 to remove the residual primary antibody. To visualize the 
distribution of the target proteins that were labelled by primary antibodies, secondary 
antibodies that were conjugated to fluorescent molecules were applied to the samples. 
Each secondary antibody was raised against immunoglobulin of the species that one 
primary antibody was raised in, which allows specific targeting. The secondary 















Table 2.2  Secondary antibodies used in immunocytochemistry and information 
on dilution factor, excitation and emission wavelengths, animal origin, supplier 





Samples were incubated with secondary antibodies diluted in blocking buffer (as 
suggested in Table 2.2) for 2 hours at room temperature in dark. To visualize nuclei, 
the samples were incubated with 4-,6-diamidino-2-phenylindole (Dapi, 1µg/ml; 
excitation 358nm, emission 461nm) for 15 minutes at room temperature. Then, the 
samples were washed 3 times with phosphate-buffered saline containing 0.1% 
Tween-20 and 2 times with phosphate-buffered saline. After 5 minutes of air dry the 
coverslips were attached to slides by anti-fading mountant (2.4 g Mowiol 4–88, 6 g of 


















































preserve the samples for longer, the coverslips were sealed with transparent nail 
polisher and stored at 4 oC. Notably, samples that were incubated with primary 
antibodies or secondary antibodies only, as well as samples that were not labelled 
were mounted as controls, which provided information on whether the primary or 
secondary antibody caused any non-specific labelling, and the level of cell 
autofluorescence when excited by laser scans. The fluorescence spectra for the 
excitation and emission wavelengths of the secondary antibodies are displayed in 
Figure 2.1. 
 
Figure 2.1 Fluorescent spectral profiles. The fluorescent spectral profiles of the 
excitation (dashed lines) and emission wavelengths of Alexa Fluor 488 (green), Alexa 





2.5 Fluorescence labelling of live pulmonary arterial smooth muscle cells 
2.5.1 Identification of endoplasmic reticulum, sarcoplasmic reticulum and outer 
nuclear membrane with ER-tracker 
ER-Tracker blue-white DPX (Thermo Fisher Scientific, catalogue number E12353) is 
a type of dapoxl dye that displays high extinction coefficients, high quantum yields 
and lower cell toxicity compared to the conventional ER stain DiOC6. The product has 
high selectivity for the endoplasmic reticulum, and can also be used to identify the 
sarcoplasmic reticulum and nucleoplasmic reticulum (Marius et al., 2006). Pulmonary 
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arterial smooth muscle cells were freshly isolated as described in section 2.2, or 
cultured as described in section 2.3 and washed 3 times with PSS. 1µM ER-tracker 
dissolved in PSS was then applied to the cells and incubated for 30 minutes at 37 oC. 
The cells were washed 5 times with dye-free PSS prior to imaging. The excitation and 
emission wavelengths for ER-Tracker white-blue are 375 nm and 550 nm, 
respectively (Figure 2.2). 
 
Figure 2.2 Fluorescent spectral profiles. The fluorescent spectral profiles of the 






2.5.2 Identification of the intracellular Ca2+ stores 
Calcium Orange (Thermo Fisher Scientific) is a Ca2+ indicator that was used for 
visualizing intracellular Ca2+, and it was essentially an acetoxymethyl (AM) ester. AM 
esters are carboxylic acid derivatives that are able to penetrate plasma membranes. 
Once inside the cells, AM esters are cleaved by intracellular esterase, and the 
resulting products could chelate cytosolic Ca2+ to generate fluorescence (Hamad et 
al., 2015). Upon binding Ca2+, the fluorescence intensity of Calcium Orange increases 
by 3 folds, which makes it less than ideal for assessing Ca2+ flux in the cytoplasm. 
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However, it is good for identifying intracellular Ca2+ stores considering that 
compartmentalization of the dye is facilitated at 37 oC (see product instruction sheet). 
Calcium Orange was dissolved in DMSO that contains 1% pluronic F127 which serves 
as a surfactant to facilitate the loading of the dye, the concentration of Calcium Orange 
in DMSO was 10 mM. The solution was then applied to acutely isolated or cultured 
pulmonary arterial smooth muscle cells with a final concentration of 5µM. The cells 
were incubated at 37o C for 30 minutes, which was followed by 5 x washes with fresh 
PSS. If the cells were to be colabelled with ER-tracker, Calcium Orange and ER-
tracker were added at the same time and incubated at 37o C for 30 minutes prior to 
imaging. The excitation and emission wavelengths of Calcium Orange are 549 nm 
and 576 nm, respectively (Figure 2.3). 
Figure 2.3 Fluorescent spectral profiles. The fluorescent spectral profiles of the 





2.5.3 Fluo-4 loading for Ca2+ imaging 
Fluo-4 is available as an AM ester, and is a Ca2+ indicator that exhibits a dramatic 
increase in fluorescence when Ca2+ is bound. Unlike Calcium Orange, the 
fluorescence intensity of Fluo-4 increases at least 100-fold upon binding Ca2+, which 
59 
 
makes it the ideal Ca2+ indicator for studying Ca2+ signalling by confocal microscopy.  
 
10 mM Fluo-4 was first dissolved in DMSO that contained 1% pluronic F127, 
sonicated for 10 minutes, and then loaded into acutely isolated or cultured smooth 
muscle cells that were bathed in PPS at a final concentration of 5µM. Following 30 
minutes of loading at room temperature, the cells were washed with 5 times in fresh 
PPS, and the cells were allowed to equilibrate for at least 30 minutes before imaging. 
The excitation and emission wavelengths of Fluo-4 are 494 nm and 506 nm, 
respectively (Figure 2.4). When Fluo-4, ER-Tracker and/or Calcium Orange were 
used in the same experiment, Fluo-4 was loaded at 25 oC and the cells washed before 
the cells were incubated with the other dyes. 
 
Figure 2.4 Fluorescent spectral profiles. The fluorescent spectral profiles of the 




2.5.4 Identification of the nuclei with Draq 5 
Draq 5 is a fluorescent probe that labels double stranded DNA in live cells, the 
excitation and emission wavelengths of the dye are 647 nm and 681 nm respectively. 
Prior to imaging, 1 µM Draq 5 (dissolved and diluted in PSS) was applied to acutely 
isolated or cultured pulmonary arterial smooth muscle cells and incubated for at least 
1 minute at room temperature. The cells can be imaged immediately without washing 
off the dye, and cells were always imaged immediately after addition of Draq5 to avoid 
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cellular toxicity.  
 
2.6 Confocal imaging 
Confocal microscopes are widely used in optical imaging for higher resolution and 
contrast, achieved by the application of pinhole apertures. As shown in Figure 2.5, 
two pinhole apertures are positioned in the confocal system; one sits between the 
light source and the dichroic mirror and the other one lies between the dichroic mirror 
and the detector. The light source, which is a light beam with a selected wavelength, 
is focused by the first pinhole aperture, and is reflected by the dichroic mirror and 
illuminates the sample. The fluorophores within the sample are excited, and therefore 
they emit fluorescent light of another wavelength which will pass through the dichroic 
mirror and reach the second pinhole aperture. Only the light emitted by the object in 
the focal plane can pass through the pinhole (indicated by solid red lines) and reach 
the detector, the light emitted by the object that is out of focus will be blocked by the 





Figure 2.5  Schematic diagram showing the principle of confocal microscopy. 






Both the live cell Ca2+ imaging and the visualization of immunocytochemistry labelling 
were conducted with a Nikon A1Rplus confocal system. Live cell experiments were 
recorded at 22 °C with a sampling frequency of 0.5 Hz, via a Nikon Eclipse Ti inverted 
microscope with a Nikon Apo 40x λS DIC N2, 1.25 n.a. water immersion objective 
(Nikon Instruments Europe BV, Netherlands). Immunocytochemistry samples were 
visualized with the same system and same settings, but a Nikon CFI Plan Apo VC 
60X oil immersion objective (Nikon Instruments Europe BV, Netherlands).  
 
Two types of experiments were conducted with the confocal system: Z stacks through 
the cell and single Z section versus time. Unhealthy cells were excluded, only 
elongated (typical shape of the differentiated pulmonary arterial smooth muscle cell) 
acutely isolated cells were selected. Rhomboid shaped cells are typical of proliferating 
pulmonary arterial smooth muscle cells, and they were selected when studying 
cultured cells. Fixed cells were labelled by fluorescent secondary antibodies for the 
investigation of nuclear membrane structure. Only cells with good labelling were 
picked and viewed under the 60X oil immersion objective. The nuclei were selected 
as the region of interest at the highest magnification possible, and Z stacks of the 
entire nuclei were taken with a step interval of 100-200 nm. Similarly, live cells labelled 
by ER-tracker, Calcium Orange or Fluo-4 were viewed under a 40X water immersion 
objective, and only cells with good loading were selected. Z stacks that covered the 
entire cells were defined and scanned with the step interval of 150-200 nm. Live cells 
loaded with Fluo-4 with or without Draq 5 were viewed with 40X water immersion 
objective. Cells with good loading and visible nuclear invaginations, that did not photo-
bleach or respond to the laser heat were selected for time-course experiments. During 
the experiments, stimuli were added to the cells and the changes of Ca2+ 
concentration reflected by changes in the fluorescent intensity of Fluo-4 within the 
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regions of interests were recorded over time, and saved as time course videos. The 
images and time course videos generated with the confocal system have the 
resolution of 150 nm to 200 nm. 
 
 
Figure 2.6 Shape of differentiated or cultured PASMCs. 
Bright field image of a typical morphology of a healthy acutely isolated, differentiated 
pulmonary arterial smooth muscle cell (left), and a cultured, proliferating pulmonary 




2.7 Deconvolution and image processing 
2.7.1 Improving the resolution of the images and time course videos by 
deconvolution 
The Point Spread Function (PSF) defines the basic building block of acquired images. 
The PSF is the spread of fluorescence from a single point recorded by an optical 
device. It is described by the Linear System theory of an incoherent imaging system 
(i.e. fluorescence microscopes), the imaging of one independent objects does not 
affect the imaging of the other at the same time. This means that any image can be 
computed as a sum of PSFs at a different position, which is the idea of convolution. 
As the figure below shows, the images recorded by fluorescence microscopy are the 
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reconstruction of 3D PSFs, which are replacements of the original sub-resolution light 
source. 
 
Figure 2.7 Schematic figure explaining blurring caused by PSF. Adapted from 





Image blurring is caused by the PSF, the whole acquired image was degraded by 
convolution, and the process can be mathematically described by the convolution 
equation: 
 
Where g stands for the image acquired, which arises from both the original light 
source f and the PSF which is h in the equation. The wider the PSF is, the more 






The PSF can be measured by recording beads, but here we used the Huygens 
Essential software (Scientific Volume Imaging B.V., Netherlands) to compute a 
theoretical PSF based on the model of our confocal microscope and microscopic 
parameters (i.e. excitation and emission wavelengths). 
 
To obtain images with higher resolution, deconvolution can be conducted, which is 
the reverse of convolution. Based on the convolution equation, as the convolved 
image g is known and the PSF h is calculated, the distribution of the original light 
source f can be inferred. After deconvolution, the dynamic range of the images is 
increased and the signal to background noise ratio is significantly improved, which 
will bring the resolution up to 100 nm-150 nm. In our experiments, all the images and 
time course videos recorded by confocal microscopy were deconvolved with Huygens 
Essential software (Scientific Volume Imaging B.V., Netherlands), which allowed us 
to visualize nanotubes in the cells. The images before and after deconvolution can be 
seen in the figure below. 
 
Figure 2.8  Deconvolution improves resolution. Confocal images of an acutely 
isolated pulmonary arterial smooth muscle cell loaded with Fluo-4 (green), before (left) 
and after (right) deconvolution. One example nanotube was indicated by an arrow to 







2.7.2 3D reconstruction of confocal Z-stack and the application of digital skin 
Z stacks of acutely isolated or cultured pulmonary arterial smooth muscle cells with 
fluorescent labelling were taken by confocal microscopy as described in section 2.6. 
The Z stacks were deconvolved as described in section 2.7.1, and imported to Imaris 
(Bitplane, Oxford Instruments, UK) for 3D reconstruction and analysis. For the ease 
of illustrating intracellular structures, a digital skin was applied to the 3D reconstruction, 
which gives better definition.  
 
Figure 2.9  3D reconstruction and digital skin. 3D reconstruction of a series of 
confocal Z-stacks showing lamin A (red) labelled nucleus of an acutely isolated 





If the sample was labelled by two or more dyes or antibodies, the colocalization 
between different staining can be calculated with Imaris as illustrated in Figure 2.10, 
which will generate a measurement of the volume of colocalization and Pearson’s 
correlation coefficient. The volume of colocalization of one staining is compared to the 
total volume of the staining, which gives the percentage of volume of this staining 
colocalised with the other. The Pearson’s correlation ecoefficiency (sometimes 
referred as Pearson’s correlation coefficient) measures the linear correlation between 
two staining. It has a value between +1 and −1, where 1 is total positive linear 




Figure 2.10  Colocalisation between two staining generated by Imaris. An acutely 
isolated pulmonary arterial smooth muscle cell was labelled by lamin A (red, upper 
panel at left) and BAF (green, upper panel at right). The red and green staining were 
merged as showed in the left lower panel, the colocalization between the two channels 






2.8 Ca2+ imaging analysis 
2.8.1 Generating Ca2+ intensity plots 
Confocal time course videos were deconvolved as described in section 2.7, and were 
imported into Image J. Video records of the response of cells loaded with Ca2+ 
indicators were compiled, with the changes in Ca2+ concentration reflected by the 
fluorescent intensity of the Ca2+ indicator. To semi-quantify the Ca2+ concentration 
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within different regions of interest, a line was drawn across all the regions of interest 
and fluorescent intensity was measured along the line (as showed in Figure 2.11) with 
the plot profile tool. 
 
Figure 2.11  Intensity plot of a pulmonary arterial smooth muscle cell loaded 
with Fluo-4.  
A confocal scan through the middle of a pulmonary arterial smooth muscle cell loaded 
with Fluo-4 was deconvolved, and a line was drawn across the cell (upper panel), the 
Fluo-4 fluorescent intensity of the regions of interest along the line was measured and 
showed in gray value as the lower panel displayed. 
 
2.8.2 Analysis of the live cell response to stimuli 
As described in section 2.6, time course videos that reflect the response of live cells 
to stimuli were recorded, and they were deconvolved as described in section 2.7 and 
opened with Image J. Three regions of interest were selected as shown in the figure 
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2.12, with the ROI manager tool. Draq 5 labelling defined where the nucleus was, 




Figure 2.12 Selecting ROIs for measurement.  
An acutely isolated pulmonary arterial smooth muscle cell was loaded with Fluo-4 and 
Draq 5 to reveal Ca2+distribution and the position of the nucleus. (I) Bright filed image 
of the cell. (II) Fluo-4 loading. (III) Drag 5 loading indicating where the nucleus was. 
(IV) Merged image of the Fluo-4 loading and Draq 5 labelling. Three ROIs were 
selected, drawn and labelled with letters. I indicates nuclear invagination, N indicates 





Once ROIs were selected, mean fluorescence intensity over time within the ROIs was 
measured using ROI manager. Upon the addition of stimuli, cell contraction might be 
observed, which would lead to the displacement of the ROIs from the desired region 
of interest. Therefore, the position of ROIs was adjusted for each frame acquired, to 
ensure that the desired regions of interest were always positioned within the ROIs as 
originally drawn. For example, the cell in Figure 2.13A contracted slightly and the 
invagination analysed moved downwards in Aii compared to Ai. To minimize the bias 
caused by cell contraction, ROI 1 was moved downward to trace the invagination as 
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the figure showed. Each image file was assessed manually to ensure accuracy and 
consistency of measurement within the regions of interest specified. We excluded 
from analysis any cell that exhibited contraction sufficient to alter the focal plane or 
other movement artefacts that might compromise our ability to take reliable 
measurements within desired regions of interest.  
 
The measured Fluo-4 fluorescent intensity was converted to a fluorescence ratio 
(FX/FC0) that normalize records and allow for cross-comparison between different cells. 
Here Fx is the mean fluorescence intensity of the selected ROI and FC0 represents the 
fluorescence intensity of the selected perinuclear cytoplasmic region at time point 0, 
which is prior to drug addition.  
 
As shown in Figure 2.13, the converting of arbitrary units into a fluorescence ratio 
does not modify the shape of the response curve. However, it provided a 
measurement that can be compared to other cells while ignoring the differences in 
basal fluorescent intensity. The fluorescence ratio at the timepoint of drug addition 
was considered as the baseline, and the delta peak change was calculated by 





Figure 2.13 Quantification of confocal Ca2+ imaging.  
(A) An acutely isolated pulmonary arterial was loaded with Fluo-4, 10 µM Angiotensin 
II was added to the cell and the response over time was recorded. 4 representative 
frames at 4 distinct time points of the record were showed in Ai, Aii, Aiii, Aiv. ROIs 
were circled and labelled, I for Invagination, N for Nucleus and C for cytoplasm. The 
white dashed line between Ai and Aii shows how the ROI was moved.  
(B) The fluorescent intensity within the selected region of invagination (red), nucleus 
(blue) and cytoplasm (orange) was plotted against time. The four time points selected 
in A was indicated on the plot.  
(C) The fluorescent ratio within the selected region of invagination (red), nucleus (blue) 
and cytoplasm (orange) was plotted against time. The four time points selected in A 
was indicated on the plot. 
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2.8.3 3D surface plot 
To demonstrate that the fluorescence intensity in different ROIs were distinct and the 
responses to stimuli were asynchronized, the 3D surface plot was produced. 
Pseudocolor (Fire LUT) was applied to the files using ImageJ. By choosing surface 
plot under the catalogue of analysis, the 3D surface plot was produced. It can be 
saved as a video, and each frame can be saved independently as an image. 
 
Figure 2.14 Process of making a 3D surface plot. 
 An acutely isolated pulmonary arterial was loaded with Fluo-4, an image was 
recorded with confocal and viewed with Image J. (i)The original file. (ii) Pseudocolor 
was applied, in the fire LUT fluorescent intensity lies on the spectrum, yellow indicates 
high fluorescent intensity whereas purple is for low fluorescent intensity. (iii)The 







2.9 RNA extraction, cDNA generation and qPCR 
2.9.1 RNA extraction 
Total RNA was extracted from first, second and third order branches of the pulmonary 
arterial tree, acutely isolated pulmonary arterial smooth muscle cells and cultured 
pulmonary arterial smooth muscle cells using Trizol reagent according to the 
manufacturer’s instructions (Invitrogen, UK). 
 
 All extraction steps were performed at room temperature unless stated otherwise. 
Pulmonary artery trees were dissected out as section 2.2 showed, endothelial cells 
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on the surface of the arteries were removed by gentle rubbing with a cotton bud. The 
tissue was homogenized with a homogenizer, 1ml of the Trizol reagent was added to 
80 mg of the homogenized tissue to lyse the cells. 
 
Acutely isolated cells in suspension were centrifuged at 1800 rpm at 4°C for 10 
minutes to collect the cell pellet without disrupting the cell membrane. The 
supernatant was discarded and 1ml of Trizol reagent was added to roughly 2 million 
cells to lyse the membrane and release DNA, RNA and protein. To assist the lysing 
process, the cell lysate was passed through a blunt 20-gauge needle for at least 5 
times. 
 
Proliferating pulmonary arterial smooth muscle cells cultured on poly-D-lysine coated 
6-well plates for 7 days, were first washed three times with 37°C PPS to remove the 
culture medium, and 1 ml Trizol reagent was added to approximately 2 million cells. 
The cells were then gently scraped down with a 22 mm sterile plastic scrapper (VWR, 
US), and the cell lysate passed through a blunt 20-gauge needle for at least 5 times 
to breakdown the membrane. 
 
The cell lysate was left at room temperature for 5 minutes, and 200 μl of chloroform 
added to 1ml of cell lysate, which was followed by vigorous shaking. After shaking the 
lysate was centrifuged at 4°C for 15 minutes with the speed of 12000g. The spinning 
is supposed to separate the lysate into three layers based on the size, weight and 
affinity of the components; the top clear layer is the RNA layer, the middle layer that 
is cloudy and dense is composed of the genomic DNA, and the bottom pink layer is 
full of proteins and cell debris. The top RNA layer was carefully removed into a new 
1ml Eppendorf, the typical yield of RNA suspension from 1ml of cell lysate is around 
200 μl. To extract RNA from the suspension, 500 μl 2-propanol, 70 μl 3M sodium 
acetate (PH 5.2) and 20 μg were added to 200 μl RNA suspension and incubated at 
-20°C overnight. The following day, the suspension was centrifuged at 15000g for 20 
minutes at 4°C for the collection of RNA pellet. To eliminate chemical contamination, 
the pellet was washed with 70% ethanol (in DEPC water) for 3 times by centrifuging 
at 7500g for 5 minutes. The pellet was air dried for 15-30 minutes until the ethanol 
was evaporated without drying out the pellet completely, and the RNA was 
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resuspended in 20-40 μl of TE buffer and for long term storage at -20°C or -80°C. 
 
2.9.2 Checking the quality, quantity and integrity of the extracted RNA. 
The quantity and quality of extracted RNA were checked by Nanodrop 
spectrophotometer (Therofisher scientific, US), RNA concentration was provided as 
ng/μl; the A260/280 and A260/230 reading were measured and calculated to show 
the quality of RNA. The ratio of the absorbance at 260 and 280 nm (A260/280) is 
calculated to assess the quality (purity) of nucleic acids based on the fact that proteins 
absorb light at a wavelength of 280 nm. The A260/280 of pure DNA is around 1.8 
while that of pure RNA is approximately 2.0. If the A260/280 is lower than 1.8 the 
sample was generally considered as contaminated with protein or other chemicals 
that absorb light at 280 nm (e.g. phenol). In our case, samples with the A260/280 
above 1.96 were considered as pure RNA without DNA contamination.  
 
The ratio of the absorbance at 260 and 230 nm (A260/230) is used to assess whether 
the sample was contaminated with chemicals, especially chemicals that absorb light 
at 230 nm including EDTA, guanidine HCL, carbohydrates and phenolic solutions like 
Trizol reagent. Samples with good purity should display an A260/230 between 2.0-
2.2, samples with higher or lower A260/230 were excluded.  
 
RNA electrophoresis was conducted to check the integrity of RNA samples. 1% 
agarose gel was prepared with Tris-base, acetic acid and EDTA (TAE) buffer. 1 μl 
RNA loading buffer containing 50% glycerol, 1mM EDTA, 0.4% Orange G and DEPC 
water was added to 0.5 μg RNA sample and was topped up to 10 μl with DEPC water. 
The mixture was heated at 65 °C for 45 minutes to denature the RNA, which could 
unwind the secondary and tertiary RNA structure. 10 μl of the denatured mixture was 
added to each well of the agarose gel, and the gel was run at 6v/cm for 45 minutes. 
In the gel that has RNA samples with good integrity, clear ribosomal RNA bands 
should be seen, while the degraded RNA sample would generate a smear with a band 





2.9.3 cDNA generation 
Reverse transcription was carried out using the Transcriptor First Strand cDNA 
Synthesis Kit from Roche Science (UK). The cDNA generation was conducted in two 
steps. First, 0.5 μl anchored-oligo(dT)18 primer and 1ul random hexamer primers 
were added to 1ng-4μg RNA with DEPC water, and the mixture was denatured by 
heating the mixture at 65 °C for 10 minutes. Then I added Transcriptor Reverse 
Transcriptase with buffer, RNase inhibitor, deoxynucleotide mix, Dithiothreitol and 
reverse transcriptase to the mixture, which was then incubated at 50 °C for 30 mins 
to allow cDNA generation. Transcriptor Reverse Transcriptase was inactivated by 
heating to 85°C for 5 minutes. The derived cDNA was stored at -20 °C. The amount 
of each reagent required for this process is summarized in the tables below. 
 
Table 2.3 Reagents required in the first step of reverse transcription 
First Step 
  
Components Volume Final Concentration 
Total RNA Variable 1ng-4μg 
Anchored oligo 0.5 μl  2.5 μM 
Random 
hexamer 1 μl  60 μM 

















Transcriptase buffer 5x 4 μl  1x 
RNase inhibitor 40V 0.5 μl  20V 
Deoxynucleotide mix, 10mM 2 μl  1mM 
Dithiothreitol 1 μl  5mM 
Reverse transcriptase 1.1 μl  10V 
Final Volume 20 μl N/A 
 
 
2.9.4 Real-time qPCR 
Real-time quantitative polymerase chain reaction (qPCR) is a technology that was 
used to monitor the amplification of targeted cDNAs. It was able to detect the 
production of the targeted cDNAs quantitatively because a non-specific fluorescent 
dye, SYBR Green, was used during PCR and it intercalates with double-stranded 
DNA. By monitoring the changes in the fluorescence intensity of SYBR Green, the 
relative production rate of the targeted cDNAs can be inferred. 
 
Master mixes were prepared prior to qPCR. 2 μl of cDNA template, 10 μl of SYBR 
Green mix (Roche, UK) and 1.6 μl of primer mix, were added to 6.4 μl of DEPC water, 
and the total volume of the master mix for 1 PCR run was 20 μl. Sequence specific 
primers that can selectively amplify rat nesprin-1, SUN 2, and lamin A cDNA were 
purchased from Qiagen (Germany), sequence specific primers that can selectively 
amplify rat emerin gene was purchased from Bio-rad (US). The master mixes were 
added to heat proof 96-well plates (20 μl) per well. Apart from mixes containing cDNA 
sample, positive control that was generated using  cDNA without RNA sample, and 
negative control that did not contain cDNA template were also included. The real-time 
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qPCR was run by StepOnePlus™ Real-Time PCR System (Thermo Fisher Scientific, 
US), using the quantitative comparative delta CT SYBR Green mode for 2 hours. The 
results were exported and analysed in Microsoft Excel 2016 (Microsoft, US). 
 
2.10 Data presentation and statistical analysis 
 
Data are presented as the mean ± SEM for ‘n’ experiments. The analysis, comparison 
and figure production were carried out using GraphPad Prism (US).  If comparing two 
datasets, t-test was conducted. If comparing between three or more groups of data, 
the variances of datasets were checked by either the one-way variance test (in 
Graphpad) or a mixed factor model (in Minitab). If the data sets have similar variances 
and fall into the normal distribution, the number of independent variables must be 
considered. For the comparison of data set that has one independent variable, the 
analysis was carried out with one-way ANOVA followed by a Tukey or holm-sidak 
multiple comparisons test. In terms of the data set that has two independent variables, 
the comparisons between the groups were carried out using two-way ANOVA 
followed by a Tukey’s multiple comparisons test. On the other hand, if the data sets 
have significantly different variances, the unpaired data sets were compared by the 
Kruskal-Wallis test whereas the paired data sets were compared by the Friedman test 
followed by Dunn’s multiple comparison. Probability values less than 0.05 were 
considered to be statistically significant. *= P ≤ 0.05, **= P ≤ 0.01, ***= P ≤ 0.001 and 






2.11 Drugs and chemicals 
All compounds were from Sigma Aldrich unless stated otherwise, detailed information 




Table 2.5 Description, supplier, catalogue number and concentration of the 
chemicals used in the study 






Angiotensin II   Abcam ab120183 10 µm, 30 µm Distilled 
water  
Maurocalcine  Alomone 
Labs 
 RTM-100 100 nM, 200 
nM, 300 nM 
Distilled 
water  
Thapsigargin Abcam ab120286 1 µm DMSO 
Ionomycin Sigma-
Aldrich 
P6188-1MG 1 µm DMSO 




100 µm DMSO 







F-14201 5 µm DMSO 
DRAQ5™ 
Fluorescent  




D62251 5 µm PSS  
Calcium 
Orange™, 





















































Chapter 3: Cytoplasmic nanocourses form a cell-wide web 
for Ca2+ signalling 
3.1 Introduction 
3.1.1 Multiple releasable pools of SR Ca2+ 
The PM-SR junction, as introduced in Chapter 1, is the junctional space formed 
between the plasmamembrane and superficial SR. It was proposed that the narrow 
cytoplasmic spaces formed between the PM and SR could effectively restrict Ca2+ 
diffusion, which facilitates SR Ca2+ intake from the junctional space, and this would 
serve as a buffer barrier to attenuate Ca2+ flux from the PM to the deep myoplasm 
(van Breemen et al., 1995). This superficial buffer barrier hypothesis indicates that 
centrally located SR compartments must serve to support other smooth muscle 
functions, for example, muscle contraction. Indeed, early studies had considered the 
possibility that the central and peripheral SR are separate compartments within the 
smooth muscle cells (Nixon et al., 1994). By staining the tissues with osmium 
ferricyanide they studied the ultrastructure of smooth muscle SR, and the results 
showed that the central and peripheral SR were parts of one continuous organelle, 
that appeared to somehow form separate compartments. The direct evidence of 
functionally segregated SR compartments was revealed later on, which showed two 
separate releasable pools of SR Ca2+ in response to different pharmacological stimuli 
(Golovina and Blaustein, 1997).  
3.1.2 Functionally segregated SR Ca2+ stores in pulmonary arterial smooth 
muscle cells 
Functionally segregated SR compartments have been reported in pulmonary arterial 
smooth muscle cells (PASMCs) (Yang et al., 2005, Clark et al., 2010a). It was first 
observed that the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) pump 
inhibitor cyclopiazonic acid seemed to deplete one releasable pool of SR Ca2+ while 
having little effects on another SR Ca2+ pool which supported Ca2+ release by cADPR 
(Dipp et al., 2001, Dipp and Evans, 2001). This suggests that segregated SR Ca2+ 
pools exist in PASMCs. In support of this view, it was shown that nicotinic acid 
adenine dinucleotide phosphate (NAADP) induced spatially restricted Ca2+ transients 
that initiated a global Ca2+ wave and contraction in PASMCs by subsequently 
triggering Ca2+ induced Ca2+ release (CICR) from the SR via ryanodine receptors 
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(RyRs); by contrast, blocking Inositol trisphosphate receptors (IP3R) had no effect on 
the NAADP induced Ca2+ signal (Boittin et al., 2002). Therefore, it was proposed that 
NAADP mobilises Ca2+ via a 2-pool mechanism, and that initial Ca2+ bursts are 
amplified by subsequent SR Ca2+ release via RyRs but not IP3Rs. This study suggests 
that RyRs and IP3Rs may target segregated SR Ca2+ pools. This view gained further 
support from the fact that cyclic ADP ribose-dependent SR Ca2+ release via RyRs 
also supported smooth muscle relaxation in the same cell type, by releasing Ca2+ 
proximal to the plasma membrane BKCa channels in response to activation of 
adenylyl cyclase-coupled receptors (Boittin et al., 2003). Combined with early 
research, this seems to show that Ca2+ release via RyRs from the SR underpins both 
vasodilation and vasoconstriction, and the signalling segregation is possibly conferred 
by segregated SR Ca2+ stores located either in the vicinity of BKca channels (near the 
plasma membrane) or near the contractile apparatus (central). 
 
The presence of multiple SR Ca2+ stores is supported by differential targeting of RyR 
subtypes. It was shown that the density of RyR3 labelling is highest within the 
perinuclear region. Lysosomes colocalised with RyR3 to form a trigger zone for 
NAADP-dependent Ca2+ signalling by the vasoconstrictor endothelin-1 in rat PASMCs 
(Kinnear et al., 2004, Kinnear et al., 2008). The density of labelling for RyR2 in the 
extraperinuclear region was not only significantly higher than the other regions, but 
also greater than the density of labelling for RyR1 or RyR3 within the extraperinuclear 
region. Comparatively, the density of RyR1 labelling was markedly higher in the 
subplasmalemmal region compared to the perinuclear or extraperinuclear region 
(Kinnear et al., 2008).  
 
A later study showed that SERCA2a and SERCA2b were also differencially targeted 
to functionally segregated SR compartments. In PASMCs, immunolabelling of 
SERCA2a and SERCA2b suggested that around 70% of the SERCA2b labelling fell 
into the subplasmalemmal region, 20% of its labelling was found in the perinuclear 
region and the rest was in the extraperinuclear region. This finding supported the 
argument that SERCA2b was primarily targeted to superficial SR which underpins the 
function of PM-SR junction (Evans et al., 2016). In contrast, SERCA2a labelling 
majorly localised to the central cytoplasm with 90% of the labelling fell into the 
perinuclear region. Moreover, it was proposed that SERCA2a supplies the central SR 
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and supports Ca2+ fluxes which underpin vasoconstriction (Clark et al., 2010a).  
 
To summarise, RyR1 is localised in the subplasmalemmal region where SERCA2b 
serves as the dominant Ca2+ pump, it is presumed that they are targeted to the 
superficial SR and possibly mediate Ca2+ signalling within PM-SR junctions for 
vasodilation. By contrast RyR3 is primarily targeted to the perinuclear region where 
SERCA2a is the predominant SERCA, they serve the central SR which, in part, forms 
lysosome-SR junction, and gives rise to global Ca2+ signals amplified by RyR2s 
distributed in the extraperinuclear region (Gilbert et al., 2014, Clark et al., 2010a) that 
support vasoconstriction (Kinnear et al., 2008, Evans et al., 2016). That there may be 
different subcompartments of the SR was further highlighted by the findings of Boittin 
et al (Boittin et al., 2002) which suggested that IP3Rs and RyRs may also be found in 




Segregated SR Ca2+ pools are observed in PASMCs, which is supported by the 
strategic targeting of different subtypes of RyRs and SERCAs. In some cases, it was 
proposed that the segregated SR compartments give rise to Ca2+ signals that are 
spatially restricted within nanospaces (i.e. PM-SR junction, lysosome-SR junction), 
and mediate distinct smooth muscle functions. Therefore, the aim of this Chapter is 
to investigate the possibility that Ca2+ signalling is segregated by cytoplasmic 
nanospaces, which are conferred by nanojunctions of the SR in a manner that 
supports the generation of spatially and functionally segregated Ca2+ signals, and 










3.2.1 Cytoplasmic nanocourses of the sarcoplasmic reticulum form a cell-wide 
web in PASMCs  
Cytoplastic nanojunctions have been identified in multiple types of muscle cells. For 
example, the T-tube-SR junction in skeletal and cardiac muscle cells (Franzini-
Armstrong, 1970, Langer and Peskoff, 1996), the PM-SR nanojunction and lysosome-
SR junction in pulmonary arterial smooth muscle cells (van Breemen et al., 2013, 
Fameli et al., 2014), and the mitochondria-SR junction in resistant arterial smooth 
muscle cells (Tong et al., 2009). These structures were visualized by electron 
microscopy, and they were proposed, on the basis of indirect functional evidence, to 
restrict free Ca2+ diffusion and demarcate local Ca2+ release (van Breemen et al., 2013, 
Fameli et al., 2014). The fact that more than one type of cytoplasmic nanojunctions 
co-exist in PASMCs led to the consideration that these cytoplasmic nanojunctions 
may demarcate functionally segregated cytoplasmic nanodomains. To investigate this 
possibility, I decided to explore the cytoplasmic nanodomains further by applying 
deconvolution to Z scans of PASMCs loaded with a Ca2+ indicator. 
 
Considering the proposal that nanojunctions are defined, at least in part, by 
membrane-membrane junctions of the SR/ER that restrict Ca2+ diffusion (Fameli et 
al., 2014, van Breemen et al., 2013), I first labelled acutely isolated PASMCs with ER-
tracker and loaded the cells with the Ca2+ indicator Fluo-4. Figure 3.1 shows an 
exemplary cell labelled with ER-tracker (orange). A scan through the middle of the 
cell was deconvolved (Figure 3.1B), revealing a network of ER-tracker labelling 
spanning the entire cell. Fluo-4 fluorescence (green) of the same deconvolved Z 
section (Figure 3.1C) illustrated that the intracellular free Ca2+ was not uniformly 
distributed as one may expect. Instead, the free Ca2+ appears to outline a network of 
“cytoplasmic nanocourses”. To specify where the structures are formed, Draq 5 (blue, 
Figure 3.1 D) was applied to identify the nucleoplasm. By merging the Fluo-4 loading 
with Draq 5 labelling (Figure 3.1G) it was clear that those linear structures highlighted 
by Fluo-4 fluorescence were observed proximal to the plasma membrane (PM), or 
within the extraperinuclear and perinuclear region of the cell, in a manner consistent 
with but more extensive than previously proposed (Clark et al., 2010a, Evans et al., 
2016, van Breemen et al., 2013). To my surprise, however, these cytoplasmic 
nanocourses extended beyond the perinuclear region of the cell, penetrating into the 
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nucleus (Figure 3.1 H). By conducting confocal microscopy followed by deconvolution, 
the resolution was improved to 100-150 nm. This allowed for reliable estimation of the 
sizes of these linear structures, which were generally less than 300 nm wide. 
Therefore, I conclude that cellular nanocourses are defined by the SR of acutely 
isolated PASMCs, forming a cell-wide web that extends from the cell periphery to the 
nucleus. Moreover, I propose that these nanocourses might be capable of restricting 
and/or directing Ca2+ flux. 
 
The nanocourses that project into the nucleus seem to be defined by the extension of 
the nuclear membrane as Figure 3.1 F shows, consistent with previous proposals that 
ER/SR is continuous with the outer nuclear membrane (OMN), which has been shown 
to extend into the nucleus to form nuclear invaginations in various cell types (Fricker 
et al., 1997b). Interestingly, as shown in Figure 3.1 E&G, the nuclear invaginations 
observed in acutely isolated PASMCs are continuous with perinuclear cytoplasmic 
nanocourses, suggesting that the lumen of nuclear invaginations are essentially 








Figure 3.1 Cytoplasmic nanocourses observed in acutely isolated PASMCs 
form a cell-wide web  
(A) Bright filed image of a pulmonary arterial smooth muscle cell 
(B) Deconvolved confocal Z section through the middle of a pulmonary arterial 
myocyte showing ER-tracker identified ER, SR and outer nuclear membrane (orange). 
(C) As for (A) but showing the distribution of cytoplasmic Ca2+ (green) by the Ca2+ 
indicator Fluo-4 loaded at 25 oC. 
(D) As for (A) but showing the nucleoplasm identified by Draq5 (blue). 
(E) Merged ER-tracker labelling with Fluo-4 fluorescence. 
(F) Merged ER-tracker labelling with Draq5 staining. 
(G) Merged Fluo-4 fluorescence with Draq5 staining. 





3.2.2 Cytoplasmic nanocourses harbour clusters of RyRs, which give rise to 
spontaneous Ca2+ fluxes at rest. 
To further characterize the nanocourses, time course videos of the Fluo-4 loaded 
acutely isolated PASMCs at rest were recorded and analyzed. Due to the fact that 
85 
 
ER-tracker is cytotoxic, and heavy photobleaching of the ER-tracker signal is always 
observed within 3 minutes, it was not possible to incorporate ER-tracker labelling in 
confocal time course experiments. However, my data described above clearly show 
that the cytoplasmic nanocourses can be identified by Fluo-4 fluorescence alone 
(Figure 3.1). Given the above, I further studied time series of raw and deconvolved 
confocal Z sections of acutely isolated PASMCs loaded with Fluo-4 alone. Figure 3.2 
Ai shows a confocal scan through the middle of an acutely isolated PASMC loaded 
with Fluo-4 (green), with Draq 5 (blue) applied to indicate the nucleoplasm. Under 
confocal microscopy where the resolution was around 200 nm, cytoplasmic 
nanocourses could not be distinguished. By contrast, deconvolved images of the 
same confocal Z section revealed the cell-wide web of cytoplasmic nanocourses 
(Figure 3.2 Aii). They are very dynamic, some of the nanocourses constantly 
rearrange over time. Pseudocolour was applied to the images to indicate relative Ca2+ 
concentrations within the nanocourse, low Ca2+ concentration was indicated by black 
and high concentration by white (Figure 3.2 Aiii). In order to further characterize basal 
activities within cytoplasmic nanocourses, they were divided into 4 groups based on 
the functional segregation of SR proposed previously (Clark et al., 2010a), where the 
cytoplasmic volume within 1.5 μm of the nucleus but excluding the nucleus was 
defined as the perinuclear region, the cytoplasmic volume within 1.5 μm of the plasma 
membrane was defined as the subplasmalemmal region, and the rest of the cytoplasm 
in between the two regions was defined as the extraperinuclear region. I defined 
cytoplasmic nanocourses that fall into each region accordingly, and they refer to four 
loosely defined subgroups, namely subplasmalemmal nanocourses, extraperinuclear 
nanocourses, perinuclear nanocourses and nuclear invaginations. 
 
One example of a subplasmalemmal (white), extraperinuclear (blue) and perinuclear 
(green) nanocourse and one nuclear invagination (yellow) were selected for detailed 
characterization in each cell studied (Figure 3.2 Aiii). Magnified images of each 
nanocourse are shown in Figure 3.2 Bi-Ei. The upper, middle and lower panels show 
images of these cytoplasmic nanocourses at 3 time points. Interestingly, the Fluo-4 
distribution seems to suggest that the Ca2+ concentration was not uniform distributed 
along the lengths of any of these nanocourses. The images clearly show that there 
were hotspots (circled in the lower panels of Figure 3.2 B, C, D and E) of Ca2+ flux 
within the cytoplasmic nanocourses. The Fluo-4 intensity of the hotspots varied with 
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time. For example, in Figure 3.2Bi, two hotspots H1 and H2 indicated by regions of 
interest (ROIs, grey) exhibited different Fluo-4 fluorescence intensities at t = 4s (upper 
panel). By contrast, both H1 and H2 exhibited relatively low Fluo-4 fluorescence 
intensity at time 12s (middle panel), with subsequent increases in fluorescence 
intensity evident for both hotspots at 14s (lower panel). Moreover, the hotspots of Ca2+ 
activity and asynchronous Ca2+ fluxes derived from adjacent hotspots were observed 
in all the cytoplasmic nanocourses, as the examples of subplasmalemmal (Figure 
3.2B), extraperinuclear (Figure 3.2C), perinuclear (Figure 3.2D) nanocourses and 
nuclear invaginations (Figure 3.2 E) show. Two exemplar hotspots H1(black) and H2 
(orange) were selected from each cytoplasmic nanocourse for semi-quantitative 
analysis.  
 
The activity of the hotspots was further investigated by plotting the Fluo-4 FX/F0 
against time (FX=mean Fluo-4 intensity within the region of interest at time point x; F0 
= mean Fluo-4 intensity within the region of interest at time point 0 (Figure 3.2 Bii-Eii). 
Across all four nanocourses, the activity of the two chosen hotspots (black for H1, 
orange for H2) revealed consistently high levels of spontaneous changes in Ca2+ flux. 
That said, the activities of two adjacent hotspots were sometimes synchronized, 
although the majority of hotspots within a single nanocourse act asynchronously with 
respect to Ca2+ flux (Figure 3.2 Bii-Eii). Plots of the average Fluo-4 FX/F0 of entire 
nanocourses (red, Figure 3.2 Biii-Eiii, regions of interests indicated in the upper panels 
of Figure 3.2 B-E) emphasizes that the Ca2+ activities  arise at defined hotspots 
because the amplitude of fluctuations in Ca2+ flux was markedly reduced compared 
to that of corresponding hotspots. This observation shows that the nanocourses, as 
narrow as they are, are not the basic Ca2+ releasing unit. Instead, the hotspots within 






Figure 3.2 Hotspots of Ca2+ fluxes are observed within the cytoplasmic 
nanocourses of acutely isolated arterial myocytes. 
(Ai) A confocal scan through the middle of a pulmonary arterial smooth muscle cell 
loaded with Fluo-4 (green) at 25 oC. The nucleus was indicated by Draq 5 (blue). (ii)As 
for (i) but showing the deconvolved image. (iii) Pseudocolour was applied to the 
confocal scan showed in (ii), black-purple indicates low Fluo-4 fluorescence intensity 
and white-yellow shows high Fluo-4 fluorescence intensity. One subplasmalemmal 
nanocourse is pointed out with white outline, one extraperinuclear nanocourse is 
indicated with blue outline, one perinuclear nanocourse is drawn out by green outline, 
and one nuclear invagination is circled by yellow. N=5 cells from 3 rats. 
(Bi) One subplasmalemmal nanocourse is shown at higher magnification. The upper, 
middle and lower panels show the same subplasmalemmal nanocourse at three time 
points. Hotspot 1 (H1, black) and hotspot 2 (H2, orange) were pointed out by grey 
circles. (ii) Fluo-4 fluorescence ratio (Fx/FC0) versus time for hotspot 1(H1, black) and 
hotspot 2 (H2, orange) were plotted. F0 = Fluo-4 fluorescence intensity for the chosen 
hotspot at time 0; Fx = fluorescence intensity for the chosen hotspot at time point x. 
(iii) Fluo-4 fluorescence ratio (Fx/FC0) versus time for the nanocourse was plotted. F0 
= Fluo-4 fluorescence intensity for the nanocourse at time 0; Fx = fluorescence 
intensity for the nanocourse at time point x 
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(C) As for (B), but showing an extraperinuclear nanocourse. 
(D) As for (B), but showing a perinuclear nanocourse. 





Spontaneous Ca2+ sparks within smooth muscle cells at rest were observed and 
characterized in the 1990s using waterfall plots derived from time series acquired in 
line-scan mode (Nelson et al., 1995). However, until now no one has attempted to 
study “Ca2+ sparks” by cell wide Z scan versus time. Analysis of my data indicates 
that the amplitude (ΔFX/F0) of Ca2+ fluxes at the hotspots within different cytoplasmic 
nanocourses were slightly different. The average amplitudes of Ca2+ fluxes of the 
subplasmalemmal hotspots, extraperinuclear hotspots, perinuclear hotspots and 
nuclear hotspots were 0.18±0.02, 0.15±0.01, 0.16±0.01 and 0.15±0.02 (black, Figure 
3.6B; n=5, Appendix 1, Table 3.2) respectively. The amplitudes of the Ca2+ fluxes are 
on a similar scale to the amplitudes of the spontaneous Ca2+ sparks reported in early 
studies (Curtis et al., 2004, Jaggar et al., 1998), which suggests that the observed 
Ca2+ fluxes might be the Ca2+ sparks arose from RyRs. 
 
Indeed, this fluctuation of Ca2+ concentration at the hotspots is likely caused by the 
spontaneous release of Ca2+ from SR resident Ca2+ channels, i.e. IP3Rs or RyRs 
(Curtis et al., 2004, Jaggar et al., 1998, Smith and Parker, 2009, Dickinson et al., 
2012). Based on my observations, I decided to investigate the impact of depleting SR 
Ca2+ stores and blocking RyRs on the activity of hotspots within defined cytoplasmic 
nanocourses. 
 
To study whether depletion of SR Ca2+ stores has any effect on spontaneous Ca2+ 
flux at identified hotspots, PASMCs were preincubated with the SERCA inhibitor 
thapsigargin for 1 hour (Du et al., 1994). Time series of confocal Z sections 
(deconvolved) confirmed that the network of cytoplasmic nanocourses was still 
identifiable under the condition (Figure3.3 Aii&iii). Significantly, while spontaneous 
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transient Ca2+ flux was still observed at defined hotspots, the amplitudes of these Ca2+ 
transients were markedly reduced compared to control cells. Following SR Ca2+ store 
depletion, the amplitudes of Ca2+ flux at hotspots within the subplasmalemmal 
nanocourses, extraperinuclear nanocourses, perinuclear nanocourses and nuclear 
invaginations were significantly reduced to 0.07±0.008, 0.08±0.007, 0.07±0.007, 
0.07±0.008 (blue, Figure 3.6B; n=3, Appendix 1, Table 3.3) respectively compared to 
the control cells (0.18±0.02, 0.15±0.01, 0.16±0.01 and 0.15±0.02 respectively, 
p<0.001 for all 4 comparisons,). Moreover, the frequency of transient Ca2+ flux at 
identified hotspots within different cytoplasmic nanocourses was similar (Figure 3.4). 
Measurements at the subplasmalemmal, extraperinuclear, perinuclear and nuclear 
hotspots respectively were 0.15±0.006 s-1, 0.15±0.006 s-1, 0.15±0.007 s-1 and 
0.14±0.006 s-1 under control conditions (Blue bars, Figure 3.4; n=3, Appendix 1, Table 
3.4) and 0.16±0.010 s-1, 0.16±0.012 s-1, 0.16±0.006 s-1, 0.16±0.006 s-1 after pre-
incubation with 1 μM thapsigargin (n=3; p>0.05 in each case compared to the control 
cells; Appendix 1, Table 3.5). This shows that the available luminal Ca2+ load / 
concentration within the SR determines the capacity for Ca2+ flux to the cytoplasm at 
identified hotspots within cytoplasmic nanocourses, but not the frequency at which 








Figure 3.3. Activity of Ca2+ flux observed in the cytoplasmic nanocourses was 
suppressed following SR Ca2+ store depletion by thapsigargin. 
(Ai) A confocal scan through the middle of a pulmonary arterial smooth muscle cell 
loaded with Fluo-4 at 25 oC, preincubated with 1µM of thapsigargin for 1 hour. (ii)As 
for (i) but showing the deconvolved image. (iii) Pseudocolour was applied to the 
confocal scan showed in (ii), black-purple indicates low Fluo-4 fluorescence intensity 
and white-yellow shows high Fluo-4 fluorescence intensity. One subplasmalemmal 
nanocourse is pointed out with white outline, one extraperinuclear nanocourse is 
indicated with blue outline, one perinuclear nanocourse is drawn out by green outline, 
and one nuclear invagination is circled by yellow. N=3 cells. 
(Bi) One subplasmalemmal nanocourse is shown at higher magnification. The upper, 
middle and lower panels show the same subplasmalemmal nanocourse at three time 
points. Hotspot 1 (H1, black) and hotspot 2 (H2, orange) were pointed out by grey 
circles. (ii) Fluo-4 fluorescence ratio (Fx/FC0) versus time for hotspot 1(H1, black) and 
hotspot 2 (H2, orange) were plotted. F0 = Fluo-4 fluorescence intensity for the chosen 
hotspot at time 0; Fx = fluorescence intensity for the chosen hotspot at time point x. 
(iii) Fluo-4 fluorescence ratio (Fx/FC0) versus time for the nanocourse was plotted. F0 
= Fluo-4 fluorescence intensity for the nanocourse at time 0; Fx = fluorescence 
intensity for the nanocourse at time point x 
(C) As for (B), but showing an extraperinuclear nanocourse. 
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(D) As for (B), but showing a perinuclear nanocourse. 




Figure 3.4 Frequencies of Ca2+ fluxes within the sub subplasmalemmal, 
extraperinuclear and perinuclear nanocourses and nuclear invaginations were 
similar. 
Frequency of the Ca2+ fluxes at the hotspots within the subplasmalemmal, 
extraperinuclear, perinuclear nanocourses and nuclear invaginations are shown in the 
bar chart. Blue bars are for control cells, orange bars represent cells preincubated 
with 1µM of thapsigargin for 1 hour, and red bar shows cells preincubated with 1mM 
of tetracaine for 4 hours. Data are shown as mean±SEM, ns=not significant. n=5 for 
control, n=3 for thapsigargin preincubated, n=4 for tetracaine preincubated. 
 
 
Next, I decided to investigate the nature of the SR Ca2+ release channels that support 
observed spontaneous Ca2+ flux within the cytoplasmic nanocourses. PASMCs were 
preincubated with the non-selective RyR inhibitor tetracaine for 4 hours, which has 
been shown to block all three subtypes of RyRs (Laver and van Helden, 2011). 
Following the block of RyRs with tetracaine, the cytoplasmic nanocourses were no 
longer well defined in either raw or deconvolved Z sections, although some evidence 
of such networks was seen on occasion but not in every Z section captured. Figure 
3.5 shows 2 consecutive frames from one deconvolved time course video, which 
shows one tetracaine treated PASMC that exhibited, albeit poorly defined, evidence 
of cytoplasmic nanocourses. As the result,  I cannot confidently trace and reliably 
analyze most of the cytoplasmic nanocourses after tetracaine preincubation.  
As Figure 3.5 shows, I was still able to identify nuclear invaginations by Fluo-4 
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intensity in all tetracaine preincubated cells, as indicated by the white star, and these 
were maintained throughout the entire time series. This suggests three possibilities 
(1) the unique geometry of nuclear invaginations and / or their demarcation by SERCA 
allows them to retain Ca2+ when other regions of the cell cannot, (2) only partial block 
by tetracaine of RyRs within nuclear invaginations was achieved after 4 hour pre-
incubation, or (3) other Ca2+ channels, i.e. IP3Rs, are targeted to the nuclear 
invaginations. My further analysis showed that while the frequency of spontaneous 
Ca2+ flux at hotspots within nuclear invaginations of tetracaine preincubated PASMCs 
(0.15±0.007 s-1, red, Figure 3.4; n=3, Appendix 1, Table 3.6) was similar to control 
(0.14±0.006 s-1), the amplitude of these spontaneous events (0.1±0.01, Figure 3.6C; 
n=4, Appendix 1, Table 3.6) was significantly reduced compared to the control cells 
(0.15±0.01). Therefore, spontaneous Ca2+ flux at hotspots within nuclear 
invaginations is very likely supported by RyRs, and the majority of the Ca2+ fluxes 
observed within other cytoplasmic nanocourses are very likely Ca2+ sparks derived 
from clusters of RyRs. 
 
Figure 3.5 The cytoplasmic nanocourses were not well maintained when RyRs 
were blocked. 
(A) A confocal scan through the middle of a pulmonary arterial smooth muscle cell 
showing the cell loaded with Fluo-4 (green) at 25 oC, preincubated with 1mM of 
tetracaine for 4 hours. Anuclear invagination is indicated with *. 







In support of this view, I show that the separation between the hotspots of Ca2+ flux 
fall in to the range of 200-700 nm, similar to the distances of separation (around 300-
800 nm) reported for the RyR clusters in atrial myocytes and cardiac myocytes 
(Soeller et al., 2007, Macquaide et al., 2015). However, my analysis suggests that the 
distances of separation of hotspots were different for the subplasmalemmal (white), 
extraperinuclear (blue) and perinuclear (green) nanocourses and nuclear 
invaginations (yellow) (Figure 3.6 A). On average, the hotspots in the nuclear 
invaginations were separated by 350±13 nm (yellow, Figure 3.6 A; n=3, Appendix 1, 
Table 3.1), which is similar to 359±15 nm for the distance of separation between 
hotspots of subplasmalemmal nanocourses (white, Figure 3.6 A; n=3, Appendix 1, 
Table 3.1).  
 
However, the distance of separation between hotspots within extraperinuclear 
nanocourses exhibited larger degrees of variability and was significantly greater on 
average at 414±22 nm (p<0.05 compared to the subplasmalemmal hotspots and 
nuclear hotspots, Figure 3.6 A; n=3, Appendix 1, Table 3.1). The distances of 
separation between hotspots of perinuclear nanocourses is 452±32 nm (green, Figure 
3.6 A; n=3, Appendix 1, Table 3.1), which is slightly larger than that for hotspots within 
extraperinuclear nanocourses and greater than that observed for either 
subplasmalemmal nanocourses or nuclear invaginations. This observation suggests 
that different RyR subtypes might target to the SR that demarcates nanocourses in 
different regions of the cell, because the separation between different subtypes of 









Figure 3.6 Distance of separation between hotspots and amplitudes of Ca2+ 
fluxes within the subplasmalemmal, extraperinuclear and perinuclear 
nanocourses and nuclear invaginations were different. 
(A) Distance of separation between hotspots within the subplasmalemmal (white), 
extraperinuclear (blue) and perinuclear (green) nanocourses and nuclear 
invaginations (yellow) were measured and shown (nm), data are presented as 
mean±SEM, n =3 cells from 3 rats. 
(B) Amplitudes of the Ca2+ fluxes at the hotspots within the subplasmalemmal (white), 
extraperinuclear (blue), perinuclear nanocourses (green) or nuclear invaginations 
(yellow) are shown in the bar chart. Bars with black outline are for control cells, bars 
with purple outline represent the measurements of cells preincubated with 1µM of 
thapsigargin for 1 hour, and the bar with grey outline shows cells preincubated with 
1mM of tetracaine. Data are shown as mean±SEM, *=p<0.05, **=p<0.01, *** 





3.2.3 Different types of RyRs and SERCA pumps are strategically targeted to 
different regions of the cell including nuclear invaginations. 
I have shown that the nuclear invaginations support Ca2+ fluxes at rest in a manner 
retained by local cytoplasmic nanospaces. Both RyR inhibition by tetracaine and 
SERCA pump inhibition by thapsigargin attenuated the Ca2+ flux, which indicates that 
RyRs and SERCA pumps may target to nuclear invaginations. This possibility gained 
unexpected support from previous studies using sequence-specific antibodies against 
each of the multiple types of SERCAs (Clark et al., 2010b, Eggermont et al., 1990) 
and RyRs (Herrmann-Frank et al., 1991, Neylon et al., 1995, Kinnear et al., 2008) 
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expressed in arterial smooth muscles.  
 
3.2.3.1 SERCA1 is strategically targeted to nuclear invaginations while SERCA2a/b 
are targeted to cytoplasmic nanocourses  
Previous work of Dr. Jill Clark in the Evans laboratory showed not only that SERCA 
2a and 2b were expressed in PASCMs, but that the former is restricted to the 
perinuclear region and the latter to the subplasmalemmal region of PASMCs (Clark 
et al., 2010a). Moreover, as yet her unpublished data show that SERCA1 is selectively 
targeted to the nucleus. This is evident from 3D reconstruction of deconvolved Z 
sections of SERCA1 labelling of PASMCS (Figure 3.7 A; n = 12), which shows that 
SERCA1 labelling (green) was found only within the boundary of the Dapi labelled 
nucleus (blue). Furthermore, SERCA1 labelling defined tubular, intranuclear networks 
consistent with nuclear invaginations (Figure 3.1). This unique, isoform-specific 
distribution was confirmed by semi-quantitative analysis of the density of labelling for 
each SERCA type within the nucleus, perinuclear region, extraperinuclear region and 
the subplasmalemmal region of the cell (Figure 3.7B; n = 10). SERCA1 may therefore 
function to supply Ca2+ to the NR and its invaginations, and thus provide for a Ca2+ 
store that is spatially and functionally segregated from the perinuclear SR, fed by 










Figure 3.7 SERCA1 is targeted to nuclear invaginations.  
(A) Upper panels show, from left to right, a bright field image of a pulmonary arterial 
smooth muscle cell and 3D rendered, deconvolved fluorescence images of SERCA1 
labelling (green) with and without DAPI labelling of the nucleus (blue). Lower panels 
show, from left to right, a digital surface blending encapsulating SERCA1 labelling 
(rotated relative to upper panels) with and without DAPI labelling and then magnified.  
(B) Bar chart shows the density of labelling (mean±SEM) for SERCA1, SERCA2a and 
SERCA2b (μm3 perμm3), labelling within the 4 designated regions of the cell. Colours 
indicate labelling within the nucleus (yellow), surrounding perinuclear region (gold; 
within 1.5 μm of the nucleus) extraperinuclear region (pink) and subplasmalemmal 
regions (blue; within 1.5 μm of the plasma membrane).    
*=p<0.05, **=p<0.01, *** =P<0.001, ****=p< 0.0001. 
 
3.2.3.2 RyR1 is strategically targeted to invaginations of the nucleoplasmic reticulum  
Dr. Jill Clark’s unpublished work also showed that allied with the targeting of SERCA1 
to nuclear invaginations, RyR1 was found to target to defined tubular, intranuclear 
networks (red, Figure 3.8A, n = 10) within the boundary of the Dapi labelled nucleus 
(blue). Moreover, of the three RyR subtypes expressed in PASMCs (Yang et al., 2005), 
only RyR1 was identified within the boundary of the Dapi labelled nucleus (blue, 
Figure 3.8B). Importantly, RyR1 labelling, like SERCA1, depicted tubular structures 
within the nucleus, suggesting that it is targeted to the nuclear invaginations. 
Therefore, NR resident SERCA1 and RyR1 are strategically positioned within nuclear 
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invaginations and likely support the local release of Ca2+ to the cytoplasmic lumen 
demarcated by each nuclear invagination. Of further note is the fact that RyR1 was 
also identified as the predominant RyR subtype targeted to the subplasmalemmal 
region of the cell, where the distances of separation for the hotspots of Ca2+ flux is 
similar to that for hotspots within nuclear invaginations. By contrast, Clark and co-
workers showed that RyR3 was restricted to the perinuclear region of the cell and 
RyR2 to the extraperinuclear region, where significantly greater distances of 




Figure 3.8 RyR 1 is targeted to nuclear invaginations.  
(A) Upper panels show, from left to right, a bright field image of a pulmonary arterial 
smooth muscle cell and 3D rendered, deconvolved fluorescence images of RyR1 
labelling (red) with and without Dapi labelling of the nucleus (blue). Lower panels show, 
from left to right, a digital surface blending encapsulating RyR1 labelling (rotated 
relative to upper panels) with and without Dapi labelling and then magnified. Colours 
indicate labelling within the nucleus (yellow), surrounding perinuclear region (gold; 
within 1.5 μm of the nucleus) extraperinuclear region (pink) and subplasmalemmal 
regions (blue; within 1.5 μm of the plasma membrane).    
(B) Bar chart shows the density of labelling (mean±SEM) for RyR1, RyR2 and RyR3 
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labelling (μm3 perμm3) within the 4 designated regions of the cell. *=p<0.05, **=p<0.01, 




3.2.4 RyR1 supports selective Ca2+ release into nuclear invaginations and 
cytoplasmic nanocourses of the subplasmalemmal region in pulmonary arterial 
myocytes  
Given above, I hypothesized that different subtypes of RyRs are preferentially 
targeted to the subplasmalemmal, extraperinuclear, perinuclear nanocourses and 
nuclear invaginations. To test this hypothesis, I investigated the effects of the 
extracellular application of a RyR1 agonist on Ca2+ flux within PASCMs. The RyR1 
agonist maurocalcine is a membrane traversing peptide from scorpion venom that can 
selectively activate RyR1 and lock it in a long-opening subconductance (Altafaj et al., 
2007).  
 
Figure 3.9 Ai-iii show the effect of extracellular addition of the RyR1 agonist 
maurocalcine on an acutely isolated PASMC loaded with Fluo-4. Consistent with the 
preferential targeting of RyR1 to subplasmalemmal region and nuclear invaginations 
of PASMCs, maurocalcine preferentially induced an increase in Fluo-4 fluorescence 
within subplasmalemmal nanocourses and nuclear invaginations. To illustrate this, 
examples of a subplasmalemmal nanocourse (white), an extraperinuclear 
nanocourse (blue), a perinuclear nanocourse (green) and a nuclear invagination 
(yellow), are indicated in Figure 3.9 Ai and shown on an enlarged scale in Figure 3.9 
Bi-Ei. The 4 panels from top to bottom show the response of each nanocourse at 4 
time points (from baseline to peak). Panel ii and iii show the Fluo-4 fluorescence 
intensity against time (FX/F0) for each hotspot identified by ROI (Figure 3.9 Bii-Eii) and 
for each nanocourse as a whole (Figure 3.9 Biii-Eiii). It is evident that maurocalcine-
induced increases in Ca2+ flux (indicated by the increase of Fluo-4 intensity) did not 
propagate away from the nanocourses, i.e. these Ca2+ signals were confined within 
the nanocourses within which they arise. Figure 3.9 B-E clearly show that 
maurocalcine induced drastic Ca2+ release at defined hotspots within the 
subplasmalemmal nanocourses and nuclear invaginations. Moreover, an increase in 
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mean Ca2+ concentration within these cytoplasmic nanocourses was observed after 
maurocalcine application, which was restricted within the nanospace. This is evident 
from the marked increase in mean Fluo-4 fluorescence against time for the entire area 
of the selected subplasmalemmal nanocourse (Figure 3.11B). That maurocalcine 
preferentially increases Ca2+ flux within subplasmalemmal nanocourses is 
emphasized by the response of a second example cell (Figure 3.10) within which 
concomitant activation of an entire series of subplasmalemmal nanocourses is 
evident within one confocal plane, with the increase in Fluo-4 fluorescence appearing 
as a bright ring spanning the entire perimeter of the cell (Figure 3.10 Aiii). Figure 3.9 
Bii shows that in response to maurocalcine, Ca2+ flux is triggered at all hotspots (H1 
in black and H2 in orange) within the subplasmalemmal nanocourse, and adjacent 
hotspots are activated in an asynchronous manner. This observation shows that the 
observed subplasmalemmal hotspots appear to be clusters of RyR1s. In contrast to 
outcomes for subplasmalemmal nanocourses, there was significantly smaller Ca2+ 
flux in the extraperinuclear (Figure 3.9 C) nanocourses and perinuclear nanocourses 
in response to maurocalcine (Figure 3.9 D). However, within the nuclear invaginations, 
a pronounced increase in Ca2+ flux was evoked by maurocalcine (Figure 3.9 E). These 
data provide strong corroboration of my hypothesis that RyR1 preferentially supports 





Figure 3.9 Maurocalcine triggers Ca2+ release majorly in the subplasmalemmal 
nanocourses and nuclear invaginations. 
(Ai) Confocal scan through the middle of a pulmonary arterial smooth muscle cell 
loaded (25o C) with Fluo-4 (green) is shown. Draq 5 was applied to indicate the 
nucleus (blue). (ii) Pseudocolour was applied to indicate high Fluo-4 intensity in white-
yellow and low Fluo-4 intensity in black-purple. The nucleus was drawn out by grey 
dotted line. Subplasmalemmal nanocourses were magnified in the white boxes. (iii) 
As in (ii), but showing the response of the cell following the extracellular addition of 
300 nM maurocalcine. n=3 cells from 3 rats.  
(Bi) Higher magnification images of one example subplasmalemmal nanocourse are 
shown. 300nM maurocalcine was added to the cell and the response was recorded, 
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images of the cell at 4 time points (from top to bottom) are displayed to illustrate the 
response. (ii) Fluo-4 fluorescence ratio (Fx/FC0) versus time for hotspot 1(H1, black) 
and hotspot 2 (H2, orange) were plotted. F0 = Fluo-4 fluorescence intensity for the 
chosen hotspot at time 0; Fx = fluorescence intensity for the chosen hotspot at time 
point x. (iii) Fluo-4 fluorescence ratio (Fx/FC0) versus time for the nanocourse was 
plotted. F0 = Fluo-4 fluorescence intensity for the nanocourse at time 0; Fx = 
fluorescence intensity for the nanocourse at time point x 
(C) As for (B), but showing an extraperinuclear nanocourse. 
(D) As for (B), but showing a perinuclear nanocourse. 






Figure 3.10 Maurocalcine triggers Ca2+ release majorly in the subplasmalemmal 
nanocourses and nuclear invaginations. 
(Ai) Confocal scan through the middle of a pulmonary arterial smooth muscle cell 
loaded (25o C) with Fluo-4 (green) is shown. Draq 5 was applied to indicate the 
nucleus (blue). (ii) Pseudocolour was applied to indicate high Fluo-4 intensity in white-
yellow and low Fluo-4 intensity in black-purple. The nucleus was drawn out by grey 
dotted line. Subplasmalemmal nanocourses are magnified in the white boxes. (iii) As 
in (ii), but showing the response of the cell following the extracellular addition of 300 
nM maurocalcine.  
(Bi) Higher magnification images of one example subplasmalemmal nanocourse are 
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shown. 300nM maurocalcine was added to the cell and the response was recorded, 
images of the cell at 4 time points (from top to bottom) are displayed to illustrate the 
response. (ii) Fluo-4 fluorescence ratio (Fx/FC0) versus time for hotspot 1(H1, black) 
and hotspot 2 (H2, orange) were plotted. F0 = Fluo-4 fluorescence intensity for the 
chosen hotspot at time 0; Fx = fluorescence intensity for the chosen hotspot at time 
point x. (iii) Fluo-4 fluorescence ratio (Fx/FC0) versus time for the nanocourse was 
plotted. F0 = Fluo-4 fluorescence intensity for the nanocourse at time 0; Fx = 
fluorescence intensity for the nanocourse at time point x 
(C) As for (B), but showing an extraperinuclear nanocourse. 
(D) As for (B), but showing a perinuclear nanocourse. 






These observations received support from the quantitative analysis of the peak 
change in Fluo-4 fluorescence within identified hotspots and corresponding 
cytoplasmic nanocourses as a whole. The peak change for maurocalcine-induced 
increases in Fluo-4 fluorescence of hotspots within nuclear invaginations was the 
greatest, measuring 1.5±0.3 (Figure 3.11 B, yellow bar; n=3, Appendix 1, Table 3.7). 
The peak change for hotspots within subplasmalemmal nanocourses was as large as 
1.1±0.1(Figure 3.11 B, white bar; n=3, Appendix 1, Table 3.7). Both of them exhibited 
greater increases in Fluo-4 fluorescence than either extraperinuclear hotspots 
(0.5±0.02; Figure 3.11 B, blue bar; n=3, Appendix 1, Table 3.7), or perinuclear 
hotspots (0.4±0.04; Figure 3.11 B, green bar; n=3, Appendix 1, Table 3.7). Analysis 
of nanocourse wide Fluo-4 fluorescence gave similar outcomes, the peak change of 
the Ca2+ signals within nuclear invaginations was 1.2±0.3 (Figure 3.11 B, yellow bar; 
n=3, Appendix 1, Table 3.8), the peak change of Ca2+ flux generated in 
subplasmalemmal nanocourses was 1.0±0.03 (Figure 3.11 B, white bar; n=3, 
Appendix 1, Table 3.8), and both were greater  compare to that of either 
extraperinuclear nanocourses (0.4±0.03, Figure 3.11 B, blue bar,; n=3, Appendix 1, 
Table 3.8) or perinuclear nanocourses (0.2±0.03, Figure 3.11 B, green bar; n=3, 
Appendix 1, Table 3.8). Moreover, the activities of subplasmalemmal and nuclear 
hotspots were enhanced following addition of maurocalcine, which gains some 
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support from the comparison of the standard deviation of the Fx/F0 under control and 
test conditions (Figure 3.11 C). Although not statistically significant, values measured 
from the subplasmalemmal hotspots and nuclear hotspots were both higher after drug 
application. 
 
In contrast to outcomes for measures of basal activity, it is notable that in response to 
maurocalcine the peak change in Fluo-4 fluorescence for hotspots was slightly higher 
than but not significantly different from that measured for the corresponding 
nanocourses, suggesting the induced Ca2+ fluxes were restricted within the 
nanocourses. 
 
The differential activation of these nanocourses by maurocalcine supports the view 
that RyR1 is preferentially targeted to the subplasmalemmal nanocourses and the 
nuclear invaginations. Moreover, outcomes are consistent with the proposal that 
vasodilators such as β-adrenoceptor agonists trigger Ca2+ flux into the PM-SR 
junction of pulmonary arterial smooth muscle cells in order to promote cell relaxation 
through, in part, consequent activation of BKca channels and plasma membrane 
hyperpolarization (Boittin et al., 2003). I observed not only preferential increases in 
Ca2+ flux within subplasmalemmal nanocourse (Figure 3.9&3.10 Aiii), but also 
concomitant cell relaxation upon application of maurocalcine. The cell area 
significantly increased from 27±3 μm2 to 30±3 μm2 (Figure 3.11 A, Appendix 1, Table 







Figure 3.11 Maurocalcine triggers Ca2+ release into the subplasmalemmal 
nanocourses and nuclear invaginations, and leads to arterial myocytes 
relaxation. 
(A) Cell area (µM2) before and after extracellular application of 300 nM maurocalcine 
was calculated and plotted, data presented as mean±SEM, n=3 cells from 3 rats. 
(B)Peak changes of the Ca2+ fluxes after extracellular application of 300 nM 
maurocalcine was calculated (Fx/F0), the peak changes of the subplasmalemmal, 
extraperinuclear, perinuclear and nuclear nanocourses (blue) or hotspots (red) were 
shown in the bar chart. Data are shown as mean±SEM, *=p<0.05, **=p<0.01, *** 
=P<0.001, ****=p< 0.0001, n=3 cells from 3 rats. 
 
(C) Standard deviation of the Fx/F0 values for the subplasmalemmal, extraperinuclear, 
perinuclear and nuclear hotspots were calculated, the standard deviation before 
maurocalcine addition (green) or after maurocalcine addition was compared. Data are 










3.2.5 Angiotensin II induces myocytes contraction by selective activation of 
Ca2+ flux into perinuclear and extraperinuclear nanocourses  
The fact that Ca2+ release into subplasmalemmal nanocourses triggers PASMC 
relaxation led to another consideration, which is whether vasoconstrictors can also 
selectively induce Ca2+ release into nanocourses that specify cell contraction. To test 
this, 30 µM angiotensin II was applied to acutely isolated PASMCs and the responses 
were recorded by confocal microscopy as above. Figure 3.12 A shows an acutely 
isolated PASMC before and during extracellular application of the vasoconstrictor 
angiotensin II. The responses observed were yet more complex than I expected. 
Figure 3.12 Ai-iv shows 6 frames from the time series of deconvolved confocal images 
that were selected to illustrate the response at key time points. The cell is first shown 
at rest (Figure 3.12 Ai; see also Figure 8.1 in appendix 1). Following addition of 
angiotensin II, it was striking that the Fluo-4 fluorescence within all cytoplasmic 
nanocourses fell (Figure3.12 Aii) immediately before the leading edge of a 
subsequent Ca2+ wave was initiated within one well defined, extraperinuclear 
nanocourse at one pole of the cell (A iii), the Ca2+ wave propagated across to the 
opposite pole of the cell (Figure 3.12 Aiv) as Fluo-4 fluorescence declined in its wake 
(Figure 3.12 Av). In marked contrast, there was a relatively small change in Fluo-4 
fluorescence within subplasmalemmal nanocourses (Figure 3.12 Ai-v, insets), which 






Figure 3.12 Vasoconstrictor triggers Ca2+ release in the extraperinuclear, 
perinuclear nanocourses and nuclear invaginations. 
(A) A series of confocal scans through the middle of a pulmonary arterial smooth 
muscle cell loaded (25o C) with Fluo-4 is shown in the upper panels. Pseudocolour 
was applied to indicate high Fluo-4 intensity in white-yellow and low Fluo-4 intensity 
in black-purple. The nucleus was drawn out by a yellow box. Subplasmalemmal 
nanocourses were magnified in the white boxes aligned at top and bottom. The 
response of the cell following the extracellular addition of 30 µM angiotensin II is 
shown by displaying the images of the cell at 6 time points (i-vi). The lower panels 
show the higher magnification images of the nucleus at the 6 time points (i-vi). 
Detection threshold was modified to show clearly the nuclear invaginations without 
signal saturation. The nucleus (N) and three sites of the nuclear invaginations (NI1, 
NI2 and NI3) are indicated by white arrow heads. 
(B) Fluo-4 fluorescence ratio (Fx/FC0) versus time for the regions of interests 
(subplasmalemmal region in white, extraperinuclear region in blue, perinuclear region 
in green, nucleus in black, nuclear invaginations in yellow, NI1 in red, NI2 in yellow, 
and NI3 in purple) were plotted. F0 = Fluo-4 fluorescence intensity for the region of 
interest at time 0; Fx = fluorescence intensity for the chosen region of interest at time 






Unfortunately, the propagating Ca2+ wave triggered by angiotensin II was 
accompanied by such marked cell contraction that it was impossible to track most of 
cytoplasmic nanocourses, although I was able to track individual nuclear 
invaginations in most cells studied. Therefore, instead of quantifying the Ca2+ increase 
in the nanocourses, I plotted the Ca2+ increase in the subplasmalemmal, 
extraperinuclear and perinuclear regions as well as in the nuclear invaginations. The 
peak change in Fluo-4 fluorescence ratio measured 1.0± 0.2 in the extraperinuclear 
region (Figure 3.13B; n=8, Appendix 1, Table 3.10), 1.3±0.3 in the perinuclear 
nanocourses (Figure 3.13B; n=8, Appendix 1, Table 3.10). By contrast, only small 
increase in Fluo-4 fluorescence was observed within the subplasmalemmal region 
(0.4±0.2; Figure 3.13B; n=8, Appendix 1, Table 3.10). As one might expect, the Ca2+ 
wave induced by angiotensin II was accompanied by contraction of all PASMCs, the 
area of cells reduced from 101±11 μm2 to 89±10 μm2 (Figure 3.13B, p<0.05; n=8, 
Appendix 1, Table 3.11). Publication showed that RyR3 is primarily targeted to the 
perinuclear region while the RyR2 is preferentially targeted to the extraperinuclear 
region of PASMCs (Clark et al., 2010a). It was therefore proposed that the Ca2+ 
transients released from RyR3 would be amplified by RyR2 as propagating Ca2+ 
waves, and the global Ca2+ waves may trigger vasoconstriction. Not entirely 
consistent with this view, I show that the vasoconstrictor angiotensin II induced Ca2+ 
release in both the extraperinuclear nanocourses and perinuclear nanocourses 
(which was initiated from extraperinuclear nanocourses), causing contraction of the 
pulmonary arterial myocytes.  
 
Surprisingly, the biggest response to angiotensin II appeared within the nuclear 
invaginations, with the peak change reaching 1.7±0.4 (Figure 3.13B; n=8, Appendix 
1, Table 3.10), yet no increase in Fluo-4 fluorescence was evident within the 
nucleoplasm. The angiotensin II induced increase in Fluo-4 fluorescence within 
nuclear invaginations was larger than that measured in response to maurocalcine but 
not significantly, which may be relevant to the differential action of vasoconstrictors 
versus vasodilators at the level of the nucleus.  
 
To conclude, the cytoplasmic nanocourses form a cell-wide web for the coordination 
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of Ca2+ signalling and the regulation of smooth muscle function. Ca2+ signals in the 
subplasmalemmal nanocourses trigger smooth muscle relaxation while Ca2+ release 
into the perinuclear and extraperinuclear nanocourses induce smooth muscle 
contraction. This coordination of Ca2+ signalling is underpinned by strategic 
positioning of different subtypes of RyRs in the cytoplasmic nanocourses. To be 
specific, RyR1 is preferentially targeted to the subplasmalemmal nanocourses 
whereas RyR3 is majorly targeted to the perinuclear nanocourses, RyR2 is perhaps 




Figure 3.13 Angiotensin II triggers Ca2+ release into the perinuclear and 
extraperinuclear nanocourses, and leads to arterial myocytes contraction. 
(A) Cell area (µM2) before and after extracellular application of 30 µM angiotensin II 
was calculated and plotted, data presented as mean±SEM, n=8. 
(B) Peak changes of the Ca2+ transients after extracellular application of 30 µM 
angiotensin II was calculated (Fx/F0), the peak changes within the subplasmalemmal, 
extraperinuclear, perinuclear and nuclear nanocourses (blue) or hotspots (red) were 
shown in the bar chart, in the absence or presence of 1µM thapsigargin, or 1mM 
tetracaine, or 100µM 8-bromo-cADPR Data are shown as mean±SEM, *=p<0.05, 
**=p<0.01, *** =P<0.001, ****=p< 0.0001, n=7 for control cells, n=5 for thapsigargin 









3.2.6 Nuclear invaginations demarcate Ca2+ signalling. 
My aforementioned data suggest that nuclear invaginations might represent a discrete 
signalling domain. To explore this further, I first assessed whether the NR holds a 
releasable Ca2+ store. 
 
3.2.6.1 Nuclear invaginations define cytoplasmic nanodomains that can shape Ca2+ 
signals arisen from the adjacent NR Ca2+ store  
Nuclear invaginations are able to generate independent Ca2+ signals in response to 
the RyR1 agonist, which arise from a thapsigargin-sensitive SR store. Consistent with 
this view, previous studies have shown that the NR is continuous with ER (Echevarria 
et al., 2003), suggesting that the NR has the capacity to function as a Ca2+ store. In 
order to determine whether or not this was the case in PASMCs, I co-labelled acutely 
isolated cells with ER-tracker and a Ca2+ indicator, Calcium Orange (Figure 3.14, n=7), 
with the nucleoplasm identified by Draq 5 (blue). A series of confocal Z sections 
through a PASMC (step interval of 200 nm) revealed the SR and the NR by way of 
ONM labelling by ER-tracker (yellow; Figure 3.14B upper panel). Loading of the SR 
and NR lumen with the Ca2+ indicator Calcium Orange (red) in the absence (Figure 
3.14B middle panel) and presence of ER-tracker (Figure 3.14B lower panel) revealed 
that the NR held a Ca2+ store that appeared to be continuous with the perinuclear SR. 
Figure 3.14 Aii&iii Show the nucleus at higher magnification, and illustrate the fact that 
the NR is essentially a Ca2+ store, that might support the local generation of Ca2+ 





Figure 3.14 The nucleoplasmic reticulum holds a Ca2+ store. 
(A) confocal Z sections through the middle of a PASMC labelled with ER-tracker 
(yellow), Calcium Orange at 37 oC (red) and Draq 5 (blue) shows that the 
nucleoplasmic reticulum (NR) serves as a Ca2+ store that is continuous with the 
perinuclear ER/SR. The nucleoplasm is labelled by Draq5 (N, blue), and one example 
of nuclear invagination is indicated with I. n=7. 
(B) The upper panel shows a series of confocal Z sections through a PASMC with the 
SR and nuclear membrane identified by ER-tracker (yellow) and the nucleoplasm by 
Draq5 (blue). The middle panel shows the same focal planes but for Calcium Orange 
(red) and Draq 5 (blue) labelling. The lower panel shows the same focal planes but 








3.2.6.2 Nuclear invaginations give rise to temporally and spatially restricted Ca2+ 
signals 
The nuclear invaginations are perhaps the most intriguing cytoplasmic nanocourses 
of all kinds, considering that they display the highest increase in Fluo-4 fluorescence 
intensity upon stimulation compared to other cytoplasmic nanocourses. My findings 
in this respect are surprising, when one considers this and the fact that the role of 
nuclear invaginations in coordinating Ca2+ signalling received little attention before. 
Until now nuclear invaginations have been considered to be little more than an 
extension of the nuclear envelope, which has been proposed to either serve as a 
“ buffer barrier” to buffer the cytoplasmic Ca2+ from entering the nucleoplasm (al-
Mohanna et al., 1994), or provide the surface area necessary to maximize direct Ca2+ 
entry from the cytoplasm or Ca2+ release from the nucleoplasmic reticulum (see 
review (Bootman et al., 2009). My data suggest a model that does not entirely agree 
with either of these proposals, in that activation of RyR1 clusters within nuclear 
invaginations triggers an increase in Ca2+ (indicated by Fluo-4 fluorescence) within 
the cytoplasmic nanospaces demarcated by each activated invagination, that neither 
propagate to the nucleoplasm nor the proximal cytoplasm (Figure 3.9, 3.10 &3.12). 
 
More detailed statistical analysis supports this proposal. The mean Fluo-4 
fluorescence intensity within the nucleus was significantly lower than that within the 
nuclear invaginations at rest (p<0.0001, Figure 3.15 A, Appendix 1, Table 3.12). In 
response to maurocalcine, the amplitude of Ca2+ transients in the nuclear 
invaginations reached 1.2±0.3 (yellow, Figure 3.15 C, Appendix 1, Table 3.13), which 
is significantly higher than the peak change in the nucleus (0.4±0.2, black bar, p<0.01, 
Figure 3.15 C, Appendix 1, Table 3.13). Notably, the nuclear increase of Fluo-4 
fluorescence is most likely an overestimate of the true values due to out of focus 
fluorescence from the adjacent nuclear invaginations. Following depletion of 
thapsigargin-sensitive Ca2+ stores, maurocalcine-induced Ca2+ release within nuclear 
invaginations was abolished (Figure 3.15 C). Moreover, inhibiting RyRs with 
tetracaine also abolished the maurocalcine induced Ca2+ signals in the nuclear 
invaginations (Figure 3.15 C). Taking these facts together, it can be concluded that 
RyR1s are targeted to the ONM of nuclear invaginations, maurocalcine evokes RyR1-
dependent Ca2+ release into the cytoplasmic nanodomain of nuclear invaginations, 
from a thapsigargin-sensitive NR Ca2+ store. Consistent with this, angiotensin II also 
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induced marked Ca2+ release into the nuclear invaginations but not the nucleoplasm 
as Figure 3.15 B shows. The peak change in Fluo-4 fluorescence within nuclear 
invaginations reached 1.7±0.4 (Figure 3.15 B, Appendix 1, Table 3.14), which is 
significantly higher than the peak change in Fluo-4 fluorescence within the 
nucleoplasm (0.6±0.2, black bar, p<0.01, Figure 3.15 B, Appendix 1, Table 3.14). 
Angiotensin II induced Ca2+ signals were abolished by the depletion of the 
thapsigargin-sensitive Ca2+ store, by the inhibition of RyRs with tetracaine. Although 
angiotensin II may induce Ca2+ release from both the RyRs and IP3Rs by inducing 
cADPR and IP3 production (Dolgacheva et al., 2016), my data seem to suggest that 
RyRs are the main Ca2+ releasing channels responsible for the induced Ca2+ release 
within nuclear invaginations. Moreover, the Angiotensin II induced Ca2+ release was 
suppressed by the preincubation of 8-bromo cyclic ADP-ribose, a cyclic ADP-ribose 
(cADPR) antagonist. This is consistent with published data that angiotensin II may 




Figure 3.15 Induced Ca2+signals were generated within the nuclear 
invaginations but not the nucleoplasm. 
(A) Basal Ca2+ concentration (F/F0) within the nucleus or the nuclear invaginations 
was calculated. Data are shown as mean±SEM, *=p<0.05, **=p<0.01, *** =P<0.001, 
****=p< 0.0001, n=7 
(B) Peak changes of the Ca2+ transients after extracellular application of 30 µM 
angiotensin II was calculated (Fx/F0), the peak changes in the nucleus (black) or the 
nuclear invaginations (yellow) are shown in the bar chart. The cells were untreated 
(n=7), or preincubated with 1 µM thapsigargin (n=5), or preincubated with 1 mM 
tetracaine (n=4), or preincubated with 100 µM 8-bromo cyclic ADP ribose (n=3). Data 
are shown as mean±SEM, *=p<0.05, **=p<0.01, *** =P<0.001, ****=p< 0.0001. 
(C) Peak changes of the Ca2+ transients after extracellular application of 300 nM 
maurocalcine was calculated (Fx/F0), the peak changes in the nucleus (black) or the 
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nuclear invaginations (yellow) are shown in the bar chart. The cells were untreated 
(n=3), or preincubated with 1 µM thapsigargin (n=4), or preincubated with 1 mM 







However, it is evident that Ca2+ signalling within nuclear invaginations is more 
complicated than one might expect, even when considering my findings thus far. As 
Figure 3.12 A lower panels show, the degrees of Angiotensin II-dependent “activation” 
varied between different invaginations within a single cell, and between different sites 
along the length of the same nuclear invaginations. To investigate whether the nuclear 
invaginations within the same cell would exhibit differential capacity to generate Ca2+ 
signals, I analyzed further the response of nuclear invaginations to maurocalcine. 
Acutely isolated PASMCS were loaded with Fluo-4, confocal Z sections were taken 
through the middle of one exemplar cell, and deconvolved. A 3D surface plot of the 
cell was built with pseudocolour representation of variations in Fluo-4 fluorescence 
intensity (Figure 3.16Aii-B). Following extracellular addition of maurocalcine, Ca2+ 
transients were induced in the nuclear invaginations. Figure 3.16 Bi-iv shows 4 
selected frames from the time series, with 3D surface plots of the nucleus illustrating 
the response at each time points. Figure 3.16 Bi shows the nucleus at rest, and 
nuclear invaginations can be clearly seen. Two nuclear invaginations were selected 
as examples, I1 indicates one nuclear invagination that is above I2, while I2a and I2b 
refer to two sites along the length of the same nuclear invagination, all of which were 
further magnified as shown in Figure 3.16 C. Interestingly, little Ca2+ increase was 
observed in I1, although a small transient was observed within I1 at time point 4 
(Figure 3.16 C, upper panels). By contrast, marked increases in Fluo-4 fluorescence 
was observed in I2b via two hotspots; the increase was initiated at time point 2 and 
was evident at time point 3. Interestingly, I2a represents a site that is adjacent to I2b 
on the same nuclear invagination. Increases in Fluo-4 fluorescence within I2a were 
limited in terms of propagation, and it was clear that induced changes were 
asynchronous to I2b (see time point 3). Given the above, it can be concluded that the 
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magnitude and kinetics of Ca2+ signals evoked within adjacent invaginations or 
adjacent sites along the same invagination vary markedly. 
 
Some of the confocal imaging mentioned in this Chapter (i.e. the angiotensin II 
experiments with thapsigargin preincubated cells) were done in collaboration with Dr. 
Jorge Navarro-Dorado, who also kindly provided technical supports and did some of 






Figure 3.16 Nuclear invaginations give rise to temporally and spatially restricted 
Ca2+ signalling in arterial smooth muscle cells. 
(Ai) Confocal Z section of a pulmonary arterial smooth muscle cell loaded (25o C) with 
Fluo-4 is shown, the fluorescence intensity indicated by pseudocolour representation 
on the vertical axis as per the scale shown in the look up table. (ii) 45o rotation of the 
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3D surface plot built from the image shown in (i). 
(B) Higher magnification confocal Z sections of nuclear region selected within (A) are 
shown at (from left to right) different time points (i, ii, iii and iv) following extracellular 
application of maurocalcine (200 nM). 
(C) As for (B) but showing higher magnification confocal Z sections of each of the 2 
nuclear invaginations (I1, I2a and I2b) indicated. 




























3.3.1 Summary of findings 
Chapter 3 shows that cytoplasmic nanocourses are defined by the SR in PASMCs, 
and they form a cell-wide web for the segregation of Ca2+ signaling that is underpinned 
by strategic positioning of RyRs. RyR1 is preferentially targeted to the 
subplasmalemmal nanocourses and nuclear invaginations whereas RyR2 and RyR3 
may target to the extraperinuclear and perinuclear regions respectively, as reported 
before (Clark et al., 2010a). It seems likely, therefore, that Ca2+ signals arising from 
different cytoplasmic nanocourses may support different smooth muscle functions. 
Consistent with this view I showed that the Ca2+ signals in the subplasmalemmal 
nanocourses trigger PASMC relaxation, whereas Ca2+ signals arising in the 
perinuclear and extraperinuclear nanocourses lead to PASMC contraction. Spatially 
restricted Ca2+ signals were also generated within the nuclear invaginations. Ca2+ 
pumps (SERCA1) and release channels (RyR1) are strategically positioned in the 
nuclear invaginations for the generation of Ca2+ signals arising from the NR, in a 
manner that may regulate gene expression (see Chapter 4). 
 
Therefore, the cytoplasmic nanocourses of the PASMCs form a cell-wide web 
extending from the cell periphery to the nucleus, where they provide a mechanism for 
the spatial and functional segregation of intracellular Ca2+ signals, that may coordinate 
different smooth muscle functions. 
 
3.3.2 Cytoplasmic nanocourses form a cell-wide web in PASMCs, within which 
hotspots of spontaneous Ca2+ flux was observed. 
By conducting high resolution live cell confocal followed by deconvolution, the network 
of cell-wide nanocourses that exhibit high Ca2+ concentrations at rest were 
successfully revealed for the first time. These nanocourses are far more extensive 
and complicated than one might expect from previous proposals regarding the extent 
and function of nanojunctions of the sarcoplasmic reticulum (Evans et al., 2016, van 
Breemen et al., 2013). Based on early studies, cytoplasmic nanocourses were divided 
into 3 groups, namely the subplasmalemmal nanocourse, extraperinuclear 




Interestingly, I observed hotspots of Ca2+ activities within all cytoplasmic nanocourses 
identified, the Ca2+ fluxes within which were suppressed by SR depletion, and 
following RyR inhibition. This suggests that at least a major part of the Ca2+ fluxes 
within cytoplasmic nanocourses of differentiated PASMCs are Ca2+ sparks generated 
by spontaneous SR Ca2+ release via RyRs. I do not exclude the possibility that some 
of the spontaneous Ca2+ flux observed are Ca2+ puffs from IP3Rs (Shuai et al., 2006) 
as I have not tested the effect of IP3R inhibition on the Ca2+ activities, but if this is the 
case the contribution made at rest would appear to be small. 
 
People started to pay attention to spontaneous Ca2+ sparks in the 1990s (Gordienko 
et al., 1998, Nelson et al., 1995), and these studies characterize Ca2+ sparks arising 
in the subplasmalemmal region of muscle cells. Here, I have completed the first cell-
wide characterization of spontaneous Ca2+ fluxes that has revealed a cell-wide web 
of cytoplasmic nanocourses within acutely isolated PASMCs, consistent with but more 
extensive than original predications (Evans et al., 2016). These hotspots in the 
nanocourses actively generate oscillating Ca2+ fluxes of a similar frequency within the 
cytoplasmic nanocourses, and with similar amplitudes for hotspots of Ca2+ flux within 
each region of approximately 0.16 (ΔFX/F0). These measures are not inconsistent with 
those for spontaneous Ca2+ sparks observed in the smooth muscle cells in several 
previous studies. In retinal arteriolar smooth muscle cells, Ca2+sparks with half 
maximum full width of 1.25±0.05 µm were recorded by line scan, the amplitude of the 
sparks was 0.81±0.04 (ΔFX/F0), and the frequency was 0.56±0.06 per second (Curtis 
et al., 2004). In cerebral arterial smooth muscle cells, spontaneous Ca2+ sparks 
appeared at the frequency of 0.24±0.15 per second, the amplitude of the sparks was 
around 0.79 (ΔFX/F0), which was calibrated as being equivalent to a local Ca2+ 
concentration of ~229 nM (Jaggar et al., 1998). In airway smooth muscle cells 3-35 
Ca2+ sparks were observed per minute (Sieck et al., 1997), and in ileum smooth 
muscle cells the Ca2+ spark amplitude was 1.75±0.23 (ΔFX/F0). Before comparing 
these results with my data it must be noted that these experiments were mostly 
conducted with confocal line scan at lower resolution, the spread of the Ca2+ spark 
ranges from 1-3µm. Considering the size of the nanocourses, it is likely that these 
“Ca2+ sparks” observed in the early studies are the combined effects of the Ca2+ 
sparks generated within multiple nanocourses by a number of hotspots, which are 
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perhaps behaving asynchronously according to my observation. This perhaps 
explains why the frequency of Ca2+ sparks I measured (which is from a single hotspot) 
is smaller than the published data on other smooth muscle cells (which is the 
combined outcome of a number of asynchronous hotspots). Moreover, due to the fact 
that different Ca2+ indicators were applied across these different studies, and the Ca2+ 
indicators display diverse gain of fluorescence upon binding to Ca2+ (Russell, 2011), 
the amplitude of Ca2+ sparks calculated based on (FX/F0) likely varies across studies, 
but they are on a similar scale to my measurement. Notably, the early studies mainly 
documented the Ca2+ sparks in the subplasmalemmal region. In addition to this, I have 
characterized and compared the Ca2+ fluxes in different intracellular nanocourses 
across the cells. My results also suggested that different subtype of RyR might target 
to different nanocourses. 
 
3.3.3 RyR1, 2 and 3 are selectively targeted to different cytoplasmic 
nanocourses. 
As discussed above, the hotspots are likely clusters of RyRs. These hotspots are 
generally separated by 300-500 nm in PASMCs. This observation is consistent with 
the published data which reported that the RyR clusters are separated by 376 ± 17 
nm in sheep atrial myocytes (Macquaide et al., 2015). Intriguingly, my data showed 
that the distances of separation of nuclear hotspots and subplasmalemmal hotspots 
are more closely aligned when compared to the same measures for perinuclear and 
extraperinuclear hotspots. It has been reported that the separation between RyR2 
clusters is around 0.97-1.87 µm in ventricular myocytes and 0.92-1.69 µm in atrial 
myocytes (Chen-Izu et al., 2006), 660 ± 60 nm in rat ventricular myocytes and 780 ± 
70 nm in human ventricular myocytes (Soeller et al., 2007). This is larger than the 
average separation of RyR clusters in PASMCs, suggesting that the separation 
between RyR2 clusters might be larger than the separation of RyR1 or RyR3 clusters. 
Inferring from this, the nuclear, perinuclear, extraperinuclear and subplasmalemmal 
hotspots might be clusters of RyRs of different subtypes. For example, the 
extraperinuclear hotspots exhibit greater separation of distance, suggesting that the 
extraperinuclear nanocourses may harbour more RyR2 clusters than other 




Consistent with the above, I showed that the RyR1 agonist maurocalcine (Chen et al., 
2003) triggers marked increases in Ca2+ flux from the nuclear and subplasmalemmal 
hotspots, but there was limited increase in Ca2+ release from the extraperinuclear and 
perinuclear hotspots within the same cell. This shows that the subplasmalemmal and 
nuclear hotspots are very likely supported by clusters of RyR1s. Moreover, my 
findings suggest that although some RyR1 clusters may be present in the 
extraperinuclear region, they are not the dominant subtype. Consistent with previous 
proposals, there is less RyR1 cluster targeted to the perinuclear region and thus the 
perinuclear nanocourses (Clark et al., 2010a, Kinnear et al., 2008). 
 
The perinuclear hotspots are likely dominated by clusters of RyR3 because it was 
reported that the RyR3 preferentially target to the perinuclear region (Kinnear et al., 
2008, Clark et al., 2010a). The extraperinuclear nanocourses may harbour a mixed 
population of RyR1, 2, and 3 clusters because the distance of extraperinuclear 
hotspots separation falls into a broader range, but the RyR2 clusters might be more 
commonly seen because 1) it was reported that RyR2s are dominant in the 
extraperinuclear region (Clark et al., 2010a); 2) the extraperinuclear hotspots exhibit 
greater distance of separation as discussed above. 
 
It has been noted previously that each RyR subtype displays differential thresholds 
for activation and inactivation by Ca2+ (Chen et al., 1997, Li and Chen, 2001). It is 
therefore plausible that RyRs subtypes of different properties are strategically 
targeted different cytoplasmic nanocourses, resulting in segregated signalling 
compartments for the coordination of smooth muscle functions.  
 
 
3.3.4 Ca2+ signals in the perinuclear and extraperinuclear nanocourses direct 
pulmonary arterial myocytes contraction 
It was shown that adenylyl cyclase-coupled receptors such as β-adrenoceptors evoke 
Ca2+ release via RyRs from the SR by increasing the production of cADPR, which 
activates BKCa and triggers vasodilation (Boittin et al., 2003). However, in the same 
cell type, hypoxia, NAADP and Endothelin-1 have been shown to trigger Ca2+ release 
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via RyRs from the SR and induce vasoconstriction (Boittin et al., 2002, Kinnear et al., 
2008). Therefore, it is intriguing that how the Ca2+ release via RyRs from the SR may 
regulate two distinct smooth muscle functions? The enigma might be resolved by the 
segregation of Ca2+ signals within the PASMCs as proposed previously (Evans et al., 
2016). 
 
My observations for maurocalcine described above show that induced Ca2+ release 
was restricted in subplasmalemmal nanocourses and nuclear invaginations, and led 
to PASMC relaxation. This is consistent with the view that Ca2+ release in the vicinity 
of plasma membrane activates BKCa, the resulting membrane hyperpolarization 
relaxes smooth muscle cells and subsequently causes vasodilation (Boittin et al., 
2003). Therefore, the subplasmalemmal nanocourses can serve as segregated 
nanospaces for the generation of Ca2+ signals that deliver vasodilation. 
 
In contrast, it has been proposed that vasoconstrictors might evoke Ca2+ signals in 
the bulk cytoplasm but not within PM-SR junctions, in order to promote PASMC 
constriction. Early studies illustrated that the activation of the RyRs causes a rapid 
increase in cytosolic Ca2+ concentration and support myocyte contraction. My data 
indicate a distinct path of Ca2+ flux that supports RyR-dependent smooth muscle 
contraction, because the Ca2+ wave induced by angiotensin II was initiated from the 
extraperinuclear nanocourses without causing a measurable rise in Ca2+ within 
subplasmalemmal nanocourses. Moreover, these signals were blocked by 
thapsigargin, tetracaine and 8-bromo cyclic ADP-ribose. In short and consistent with 
previous findings for angiotensin II (Fellner and Arendshorst, 2005), my data show 
that angiotensin II induces myocyte contraction, in part, by inducing a global Ca2+ 
wave by cADPR-dependent activation of RyRs in the vicinity of some extraperinuclear 
nanocourses, which triggers Ca2+ release in those extraperinuclear nanocourses that 
propagates across the cell. The induced Ca2+ wave propagates to, being amplified 
(via CICR by RyRs) and is carried on by the neighboring extraperinuclear 
nanocourses and RyR3 targeted perinuclear nanocourses, resulting in cell-wide Ca2+ 
release and smooth muscle contraction. Therefore, cytoplasmic nanocourses provide 
the mechanism for the segregation of intracellular Ca2+ signalling for the regulation of 




In light of my findings it would appear that, as previously proposed (Evans et al., 2016), 
the signalling segregation by cytoplasmic nanocourses is underpinned by strategic 
positioning of RyR subtypes, because the RyR1, 2 and 3 display differential sensitivity 
to inactivation by Ca2+ (Li and Chen, 2001, Chen et al., 1997).  Both RyR3 and RyR2 
exhibit lower sensitivity to inactivation by Ca2+ compared to RyR1, their channel 
activity may still be observed at when the Ca2+ concentrations reach 10 mM or more 
(Chen et al., 1997; Li & Chen, 2001). Therefore, they are designed to carry 
propagating Ca2+ waves that are not prone to failure.  
In marked contrast, RyR1 inactivation occurs within the micromolar range and full 
inactivation is achieved by 1 mM Ca2+. This means, the RyR1 can cause the elevation 
of Ca2+ concentration in the subplasmalemmal nanocourses and reach the required 
Ca2+ concentration (around 10µM) for BKca channel activation (Zhuge et al., 2002) 
and the subsequent smooth muscle relaxation. However, when a global Ca2+ wave is 
triggered for smooth muscle contraction, which also leads to the opening of Ca2+ 
receptors on the plasma membrane, the RyR1s are perhaps inhibited by the high Ca2+ 
concentration and therefore favours cell contraction.  
 
In this respect it is also interesting to note that Boittin et al showed that RyRs and 
IP3Rs seem support Ca2+ release from segregated SR Ca2+ pools (Boittin et al., 2002). 
Although not studied here, it is therefore possible that some cytoplasmic nanocourses 
are IP3R positive and RyR negative, or at least IP3R dominant. In short, cytoplasmic 
nanocourses may provide for the segregation of different pathways to myocyte 




3.3.5 Invaginations of the nucleoplasmic reticulum in arterial myocytes form 
trans nuclear networks of cytoplasmic nanospaces that give rise to spatially 
restricted Ca2+ signals 
 
I have demonstrated that extensive invaginations of the nucleoplasmic reticulum exist 
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within nuclei of fully differentiated pulmonary arterial smooth muscle cells. It was 
shown that juxtaposed ONM membranes of these invaginations form a network of 
tubules that are continuous with the cytoplasm and project deep into the nucleus of 
arterial myocytes, conferring cytoplasmic nanotubes.  
 
Fluorescent labelling for the sarcoplasmic reticulum and its luminal Ca2+ store 
demonstrated that invaginations of the nucleoplasmic reticulum not only demarcate 
cytoplasmic nanotubes but also provide a releasable Ca2+ store along the entire extent 
of their boundaries. This is consistent with the early finding that the NR can serve as 
a releasable Ca2+ pool (Papp et al., 2003). In support of the releasable NR Ca2+ store, 
a unique S/ER Ca2+ ATPase, SERCA1, was selectively targeted to nuclear 
invaginations, and thus provides for a Ca2+ store that is not only spatially but also 
functionally segregated from the perinuclear SR, fed by SERCA2a, and the superficial 
SR, fed by SERCA2b (Clark et al., 2010b). Moreover, of the three RyR subtypes 
expressed in arterial myocytes (Herrmann-Frank et al., 1991, Neylon et al., 1995), 
only RyR1 was identified within the boundary of the nucleus.  RyR labelling lined 
tubular structures, spatially segregated from labelling for both RyR3 and RyR2. 
Clearly, NR resident SERCA1 and RyR1 deliver the capacity to support site-specific 
Ca2+ signalling within invaginations of the nucleoplasmic reticulum, because both 
pump and channel exhibit different kinetics, “affinities” for Ca2+ and mechanisms of 
regulation when compared to those subtypes targeted to the SR that feeds other 
aspects of the cell. For example, SERCA1 has a higher affinity for Ca2+ than 
perinuclear SERCA2a (Odermatt et al., 1998) and would therefore be the dominant 
path for Ca2+ uptake proximal to the ONM, while RyR1 may restrict signal propagation 
along the invaginations since it provides limited support for Ca2+-induced Ca2+ release 
(Yang et al., 2001, Li and Chen, 2001, Chen et al., 1997). 
 
Consistent with this view, I show that both the RyR1 agonist maurocalcine and the 
vasoconstrictor angiotensin II induced spatially restricted Ca2+ signals within nuclear 
invaginations, that did not propagate to the nucleus. The maurocalcine induced Ca2+ 
transients are clearly released via clusters of RyR1s, because they are blocked by 
tetracaine. Moreover, distances of separation for the hotspots of Ca2+ flux are around 
300 nm along the length of the nuclear invaginations, reflecting the nanopatterning of 




I do not exclude the possibility that other Ca2+ releasing channels (i.e. IP3R) may target 
to nuclear invaginations, although the contribution of IP3Rs present in differentiated 
PASMCs observed here might be limited because the angiotensin II induced Ca2+ 
signals were blocked by the RyR inhibitor tetracaine. 
 
3.3.6 Conclusion 
Nanocourses of the SR form a cell-wide web for Ca2+ signaling in differentiated 
PASMCs, which is underpinned by strategic positioning of different subtypes of RyRs 
and perhaps SERCAs in those nanocourses as Figure 3.17 shows. These 
nanocourses provide mechanism by which intracellular Ca2+ signals are segregated 
for the regulation of smooth muscle functions, from relaxation by the 
subplasmalemmal nanocourses to contraction by the extraperinuclear and 
perinuclear nanocourses. The nuclear invaginations form a trans-nuclear network of 
cytoplasmic nanocourses for Ca2+ signaling, supported by RyR1 and the NR Ca2+ 
store fed by SERCA1. However, the function of the Ca2+ signalling in nuclear 





Figure 3.17 Schematic imaging showing the network of intracellular 
nanocourses 
A PASMC was loaded with the Ca2+ indicator Fluo-4, pseudocolour was applied to 
show high fluorescence intensity in yellow and low fluorescence intensity in blue. 
Predicted position of RyR1, 2, 3; SERCA2a, 2b, 1; IP3R, and BKca channel are 
labelled. The nucleus is circled by grey dotted line. A diagram of the model is showed 





Chapter 4: Nuclear invaginations harbour the machinery 
required to coordinate chromatin attachment 
4.1 Introduction 
4.1.1 Identification of nuclear invagination in a variety of cell types 
The nuclear envelope (NE) is the structure that defines the boundary of the nucleus. 
It is composed of lipid bilayers, namely the outer nuclear membrane (ONM) and the 
inner nuclear membrane (INM). The luminal space that separates the ONM and INM 
by 30-50 nm has been termed perinuclear space (PNS) (Franke et al., 1981). It was 
proposed almost 30 years ago that the nucleus may harbour functionally segregated 
subdomains (Strouboulis and Wolffe, 1996), it was indicated that the transcriptional 
and translational activities involving DNA and RNA occur within defined territories, but 
these subdomains were not bound by membrane. Meanwhile, other scientists started 
to consider the possibility that the NE may contain intranuclear membrane extensions 
that form grooves, tubes or even channels that transverse the nucleus. As early as 
1970s, researchers already identified nuclear invaginations in plant cells (Dickinson 
and Bell, 1972) and mammalian cells (Bourgeois et al., 1979). Benefiting from the 
improvement of confocal microscopy, people confirmed the existence of nuclear 
invaginations within the interphase nuclei of a series of established cultured cell lines 
including HeLa, Vero, NRK, 3T3, A431 and NOR10 (Fricker et al., 1997b). Therefore, 
it can be concluded that nuclear invaginations present in a wide range of cell types; 
they are a universal cellular structure. Nuclear invaginations have also been identified 
in primary cultures of human vascular smooth muscle cells (Avedanian et al., 2011). 
Intriguingly, these structures were not retained after nuclei were isolated from cells, 
which suggests that nuclear invaginations are dynamic structures that may be 
assembled and disassembled in short periods of time.  
 
4.1.2 Nature of nuclear invaginations 
As described above, nuclear invaginations are intranuclear extensions of the NE, 
forming either tubes that end in the centre of a nucleus, or channels that connect two 
sides of the nucleus. They can be classified into two groups based on their membrane 
components. Type 1 invaginations are defined only by the INM whereas type 2 
invaginations are formed by both the ONM and INM as Figure 4.1 shows (Malhas et 
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al., 2011). The two types of invaginations can occur in the same cell, or even coexist 
in the form of type 1 branches at the intranuclear tip of a type 2 invagination. Together 
the NE and the nuclear invaginations form a complex network which has been termed 
as nucleoplasmic reticulum (NR). The number of nuclear invaginations found within a 
single cell varies from zero to more than ten (Fricker et al., 1997a, Broers et al., 2006), 
and it seems that the number of nuclear invaginations is not directly linked to cell-
cycle stage (Fricker et al., 1997b). Consistent with other intracellular nanojunctions, 
the size of nuclear invaginations is on the nanoscale, with the upper limit of their 
diameter estimated, on the basis of immunostaining, ranges from 100-500 nm 
(Schoen et al., 2017). The electron micrographs showed in Figure 4.1 illustrated that 
the diameter of some invaginations may be within 100 nm. 
 
Figure 4.1 Type 1 and type 2 nuclear invaginations are revealed by electron 
microscopy.  
Electron micrograph of mouse embryo fibroblast showing type 1 and type 2 nuclear 
invaginations. Adapted from “The nucleoplasmic reticulum: form and function”, by 





4.1.3 Trans-nuclear envelope proteins 
A particular group of trans-membrane proteins localises to the NE, and they are 
termed as Nuclear Envelope Transmembrane proteins (NETs). These proteins link 
the nucleoplasm to the cytoplasm, and they are responsible for the transduction of 
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signals across the NE. For example, the LINC (linkers of the nucleoskeleton and 
cytoskeleton) complex tethers the NE to the cytoskeleton, and has been proposed to 
transduce mechanical forces across the cell to the nucleus (Hieda, 2017, Kim et al., 
2015, Banerjee et al., 2014). The LINC complex is composed of klarsicht-ANC-1-
SYNE homology (KASH) domain proteins and sad1/UNC-84 homology (SUN) domain 
proteins. KASH domain proteins span the ONM, while the transmembrane domain of 
SUN forms trimers in between the inner and outer nuclear membranes. Moreover, 
either component of the LINC complex can associate with other inner nuclear proteins 
including emerin and the nuclear lamina (see review (Rothballer et al., 2013)).  
 
The nuclear lamina is a protein meshwork that is roughly 15-20 nm thick (Gerace and 
Huber, 2012). It is a prominent feature of metazoan nuclear envelope (Burke and 
Stewart, 2013), lying directly underneath and forming close associations with the inner 
nuclear membrane. The meshwork is constructed with A-type lamins (lamin A, lamin 
C, lamin C2 and lamin AΔ10) and B-type lamins (lamin B1, lamin B2 and lamin B3). 
Considering that the nuclear lamina is extended across the entire inner surface of the 
inner nuclear membrane, it is reasonable to infer that the lamina could possibly 
delineate nuclear invaginations. Indeed, multiple studies identified nuclear 
invaginations by the immunostaining of lamin A or B (Bridger et al., 1993, Luo et al., 
2009). Importantly, the nuclear lamina is proposed to contribute to chromatin 
organization and probably direct transcription and replication (Wilson and Foisner, 
2010). Consistent with this view, a recent study has revealed that lamin A binds the 
lamin-associated-domains on chromatins and thus tethers the chromatin to the 
nuclear periphery, which results in the suppression of gene expression (Harr and 
Reddy, 2016). 
 
Alternatively, chromatin anchoring may be achieved by LAP2-emerin-MAN1 (LEM)-
domain containing proteins, which can facilitate transcriptional silencing (Brachner 
and Foisner, 2011). One well-studied example of LEMs is emerin, which is known to 
associate with the nuclear lamina and is able to bind the barrier-to-autointegration 
factor (BAF). BAF bridges chromatin to emerin, and by influencing histone post-
translational modifications BAF may regulate gene expression (Segura-Totten and 




4.1.4 Aim and hypothesis 
The aim of this chapter is to characterize nuclear invaginations, and to investigate 
their function in pulmonary arterial myocytes. I hypothesize that the nuclear 
invaginations, as a distinct subset of cytoplasmic nanocourses, form a trans-nuclear 
























4.2.1 Key elements of the nuclear envelope transmembrane protein complexes 
are selectively targeted to the NR 
In Chapter 3 I provided the evidence in support of the view that: (1) Nuclear 
invaginations support highly localised Ca2+ release via the NR, into the cytoplasmic 
nanospaces they demarcate but not into the adjacent nucleoplasm; (2) The 
pharmacology of Ca2+ signals generated is consistent with the fact that they arise via 
RyR1 and in a manner supported by the refilling of NR Ca2+ stores via SERCA; (3) 
RyR1 and SERCA1 are selectively targeted to those sections of the NR that comprise 
nuclear invaginations. These findings raise the following question: do Ca2+ signals 
arising within nuclear invaginations regulate genome reorganization and gene 
expression? 
 
Clearly, the transduction and interpretation of Ca2+ signals that enter the cytoplasmic 
nanotubes demarcated by nuclear invaginations cannot directly influence the 
machinery that orchestrates transcriptional processes within the nucleoplasm. 
Therefore, I considered the possibility that the release of NR Ca2+ via RyRs might 
regulate “outside-in” signalling via adjacent protein complexes, that may comprise 
effector proteins. The nuclear envelope transmembrane (NET) proteins are one such 
example. Key among these are the proteins that comprise the nuclear lamina, a 
protein meshwork that lines the entire inner surface of the inner nuclear membrane. 
This nuclear lamina serves as the bridge that connects the nucleoplasm to the 
cytoplasm through the LINC complex and its components, and has been widely used 
to identify and investigate the composition of nuclear invaginations in multiple studies 
(Avedanian et al., 2011, Legartova et al., 2014). My investigations of the role of NET 
proteins were founded on the characterization of nuclear invaginations with lamin A 
and lamin B. 
 
4.2.1.1 Lamin A lines the entire inner nuclear surface of PASMCs, including the 
nuclear invaginations  
It was confirmed by confocal imaging (Figure 4.2 Ai) of acutely isolated arterial 
myocytes labelled for lamin A (red, n=54) that this major component of the nuclear 
lamina lines the entire nucleoplasmic surface of the INM identified by Dapi (blue), 
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which is consistent with previous findings (Burke and Stewart, 2013). Importantly, 
labelling for lamin A not only resolved the entire boundary of the INM, but also clearly 
identified the larger nuclear invaginations (Figure 4.2Aii&Bii), which formed a network 
of tubular structures within the nucleoplasm boundary outlined by lamin A.  
 
Based on morphology, three forms of nuclear invaginations could be identified by 
lamin A labelling. The left panel of Figure 4.2 Aii shows a section of the 3D 
reconstruction of the lamin A labelled nucleus, in the middle panel a region within this 
section is magnified to show an example of the trans-nuclear invaginations (indicated 
with T), which are nuclear invaginations that spanned the entire diameter of the 
nucleus. Next to the trans-nuclear invagination, there is also an example of the blind 
invaginations (indicated with B), which generally take the form of blind-ended tubes 
that exhibit various depths of extension into the surrounding nucleoplasm. The right 
panel of Figure 4.2 Aii displays the same trans-nuclear and blind invaginations at a 
different angle. It can be observed that these invaginations are not plain straight tubes, 
but instead structures that exhibit various curvatures along their lengths. A different 
section of the same 3D model of the nucleus was cropped out as shown in Figure 4.2 
Bii (left panel). This section was magnified to reveal an example (Figure 4.2 Bii middle 
panel, indicated with S) of the superficial invaginations that form “short bridges” that 
appear to cross-connect two closely aligned sites on the NE (Figure 4.2 Bii right panel). 
Moreover, by showing the nuclear invaginations in high magnification, it is clear that 
the diameter of the same invagination varies along its length (Figure 4.8Aii&Bii), 
suggesting that the nuclear invaginations are non-uniform bodies, consistent with the 
observations with electron microscopy (Malhas et al., 2011). This raised the possibility 
that NET proteins might be differentially distributed along the length of nuclear 
invaginations, because NET proteins have been proposed to determine NE 
architecture and luminal diameters (Rothballer et al., 2013). 
 
Unlike published data on the lamin A staining in mouse embryonic fibroblasts that 
showed rounded nuclei with relatively smooth surfaces (Legartova et al., 2014), the 
lamin A staining in acutely isolated PAMSCs uncovered irregularly shaped nuclei with 
“crumpled” surfaces. This is more obvious after the application of a digital skin to the 
3D reconstruction showed in Figure 4.2 A&B (Figure 4.2 Ci), which reveals clear 
grooves and infoldings of the NE that were identified by lamin A labelling. One 
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example of such grooves/infoldings was cropped out from the 3D model and enlarged 
as the left panel of Figure 4.2Cii shows. The structure is displayed at different angles 
(Figure 4.2 Cii, middle and right panel) to show that it is in the shape of a cleft. These 
cleft-like structures have previously been identified by EM (Wittmann et al., 2009), 
and will be referred to from here on as clefts. Aside from clefts, by increasing the 
threshold above which lamin-A labelling was visualized by the image analysis 
software, I identified on the surface of nuclei, a large number of areas of variable sizes 
that could be separated by density from the surrounding lamin A positive lamina. 
These densities are shown in Figure 4.2 Di by displaying the 3D reconstruction of the 
same nucleus (as shown in Figure 4.2 A, B&C) with a digital skin under a higher 
detection threshold. These apparent linear structures ran for variable distances, and 
the rotated section of the 3D model shown in Figure 4.2 Dii revealed that these 
structures ran across the peripheral aspect of the nucleus. Based on the morphology 
of these linear structures as the high magnification images shown in Figure 4.2 Dii 
(middle and right panel), they were named as ridges. Notably, nuclear invaginations 
and the surface infoldings (clefts) have been reported previously (Wittmann et al., 







Figure 4.2 Lamin A labelling of the inner nuclear membrane reveals 3 types of 
nuclear invaginations and peripheral ridges and clefts. 
(Ai) 3D reconstruction of deconvolved Z stacks of confocal images through the 
nucleus of a pulmonary arterial smooth muscle cell labelled for lamin A (red). (ii) 
Rotation and transverse section through the 3D image shown in (i) following 
application of a higher fluorescence threshold and blending (left panel), which 
identifies by sectioning and magnification blind (B) and transnuclear (T) invaginations 
(middle and right panels). 
(B) as in (A) but identifying a blind invagination (B) and a superficial invagination (S). 
(C) Digital skin is applied to the 3D reconstruction showed in (Ai), with low 
fluorescence threshold and blending. (ii) A peripheral cleft is identified by sectioning 
and rotation, and is shown in higher magnification. 






To define and investigate the peripheral ridges, 3D reconstructions of lamin A labelled 
PASMCs were built in a manner that reveals the density of lamin A labelling. For 
example, as Figure 4.3 Ai shows, 3D reconstruction with low detection threshold 
allows the visualization of the entire inner nuclear surface defined by lamin A, which 
becomes evident after the application of a digital skin that sets the boundary (right 
panel). However, there were clearly densities of lamin A surrounded by the lamin A 
positive lamina as shown in the left panel, and they are the peripheral ridges. To 
reveal the ridges, the detection threshold was raised to remove the surrounding lamin 
A positive lamina but showing only the densities of lamin A as Figure 4.3 Aii shows 
(left panel). Following the application of the digital skin (Figure 4.3 Aii, right panel), 
the ridges can be clearly viewed and characterized. 
 
Three types of ridges were identified in PASMCs based on their morphologies. The 
most obvious structures revealed by lamin A density are the deep Y/I shaped ridges, 
which are indicated by a blue box in Figure 4.3. The section of the 3D reconstruction 
outlined by the blue box was cut out and magnified as shown in Figure 4.3Bi with (left 
panel) or without (right panel) the digital skin. These linear structures generally extend 
for a couple of micrometers (n=54). Moreover, it can be seen from the example (Figure 
4.3 Bi) that the deep Y/I shape ridge was the extension of a cleft (indicated with C). 
The same ridge was rotated 90 degrees clockwise and viewed from the side as Figure 
4.3 Bii left panel shows. Judging by the shape and size of the extension, it can be 
concluded that the deep Y/I shape ridges are in fact sheets that extend into the 
nucleus. A section of the ridge was outlined by a white box (Figure 4.3 Bii, middle 
panel), which was magnified and rotated 90 degrees anticlockwise to allow the 
viewing from the front. A dark orange line indicates where the ridge is connected to a 
cleft, and a yellow line was positioned in the middle of the ridge. The 3D model was 
cut at where the dark orange and yellow lines indicate, and was rotated to reveal the 
cross-section (Figure 4.3 Bii, right panel). Judging by the shape of the cross-section 
indicated by the orange box, it can be postulated that the deep Y/I shape ridges are 
extensions of clefts, but not like the wide-open clefts, they are very narrow and deep 
infoldings of the NE. Within the regions indicated by the yellow box, the gaps of the 
infoldings were too narrow to be resolved by the limited resolution provided by 
confocal microscopy, which suggests that the sizes of gaps between their opposing 
membranes are less than 100 nm. 
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As Figure 4.3 Aii showed, there was a group of ridges that are in the shape of blind 
tubes (green box), and they were the tubular ridges. One section of the 3D 
reconstruction containing an example of the tubular ridges was cropped out and 
magnified as Figure 4.3 Ci shows. The lamin A density (right panel) can be clearly 
identified following the application of the digital skin, and it was obvious that, not like 
the deep Y/I shape ridges, the tubular ridges are stand-alone structures that are not 
extensions of clefts. The lengths of the tubular ridges range from several hundreds of 
nanometers to several micrometers. More importantly, by rotating the 3D model 90 
degrees clockwise it can be observed that these tubular ridges are not sheet-like 
(Figure 4.3 Cii, left panel). Similarly, by cutting through the middle of this example 
ridge at where the yellow line indicates (Figure 4.3Cii, middle panel) and rotate the 
3D model to show the cross-section, it was confirmed that the tubular ridges were not 
deep infoldings, but instead tubular structures spanning the nuclear surface. 
 
In contrast, I have identified groups of lamin A densities that were not isolated linear 
structures, but resembled a tree branch (Figure 4.3 Aii, indicated by orange box), and 
they were termed as branched ridges. One example of the branched structures 
defined by lamin A densities (Figure 4.3 Di, right panel) was sectioned and magnified 
following the application of the digital skin (Figure 4.3 Di, left panel). Different from the 
tubular ridges, the branched ridges were smaller in size, and each branch was only 
several hundreds of nanometers in length. Rotating the section by 90 degrees, it can 
be seen that the branched ridges did not extend into the nucleoplasm like the deep 
Y/I shape ridges (Figure 4.3 Dii, left panel), which is confirmed by the shape of the 





Figure 4.3 Labelling for lamin A identifies three types of peripheral ridges. 
(A) PASMC nucleus labelled for A-type Lamin (red) in low detection threshold (i, left), 
a digital skin was applied to the 3D reconstruction to show detailed structures (i, right). 
(ii) As for (i), but at a higher detection threshold. Three ridges are pointed out with 
boxes in different colours.  
(B) A deep Y/I shaped ridge is shown in higher magnification (i) with or without digital 
skin. (ii) The ridge coated with a digital skin is turned 90° clockwise (left panel), and 
is magnified with a 90° anticlockwise turn (middle panel). The cross section of (ii) is 
shown in the right panel by turning 90° downwards. 
(C) As for (B), but showing a tubular ridge. 




The ridges and the clefts are peripheral structures that run along the perimeter of the 
NE; only the nuclear invaginations reach the interior of the nuclei. In this respect it is 
notable that ridges and clefts were identified in every cell studied, but only around 70% 
of the studied cells exhibited nuclear invaginations (Figure 4.4Ai, black). Blind 
invaginations were most common, and they were found in around 62% of cells 
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PASMCs (Figure 4.4Ai, blue); whereas 45% of cells harboured trans-nuclear 
invaginations (Figure 4.4Ai, red). By contrast, superficial invaginations were relatively 
rare, with only 28% of the studied cells harbouring clearly identifiable superficial 
invaginations (Figure 4.4Ai, orange); although this deficit might be due to the 
superficial invaginations being more prone to compression against the INM during the 
process of fixation. 
 
The average number of each of these structures (Figure 4.4 Aii) suggested that there 
were significantly fewer nuclear invaginations than clefts or ridges. On average, 
2.6±0.41 nuclear invaginations were identified per cell (Figure 4.4Aii, black) with 
0.8±0.25 trans-nuclear invaginations (red), 1.4±0.21 blind invaginations (blue) and 
0.4±0.09 superficial invaginations (orange) per cell (n = 54). However, by removing 
the 30% cells that did not exhibit nuclear invaginations (Figure 4.4 B), percentage of 
cells that harboured trans-nuclear (red), blind (blue) and superficial (orange) 
invagination increased to around 64%, 81% and 35% respectively (Figure 4.4 Bi, 
n=38). As the result, the average number of nuclear invagination per cell was raised 
to 3.8±0.36 (black), and the average number of trans-nuclear (red), blind (blue) and 
superficial (orange) invaginations per cell were 1.3±0.21, 2.0±0.12 and 0.5±0.06 
respectively (Figure 4.4 Bii, n = 38). In great contrast, ridges and clefts were found in 
every cell studied (Figure 4.4 Aii), with 15±1.4 ridges (green) and 14±1.6 clefts (grey) 
per cell (n =54). The results show that there was evidently higher number of peripheral 
ridges and clefts compared to nuclear invaginations (p<0.0001). In terms of the three 
types of ridges (Figure 4.4 Aii), the tubular ridges (light grey) were most commonly 
found in PASMCs, 10±1.1 tubular ridges were identified per cell. On average, only 
2.8±0.26 branched ridges (dark green) and 2.5±0.21 deep Y/I shaped ridges (pink) 





Figure 4.4 lamin A-positive nuclear invaginations are not evident in all cells   
(A) Percentage of PASMCs that contain nuclear invaginations (black), trans-nuclear 
invaginations (red), blind invaginations (blue), superficial invaginations (orange), 
ridges (green) or clefts (grey) is shown in the left bar chart. Number of structures per 
cell is shown in the bar chart at right, with the total nuclear invagination in black, trans-
nuclear invaginations in red, blind invaginations in blue, superficial invaginations in 
orange, ridges in green, deep Y/I shaped ridge in pink, tubular ridge in light grey, 
branched ridge in dark green and clefts in grey. n= 54, which includes all the cells 
studied. Data are presented as mean±SEM, *=p<0.05, **=p<0.01, *** =P<0.001, 
****=p< 0.0001, n=52 




Due to this apparent variation in number of lamin A labelled structures, I plotted the 
number of structures per cell that were identified by lamin A density (Figure 4.5A) with 
the trans-nuclear invaginations in red, blind invaginations in blue, superficial 
invaginations in orange, ridges in green, and clefts in grey. The total number of 
nuclear structures identified by lamin A density in any given cell varied from 57 to 14. 
Of these structures, the number of nuclear invaginations was not correlated to the 
number of peripheral structures as it was shown in Figure 4.5 A. This observation 
received strong support from the linear regression analysis which showed non-linear 
relationship between the two datasets with the R2 of 0.01145 (y=0.3499*x+34.91, 
Appendix 2 Table 4.1), suggesting that although both the nuclear invaginations and 





As shown in Figure 4.5 B, the total number of all three categories of nuclear 
invaginations (trans-nuclear invaginations in red, superficial invaginations in orange, 
and blind invaginations in blue) also varied from 17 to 0. Furthermore, the number of 
each form of nuclear invaginations in each cell appeared to vary randomly, and the 
linear regression analysis confirmed that the number each form of the nuclear 
invaginations was poorly correlated with the number of others (R2 =0.2372 for trans-
nuclear invaginations versus blind invaginations, R2 =0.02343 for trans-nuclear 
invaginations versus superficial invaginations, Appendix 2 Table 4.1). This 
observation indicates that the formation of each type of invagination might be 
dynamically regulated.  
 
Moreover, the numbers of ridges (green) and clefts (grey) per cell (Figure 4.5 C) 
varied, and it is apparent that the presence of a high number of ridges was not 
necessarily associated with the presence of more clefts and vice versa. This was 
confirmed by the linear regression analysis (R2=0.1150, y=0.2033*x+14.12, Appendix 
2 Table 4.1), which showed a poor fitness of linear relationship between the two 
datasets.  
 
To conclude, nuclear invaginations appear to exhibit diversity with respect to form and 
number in PASMCs. Either comparing between the three forms of nuclear 
invaginations, or between the two peripheral structures, or compare the total 
invaginations with the total peripheral structures, the presence of one structure does 




Figure 4.5 Variation in the number of nuclear invaginations between cells 
indicates a high level of plasticity  
(A) The number of structures identified by lamin A in each cell is shown in the stacked 
bar chart, with the clefts in grey, ridges in green, trans-nuclear invaginations in red, 
blind invaginations in blue, superficial invaginations in orange. Each bar represents a 
cell, n=54 
(B) The number of structures identified by lamin A in each cell is shown in the stacked 
bar chart, with the trans-nuclear invaginations in red, blind invaginations in blue, 
superficial invaginations in orange. Each bar represents a cell, and cells without 
nuclear invaginations were indicated by a black line, n=54 
(C) The number of structures identified by lamin A in each cell is shown in the stacked 






4.2.1.2 Lamin B1 lines peripheral structures but not nuclear invaginations 
The nuclear lamina is composed of not only A-type lamin but also B-type lamin, and 
labelling for both has been used to identify nuclear invaginations in other cell types 
(Luo et al., 2009, Avedanian et al., 2011). Therefore, PASMCs were also labelled for 
one member of the B-type lamin (lamin B1) to characterize the nuclear invaginations. 
As Figure 4.6 Ai shows, one PASMC was labelled for lamin B1 (purple), and the 3D 
reconstruction was displayed. Clearly and quite unlike the labelling for lamin A which 
lines the entire inner surface of the INM and its invaginations, lamin B1 labelling was 
punctate. This is more evident after raising the detection threshold and applying a 
digital skin to the 3D reconstruction (Figure 4.6 Aii). The density of lamin B labelling 
identified peripheral ridges (Figure 4.6 Aii, left and middle panel), by sectioning and 
rotating it was confirmed that the lamin B1 labelling also identified clefts (Figure 4.6 A 
ii, right panel). Indeed, as the statistical analysis showed (Figure 4.6 B), lamin B1 
labels 14±1.1 ridges and 16±0.9 clefts per cell (magenta with grids, n=12, Appendix 
2 Table 4.2), which is very similar to the numbers of lamin A (red) labelled ridges 
(compared by t-test, p=0.428) and clefts (compared by t-test, p=0.5829) per cell. In 
great contrast, across all 12 cells labelled by lamin B1, no nuclear invagination was 
identified. In short, lamin B1 appears to be restricted to the periphery of the INM and 















Figure 4.6 Lamin B1 labels peripheral structures but not nuclear invaginations 
(Ai) The nucleus of a PASMC is labelled for lamin B1 (purple), (ii) 3D reconstruction 
of the nucleus is shown with the application of digital skin and blending. (iii) The 3D 
model was sectioned to show a ridge (iii. left panel), and then displayed at higher 
magnification with a 90° turn to show a cleft (iii, right panel). 
(B) Average number of structures per cell identified by either lamin A (red) or lamin 
B1 (purple) are displayed in the bar chart. Structures include nuclear invaginations, 
trans-nuclear invaginations, blind invaginations, superficial invaginations, ridges, and 
clefts. Data are shown as mean±SEM, *=p<0.05, **=p<0.01, *** =P<0.001, ****=p< 




4.2.1.3 The LINC complex is selectively targeted to nuclear invaginations 
 
As mentioned previously, the nuclear lamina is the protein meshwork that serves as 
the bridge that connects the nucleoplasm to the cytoplasm through the LINC complex, 
with A-type lamin and B-type lamin acting as binding partners for different components 
of the LINC complex and/or inner nuclear membrane proteins. Due to the fact that 
lamin A, but not lamin B lined all three forms of nuclear invaginations, I decided to 
examine whether similar selectivity of targeting could be observed with respect to the 
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components of the LINC complex, with particular reference to nuclear invaginations. 
 
Using lamin A labelling (red) to identify nuclear invaginations, it was shown in the 3D 
reconstruction of a lamin A-nesprin-1 double labelled PASMC (Figure 4.7Ai) that the 
labelling for nesprin-1 (magenta), a trans-outer nuclear membrane protein, was widely 
distributed across the entire surface of the NE, including the nuclear invaginations. It 
was notable that, however, unlike lamin A labelling which covers the entire inner 
nuclear surface albeit with variable density, nesprin-1 labelling was punctate 
throughout, and these puncta of nesprin-1 can be clearly viewed following the 
increase of detection threshold and the application of a digital skin to the 3D 
reconstruction (Figure 4.7 Ai). Focusing on nuclear invaginations, the middle section 
of the 3D reconstruction was cropped out (Figure 4.7 Aii, left panel), and the region 
containing a blind invagination (indicated with B) and a trans-nuclear invagination 
(indicated with T) was magnified (Figure 4.7 Aii, middle panel). The puncta of nesprin-
1 spanned both the blind and trans-nuclear invaginations in a manner that wraps 
around the lamin A labelling. To investigate the possible localisation of the nesprin-1-
lamin A protein complex, the colocalisation of the two was calculated using the Imaris 
software, and showed in yellow (Figure 4.7 Aii, right panel). The punctate nature of 
nesprin-1 labelling was most evident when examining regions of lamin-nesprin 
colocalisation, and particularly so along the length of the transnuclear and blind 
nuclear invaginations. The colocalisation in yellow revealed well-defined puncta along 
the length of all lamin A positive structures in every cell thus far studied (n=3).  
 
The distribution of SUN2, the inner nuclear membrane protein that combines with 
nesprin-1 to form the LINC complex, was also studied. As shown in Figure 4.7 B, a 
PASMC was co-labelled by SUN 2 and lamin A. The 3D reconstruction of the nucleus 
is shown in the left panel, and the structures identified by lamin A density were 
revealed by increasing the threshold, which was followed by the application of the 
digital skin (right panel). SUN2 (green), like lamin A (red), covers almost the entire 
inner nuclear surface, exhibiting little or no evidence of the type of punctate labelling 
seen for nesprin-1 (n=7). By cropping out the middle section of the 3D model (Figure 
4.7  Bii, left panel) and zooming into the superficial invagination identified (Figure 
4.7 Bii, middle panel), it seems that SUN 2 lines the entire superficial invagination, 
which is confirmed by the colocalisation analysis of SUN2 and lamin A shown in yellow 
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(right panel). In fact, SUN2 lines some nuclear invaginations but are absent from 
others (Appendix 2 Table 4.3). 
 
In support of this view, co-labelling for SUN2 and nesprin-1 was conducted to identify 
the possible localisation of the LINC complex. Figure 4.7 Ci (left panel) shows the 3D 
reconstruction of a co-labelled nucleus, in which nesprin-1 is displayed in magenta 
and SUN2 in green. Similarly, a digital skin was applied to the high threshold 3D 
reconstruction to illustrate structures (Figure 4.7 Ci, right panel). The rotated middle 
section of the 3D model and the magnified image clearly shows that a trans-nuclear 
invagination was selectively lined by nesprin-1 but not SUN 2 (Figure 4.7 Cii, left and 
middle panel). This is confirmed by the high magnification illustration with regions of 
colocalisation (yellow) between nesprin-1 and SUN2, the colocalisation was restricted 
to the periphery of the INM, evident at the entry point to nuclear invaginations but 
thereafter being entirely absent from the deeper, intranuclear sections of trans-
nuclear invaginations. On average, 50±3.5% of nesprin-1 labelling colocalise with 
SUN2 labelling in PASMCs, and the Pearson’s correlation coefficient is only 
0.36±0.06 (n=3, Appendix 2 Table 4.4). This shows that the LINC complex formed by 
nesprin-1 and SUN2 are restricted to the periphery of the INM and to some nuclear 
invaginations, where nesprin-1 might serve to connect the cytoplasmic structures 
such as actin filaments to the peripheral NE and superficial invaginations, and 
perhaps the entry vestibule to trans-nuclear invaginations for mechano-sensing or 
nuclear positioning (Jorgens et al., 2017). By contrast punctate regions of nesprin-1 
association with lamin-A are evident along the full length of blind and trans-nuclear 
invaginations, and may thus support the bridging between the nucleoplasm 
(chromatins) to the cytoplasm directly through the lamin associated domains (LADs) 






Figure 4.7 Components of the LINC complex are selectively targeted to nuclear 
invaginations 
(A) Nucleus of a PASMC is labelled for lamin A (red) and Nesprin-1 (pink, i, left), and 
reconstructed into a 3D model of the nucleus (i, right panel), sectioned (ii, left panel) 
and displayed at higher magnification (ii, middle panel) shows nesprin-1 (magenta) 
and regions in which nesprin-1 colocalises (yellow) with lamin A (ii, right hand panel). 
(B) As for A, but labelled for lamin A (red) and SUN 2 (green). 




In this respect, one must bear in mind that the selective positioning of the LINC 
complex was conferred by SUN2 rather than nesprin-1. This is significant because 
the antibody used for identifying nesprin-1 can recognize two isoforms of this NET, 
namely giant nesprin-1 and the small isoform nesprin-1α. Giant nesprin-1 is dominant 
on the ONM and here it is thought to interact with SUN domain proteins to form LINC 
complexes that cross the nuclear membranes (Sosa et al., 2012). By contrast, 
nesprin-1α sits on the INM, which is significant because nesprin-1α not only co-
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associates lamin A (Mislow et al., 2002a) but has also been shown to associate with 
nuclear targeted RyR1 (Pare et al., 2005a, Pare et al., 2005b). Therefore, instead of 
forming the classical LINC complex within nuclear invaginations, it is feasible that 
nesprin-1 α may form distinct protein complexes with lamin A and RyR1 along the 
length of the nuclear invaginations, providing for chromatin attachment points that 
may be modulated in some way by Ca2+ flux across the ONM via RyR1. 
 
4.2.1.4 Emerin is present at all lamin A positive nuclear invaginations, but also 
identifies lamin A negative invaginations. 
In PASMCs it would appear that the LINC complex, comprising nesprin, SUN2 and 
lamin A, seems to be part of the machinery that bridges the gap between the 
cytoplasm and the nucleoplasm at the periphery of the INM, where it likely provides 
chromatin attachment points for repression of gene expression. By contrast, our data 
suggest that co-association of nesprin-1 with lamin A, but not SUN2, may support 
chromatin attachment within the trans-nuclear nuclear invaginations. I therefore 
investigated the possibility that nesprin-1 and lamin A might co-associate in trans-
nuclear nuclear invaginations with emerin, a LEM domain-containing protein and an 
integral component of the INM (Demmerle et al., 2013, Zhang et al., 2005) which has 
previously been shown to interact with both nesprin-1α and lamin A (Mislow et al., 
2002a). It is important to note in this respect that lamin A and emerin are known to 
support chromatin attachment through different mechanisms.  
 
Figure 4.8 A, B& C show three acutely isolated PASMCs that were co-labelled for 
lamin A (red) and emerin (cyan). The 3D reconstructions of the three labelled nuclei 
are displayed in the left panels of Figure 4.8 Ai, Bi&Ci, whereas the right panels exhibit 
the high threshold 3D reconstruction coated with the digital skin. The middle sections 
of the three 3D models were cropped out and rotated to display the interior of the 
nuclei (Figure 4.8 Aii, Bii&Cii, left panel), and the regions containing examples of a 
ridge (Figure 4.8 Aii, middle panel), or trans-nuclear invaginations (Figure 4.8 Bii&Cii, 
middle panel) were magnified. The colocalisation between emerin and lamin A 
labelling was calculated and shown in yellow on top of the lamin A labelling (Figure 
4.8 Aii, Bii&Cii, right panel). It can be observed in all three cells that the emerin 
labelling (cyan) extended across most of the INM identified by lamin A labelling (red), 
including the peripheral ridges and clefts (Figure 4.8 A, Figure 4.9). Most importantly 
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in the context of my investigations, labelling for emerin was present along the entire 
length of all 3 types of nuclear invaginations identified by lamin A (Figure 4.8 C, Figure 
4.9 Ai). Moreover, as reported in section 4.2.1.1 for lamin A labelled invagination, the 
diameters of the nuclear invaginations identified by emerin labelling were variable 
both between such structures and along the length of a nuclear invagination, and this 
variability was also evident in co-labelled cells (Figure 4.8 Bii&Cii, left and middle 
panels). While not strictly punctate in nature at our working resolution, higher 
magnification images of emerin-positive nuclear invaginations (Figure 4.8 Cii, middle 
panel) show that the emerin appears to “wrap around” lamin A positive invaginations 
without completely covering the inner surface of lamin A labelling, i.e. while less 
obvious emerin labelling of nuclear invaginations exhibits non-uniformity too. This 
suggests that emerin and lamin A do not always co-associate along the length of a 
nuclear invaginations. 
 
Consistent with this view, I also identified emerin-positive nuclear invaginations that 
could be sub-categorised into two groups, namely the lamin A positive (Figure 4.8 Cii) 
and lamin A negative (Figure 4.8 Bii) invaginations. This is evident when showing the 
lamin A-emerin colocalisation sites along the given nuclear invaginations. I have 
identified lamin A positive invaginations with the full length of the invagination covered 
by the colocalisation sites in yellow (Figure 4.8 Cii), and lamin A negative 
invaginations within which the colocalisation sites were absent from the main body of 





Figure 4.8 Labelling for emerin reveals that there are lamin A positive and 
negative invaginations. 
(A) PASMC nucleus labelled for lamin A (red) and emerin (cyan, i, left panel), and 3D 
reconstruction of the nucleus (i, right panel), which was sectioned (ii, left panel) to 
show a peripheral ridge at higher magnification (ii, middle panel) with emerin (blue) 
and colocalisation (yellow) of emerin with lamin A (ii, right hand panel). 
(B) As for A. but showing emerin labelling lamin A negative nuclear invaginations. 




The fact that emerin identifies both lamin A positive and negative nuclear 
invaginations received the strongest possible confirmation through cross-comparison 
of the number of lamin A and emerin positive structures in co-labelled PASMCs.  
 
Due to the fact that I was trying to label two INM proteins in a very narrow space 
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(nuclear invagination), competition for space may occur between antibodies (primary 
and/or secondary). To exclude the possibility of such effects, the antibodies were 
applied in different orders, either by applying one primary/secondary antibody after 
the other and vice versa, or by applying all primary antibodies mixed together at once.  
Irrespective of the approach used and across all co-labelled PASMCs (n=32), no 
emerin negative and lamin A positive nuclear invagination were identified, regardless 
of the order of antibody application. By contrast, I consistently identified two 
populations of emerin-positive nuclear invaginations, one being co-lablled for lamin A 
while the other was not.  
 
Based on this finding, I plotted the number of structures per cell identified by emerin 
alone (Figure 4.9 Ai) or emerin-lamin A colocalisation (Figure 4.9 Aii) in the cells that 
exhibited nuclear invaginations. The number of total invaginations, trans-nuclear 
invaginations, superficial invaginations, blind invaginations, ridges and clefts are 
shown in black, red, orange, blue, green and grey respectively. Interestingly, in these 
cells lamin A colocalised with emerin at all the peripheral structures (Figure 4.9 Ai&ii), 
suggesting that the observed selectivity of labelling for emerin alone occurs at the 
nuclear invaginations but not the peripheral ridges (green) or clefts (grey). Moreover, 
the number of trans-nuclear invaginations (red), blind invaginations (red), superficial 
invaginations (blue) per cell were sorted based on the values and plotted in Figure 
4.9 B, either identified by emerin alone (Figure 4.9 Bi) or emerin-lamin A colocalisation 
(Figure 4.9 Bii). Both the trans-nuclear and superficial invaginations could be 
identified as being positive for emerin alone or exhibiting emerin-lamin colocalisation 
(Figure 4.9 B), while it remains inconclusive for blind invaginations due to the limited 
sample size. In short, emerin positive lamin A negative nuclear invaginations were 




Figure 4.9 The number of emerin-positive nuclear invaginations varies between 
cells. 
(Ai) Number of structures identified by emerin labelling per cell. (ii) Number of emerin 
identified structures colcalised with lamin A in each cell. Total nuclear invaginations 
(black), trans-nuclear invaginations (red), blind invaginations (blue), superficial 
invaginations (orange), ridges (green) or clefts (grey) are distinguished by colour, n=6. 
(B) As for (A), but showing only the number of different forms of nuclear invaginations 





Given the fact that emerin also identifies lamin A negative nuclear invaginations, 
emerin may serve as a better indicator for nuclear invaginations. To test whether 
emerin identifies more structures, the number of emerin labelled structures per cell 
(Figure 4.10 D) was plotted. In this instance the result was very similar to the number 
of lamin A identified structures. On average, 2.9±0.5 nuclear invaginations were 
identified in each cell with 0.9±0.2 trans-nuclear invaginations, 1.6±0.3 blind 
invaginations and 0.4±0.15 superficial invaginations per cell (n=22), these numbers 
are higher but not significantly different from those of the lamin A labelled nuclear 
invaginations (p=0.9619 for trans-nuclear invaginations, p=0.6842 for blind 
invaginations, and p=0.8267 for superficial invaginations). 77% of all cells labelled for 
emerin harboured nuclear invaginations whereas 70% of the lamin A labelled 
PASMCs displayed nuclear invaginations. Together these findings suggest that while 
emerin positive lamin A negative nuclear invaginations may well exist, there is a much 
lower probability of formation of this type of nuclear invagination. 
 
Moreover, the inter-cell variability of structures observed with lamin A labelling was 
also confirmed for emerin labelling (Figure 4.10 A). The number of structures per cell 
labelled by emerin was plotted with the trans-nuclear invaginations in red, blind 
invaginations in blue, superficial invaginations in orange, ridges in green, and clefts 
in grey. Once again, the number of nuclear invaginations did not correlate with the 
number of peripheral structures, which was confirmed by the linear regression 
analysis (R2=0.05368, y=-0.6420*x+33.41, Appendix 2 Table 4.5). This suggests that, 
consistent with the lamin A labelled structures, although both the nuclear 
invaginations and ridges/clefts were derived from the NE, they are formed 
independently. As Figure 4.10 B shows, the number of all three forms of emerin-
positive nuclear invaginations (trans-nuclear invaginations in red, blind invaginations 
in blue, superficial invaginations in orange) was variable, ranging from 9 to 0 in the 
cells studied here. The number of each form of nuclear invagination that appeared in 
one cell seemed to be random, and the non-linear relationship between each forms 
of nuclear invaginations was confirmed by the linear regression analysis (Appendix 2 
Table 4.5). Moreover, as Figure 4.10 C shows, the cells that displayed high numbers 
of ridges (green) did not necessarily harbor more clefts (grey), which supports the 
conclusion drawn based on lamin A identified structures that the formation of the 
peripheral ridges and clefts was regulated independently (R2=0.001007, 
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y=0.04501*x+17.11, Appendix 2 Table 4.5). 
 
I conclude that the numbers of all the structures identified by either lamin A or emerin 
densities in PASMCs showed a high degree of plasticity, and that the presence or 
absence of one structure did not correlate with the presence or absence of any others. 
 
 
Figure 4.10 Emerin positive nuclear invaginations vary in number between cells, 
indicating a high degree of plasticity. 
(A) The number of structures identified by emerin in each cell is shown in the stacked 
bar chart, with the clefts in grey, ridges in green, trans-nuclear invaginations in red, 




(B) The number of structures identified by emerin in each cell is shown in the stacked 
bar chart, with the trans-nuclear invaginations in red, blind invaginations in blue, 
superficial invaginations in orange. Each bar represents a cell, cells without 
invaginations were indicated by a black line, n=22. 
(C) The number of structures identified by emerin in each cell is shown in the stacked 
bar chart, with the clefts in grey and ridges in green, n=22. 
(D) Average numbers of emerin-positive trans-nuclear invaginations, blind 
invaginations, superficial invaginations, ridges and clefts per cell are shown in the bar 






4.2.2 The inner nuclear membrane of nuclear invaginations is lined by puncta 
of chromatin-anchoring protein complexes constructed by either lamin A or 
emerin 
In section 4.2.1.3 it was illustrated that emerin identified two sub-sets of nuclear 
invaginations, one with and one without lamin A. More importantly, this selective 
targeting was observed only in nuclear invaginations while all the peripheral ridges 
and clefts were lamin A and emerin positive, suggesting that it is very likely that this 
selective targeting is associated with the function of nuclear invaginations. In fact, 
either lamin A or emerin may construct a NET protein complex capable of directing 
chromatin attachment. Lamin A can promote transcriptional suppression by binding 
to the lamina-associated domain (LAD) of heterochromatin (Burke and Stewart, 2013), 
in a manner facilitated by co-association with histones such as H3K9me2/3(Harr et 
al., 2015). By contrast, emerin has been shown to provide discrete chromatin 
attachment points along the surface of the INM through its co-association with BAF 
(barrier to auto-integration factor)(Berk et al., 2014, Cai et al., 2001, Lee et al., 2001), 
which binds DNA (Zheng et al., 2000) and may thus either repress or enhance gene 
expression (Takama et al., 2013, Cox et al., 2011). Given the above, I decided to 
investigate the possibility that different chromatin anchoring protein complexes might 




4.2.2.1 Puncta of emerin-BAF complexes line nuclear invaginations, but were less 
commonly seen on peripheral ridges and clefts. 
As emerin labelling can effectively identify all the structures I aimed to study, PAMSCs 
were co-labelled with emerin and BAF to investigate the distribution of the emerin-
BAF complexes in relation to the nuclear structures identified above. Figure 4.11 A, 
B, C &D show 4 emerin and BAF co-labelled acutely isolated PASMCs, the 
colocalisation between the two labelling was calculated, and the 3D reconstructions 
of the four nuclei labelled by emerin (cyan) and the colocalisation (yellow) were shown 
in Figure 4.11 Ai, Bi, Ci&Di. To illustrate the structures identified by emerin density, 
the detection threshold was raised, followed by the application of the digital skin 
(Figure 4.11 Aii, Bii, Cii&Dii, left panels). The 3D models of nuclei defined by emerin 
labelling in Figure 4.11 Aii, Bii, Cii were sectioned and rotated to reveal the nuclear 
invaginations (middle panels). Interestingly, the colocalisation between emerin and 
BAF (yellow) forms puncta along the length of all three categories of nuclear 
invaginations. The right panel of Figure 4.11 Aii shows two trans-nuclear invaginations 
in higher magnification, puncta of colocalisation were observed on both invaginations, 
albeit quite separated. In contrast, the right panel of Figure 4.11 Bii shows two trans-
nuclear invaginations that were fully covered by the puncta of colocalisation. These 
puncta were of variable sizes, and were separated by several hundreds of 
nanometers or less.  
 
The right panel of Figure 4.11 Cii displays a section of the nucleus that harboured 
both superficial and blind invaginations. At a higher magnification, puncta of 
colocalisation can be clearly viewed on the superficial invaginations (indicated with S). 
More interestingly, it also shows a network of blind invaginations (indicated with B), 
with one major branch decorated by the puncta whereas the branch to the left of it 
was entirely free of such puncta. This suggests that these puncta targeted to the inner 
membrane of nuclear invaginations appear, in an invagination-dependent manner, to 
be either very abundant or relatively isolated, sometimes even absent. On average, 
they were separated from adjacent regions of BAF colocalisation by 495.5±62nm, with 




Figure 4.11 D focused on the peripheral ridges and clefts. One example cleft was 
sectioned and rotated as shown in Figure 4.11 Dii (middle and right panel), and no 
puncta of colocalisation were observed on this cleft. The 3D model of the same cell 
was sliced through the middle, and the top-half of the model was flipped (Figure 4.11 
Diii). With the application of the digital skin, half of the NE was clearly visualized, which 
displayed various ridges (Figure 4.11 Div). This piece of NE is shown in a high 
magnification (Figure 4.11 Div, right panel), and it was evident that only some of the 


















Figure 4.11 BAF and emerin preferentially co-localise on nuclear invaginations.  
(Ai) 3D reconstruction of deconvolved Z stacks scanning through the nucleus of a 
pulmonary arterial smooth muscle cell labelled for emerin (cyan) and showing regions 
of colocalisation with BAF (yellow). (ii) From left to right, same 3D image as shown in 
(i) but following application of blending (Imaris image analysis software), and a 
transverse section through, rotated to identify a trans-nuclear invagination and a 
further section with magnification that shows punctate regions of BAF colocalisation 
on this structure. 
158 
 
(Bi-ii) As in (A) but showing a trans-nuclear invagination which exhibits BAF 
colocalisation across its entire surface.  
(Ci-ii) As in (A), but showing BAF colocalisation on the surface of emerin labelled 
blind and superficial invaginations. 
(Di-ii) As in (A), but showing BAF co-localization on the surface of an emerin labelled 
cleft. (iii-iv) Slice through the middle of the cell showed in (Di) and flip the top to reveal 







The observation above seems to suggest that the emerin-BAF colocalisation 
preferentially targets nuclear invaginations compared to the peripheral structures. To 
test this, I plotted the number of structures per cell identified by emerin alone (Figure 
4.12 Ai) or emerin-BAF colocalisation (Figure 4.12 Aii). The bar chart shows that a 
good number of ridges and clefts with no emerin-BAF colocalisation were identified in 
every cell studied (Figure 4.12 Bi&ii), whereas the majority of nuclear invaginations 
harboured the emerin-BAF colocalisation, and in some cells (i.e cell5, cell6) all the 
nuclear invaginations were positive for such colocalisation. This suggests that the 
emerin-BAF colocalisation is preferentially found on the INM of nuclear invaginations 
but not the peripheral structures. This view received support from the bar chart 
showing the percentage of structures exhibiting emerin-BAF colocalisation (Figure 
4.12 C). 81% of all nuclear invaginations harboured sites of emerin-BAF colocalisation. 
Subdividing these, puncta of emerin-BAF colocalisation were identified along 67% 
superficial invaginations, 77% blind invaginations and 88% of trans-nuclear 
invaginations. In contrast, only 41% of the clefts and 63% of the ridges harboured 
sites of emerin-BAF colocalisation. 
 
To conclude, the emerin-BAF colocalisation sites, which indicates where the 
chromatin anchoring NET protein complexes may form, were found on the inner 
membrane of nuclear invaginations in an invagination-dependent manner, they can 
be either very abundant or relatively isolated, sometimes even absent. However, 
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compared to the peripheral ridges and clefts, the chromatin anchoring NET protein 
complexes preferentially target the nuclear invaginations. 
 
Figure 4.12 The number of BAF and emerin positive structures varies between 
cells.  
(Ai) Number of emerin identified structures in each cell with the clefts in grey, ridges 
in green, trans-nuclear invaginations in red, blind invaginations in orange, superficial 
invaginations in blue. (ii) As for (i), but showing number of emerin identified structures 
per cell that exhibit colocalisation with BAF, n=10. 
(B) As for (A), but showing only the counts for nuclear invaginations per cell, n=10 




4.2.2.2 Puncta of lamin A-H3K9me2 complexes line all types of lamin A positive 
nuclear membrane structures 
I have identified two sub-sets of emerin-positive nuclear invaginations, one being 
lamin A-positive and one lamin A-negative. This led to the consideration that 
chromatin attachment might be regulated through distinct mechanisms via emerin or 
lamin A. Indeed, it is evident that lamin A may promote transcriptional suppression by 
binding to the LAD of heterochromatin (Burke and Stewart, 2013), in a manner 
facilitated by co-association with histones such as H3K9me2/3(Harr et al., 2015). 
Based on this possibility, I investigated the distribution of lamin A-H3K9me2 
complexes on the lamin A identified structures. 
 
Similar to section 4.2.2.1, PAMSCs were co-labelled by lamin A and H3K9me2 to 
investigate the distribution of the chromatin anchoring LADs in relation to the nuclear 
structures identified above. Figure 4.13 A, B, C &D show 4 lamin A and H3K9me2 co-
labelled acutely isolated PASMCs. The colocalisation between the two labelling was 
calculated, and the 3D reconstructions of the four cells labelled by lamin A (red) and 
the colocalisation (white) are shown in Figure 4.13 Ai, Bi, Ci&Di. To demonstrate the 
structures defined by lamin A density, the detection threshold of the lamin A labelling 
was raised, which was followed by the application of the digital skin (Figure 4.13 Aii, 
Bii, Cii&Dii, left panels). The 3D models of nuclei in Figure 4.13 Aii, Bii, Cii were 
sectioned and rotated to reveal the nuclear invaginations (middle panels). Like the 
emerin-BAF colocalisation, the colocalisation between lamin A and H3K9me2 forms 
puncta along the length of all three categories of nuclear invaginations. The right panel 
of Figure 4.13 Aii shows a trans-nuclear invagination at high magnification, which was 
spanned by separated puncta of colocalisation. In contrast, the right panel of Figure 
4.13 Bii shows a trans-nuclear invagination that was fully covered by such 
colocalisation.  
 
The right panel of Figure 4.13 Cii shows a section of the nucleus that harboured a 
superficial invagination with a branch being a blind invagination. At a higher 
magnification, puncta of colocalisation can be clearly viewed on both the superficial 
invaginations (indicated with S) and the blind invaginations (indicated with B). Not like 
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the emerin-BAF colocalisation, the lamin A-H3K9me2 colocalisation did not seem to 
be absent from any nuclear invagination. The diameters of these puncta of lamin A-
H3K9me2 colocalisation ranges from ~200 nm to ~600nm, and the separation 
between puncta was 335.50±46 nm on average (Appendix 2 Table 4.7). 
 
Figure 4.13 D showed the puncta of colocalisation on the peripheral ridges and cleft. 
One example cleft was sectioned and rotated as shown in Figure 4.13 Dii (middle and 
right panel). In contrast to the emerin-BAF co-labelled cells, the cleft was fully covered 
by broad “plaques” of colocalisation. The 3D model of the same cell was sliced 
through the middle, and the top-half of the model was flipped (Figure 4.13 Diii). With 
the application of the digital skin, half of the nucleus was clearly visualized, which 
displayed various ridges, and each of the ridge carried abundant puncta of 
colocalisation (Figure 4.13 Div). One of the ridges is shown at a high magnification 
(Figure 4.13 Div, right panel), and it was evident that the entire length of the ridge was 








Figure 4.13 The histone mark H3K9me2 and lamin A co-localise at puncta on 
nuclear invaginations, but regions of colocalisation are most widespread at the 
periphery of the nucleus. 
(Ai) 3D reconstruction of a deconvolved Z stacks through the nucleus of a pulmonary 
arterial smooth muscle cell labelled for lamin A (red), showing regions of colocalisation 
with H3K9me2 (white). (ii) From left to right, same 3D image as shown in (i) but 
following application of blending (Imaris image analysis software), and a transverse 
section through, rotated to identify a trans-nuclear invagination and a further section 
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with magnification that shows punctate regions of H3K9me2 colocalisation on this 
structure. 
(Bi-ii) As in (A) but showing a trans-nuclear invagination, which exhibits H3K9me2 
colocalisation across its entire surface. 
(Ci-ii) As in (A), but showing H3K9me2 colocalisation on the surface of lamin A 
labelled blind and superficial invaginations. 
(Di-ii) As in (A), but showing H3K9me2 colocalisation on the surface of a lamin A 
labelled cleft. (iii-iv) Slice through the middle of the cell showed in (Di) and flip the top 
to reveal the top-half of the cell, and shows H3K9me2 co-localisation on the surface 




The evidence above seems to suggest that the lamin A-H3K9me2 colocalisation 
targets all the lamin A defined structures non-selectively. Indeed, I plotted the number 
of structures per cell identified by lamin A alone (Figure 4.14 Ai) or lamin A-H3K9me2 
colocalisation (Figure 4.14 Aii). The result showed that all the peripheral ridges (green) 
and clefts (grey) in the studied cells displayed the colocalisation. Similarly, the number 
of nuclear invaginations identified by lamin A alone (Figure 4.14 Bi) or lamin A-
H3K9me2 colocalisation (Figure 4.14 Bii) showed that all the trans-nuclear and 
superficial invaginations displayed the colocalisation sites. Among the 14 cells studied, 
only one cell (cell 7) exhibited one blind invagination that lacked the colocalisation. 
 
Unlike the emerin-BAF colocalisation that prefers nuclear invaginations compared to 
peripheral ridges (yellow) and selects for certain nuclear invaginations, the lamin A-
H3K9me2 colocalisation non-differentially flags almost all the structure thus far 
studied (white, Figure 4.14 C), which is significantly different from emerin-BAF 
colocalissation as the Chi-square tests showed (p=0.0189) In short, there appeared 
to be a large and variable number of BAF negative, emerin positive structures in all 
cells studied, indicative of great plasticity of association in comparison to the 
H3K9me2 negative, lamin A positive structures. 
 
Part of the lamin A related immunocytochemistry mentioned in this Chapter (i.e. the 
lamin A-histone mark co-labelling and part of lamin A labelling) was done in 
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collaboration with Dr. Jorge Navarro-Dorado, who kindly provided technical supports, 
did part of the immunocytochemistry and confocal imaging. 
 
 
Figure 4.14 H3K9me2 and lamin A colocalisation is widespread  
(Ai) Number of lamin A identified structures in each cell with the clefts in grey, ridges 
in green, trans-nuclear invaginations in red, blind invaginations in orange, superficial 
invaginations in blue. (ii) As for (i), but showing number of lamin A identified structures 
per cell that showed colocalisation with H3K9me2, n=14. 
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(B) As for (A), but showing the counts for nuclear invaginations only, n=14 
(C) Percentage of lamin A identified structures colocalised with H3K9me2 (white) 





4.3.1 Summary of findings 
Chapter 4 shows that nuclear invaginations of pulmonary arterial myocytes may 
provide sites for chromatin attachment and transcriptional regulation. Lamin A and 
emerin appear to line the inner nuclear surface of these cells, and each may colocalise 
with nesprin-1 positive puncta. Notably, lamin A was absent from some emerin 
positive nuclear invaginations. By contrast, lamin B1 is distributed only at the 
periphery of the INM, and is absent from all nuclear invaginations.  
Intriguingly, a subpopulation of nuclear invaginations harboured punctate regions of 
colocalisation between lamin A and the suppressive heterochromatin mark H3K9me2. 
Moreover, emerin-positive invaginations harboured puncta of BAF colocalisation and 
thus may serve as an alternative pathway to the regulation of gene expression. In 
each case, the distances of separation between these chromatin anchoring puncta 
were in the range of 300-400 nm, which may be significant in terms of the cells 
capacity to independently regulate such associations. In short, nuclear invaginations 
may form a trans-nuclear network within which nano-patterning of chromatin 
anchoring protein complexes may support stochastic modulation of transcriptional 
suppressors. 
 
4.3.2 Lamin A, but not lamin B1, lines the nuclear invaginations. 
By their higher densities of labelling for lamin A, I defined a number of nuclear 
membrane structures. Most importantly, blind, superficial and trans-nuclear 
invaginations. Consistent with early studies (Broers et al., 2006, Fricker et al., 1997b), 
the number of nuclear invaginations identified within a single pulmonary arterial 
myocyte was variable and could range from 0 to 17. Therefore, these nuclear 
invaginations are truly dynamic structures. The trans-nuclear invaginations span the 
entire nucleoplasm, forming channels that connect the two sides of the nucleus. There 
are also blind invaginations that are in the shape of blind tubes that project variable 
distances into the middle of a nucleus. Superficial invaginations represent a distinct 
type, that form short bridges that span short distances of the nucleoplasm and connect 
to the same side of the nucleus from which they arise. Blind and trans-nuclear 
invaginations have been described previously (Fricker et al., 1997b, Legartova et al., 
2014) but to my knowledge the superficial invaginations have not been presented as 
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a unique category. 
 
I also identified, by density of lamin A labelling, large numbers of ridges and clefts at 
the periphery of the nucleus. These structures were very abundant but have not been 
extensively studied in the literature. However, previous studies may have considered 
nuclear infoldings (which form clefts) as a form of the nuclear invaginations (Wittmann 
et al., 2009). Moreover, it seems plausible that the deep Y shaped ridges may confer 
“nuclear infoldings” that demarcate small junctional spaces that cannot be resolved 
by confocal microscopy. The tubular and branched ridges described here have not 
been characterized previously, and these too may, by virtue of their high density of 
lamin A binding and the fact that they harbour lamin A-H3K9me2 association sites, 
represent sites of active regulation of chromatin attachment via lamin associated 
domains, but further investigation is required before any conclusion can be made. 
 
That lamin B1 lines the entire periphery of the nuclei but strategically avoids all the 
nuclear invaginations, provides new insights into cell-specific organization of the 
nuclear lamina. This is evident from the fact that lamin B1 positive nuclear 
invaginations have been identified in other cell types, such as embryonic stem cells 
(Luo et al., 2009). In acutely isolated PASMCs, however, nuclear invaginations were 
lined by lamin A but not by lamin B1, whereas peripheral ridges and clefts were 
labelled for both. This piece of evidence strongly suggests that the nuclear 
invaginations are not simply an extension of the NE. Instead, they appear to be 
sophisticatedly designed structures that are selectively lined by chosen NET proteins, 
and they likely underpin region-specific functions.  
 
4.3.3 NET proteins are selectively targeted to nuclear invaginations, providing 
nanopatterning for the regulation of chromatin attachment. 
Lamin A is associated with multiple NET proteins, and may form NET protein 
complexes that link the nucleoplasm to the cytoplasm. Following this lead, I studied 
the distribution of a variety of NET proteins. Immunofluorescence labelling against 
nesprin-1 showed that this NET protein lines all the lamin A identified structures. It is 
important to note, however, that the antibodies used here do not discriminate between 
giant nesprin-1 and nesprin-1α. These proteins differ in terms of their size and nature 
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of association with the nuclear envelope. Nesprin-1α is a small isoform (131 kDa) of 
nesprin-1 that has been identified as an inner nuclear membrane protein, it has been 
shown to interact with lamin A/C (Mislow et al., 2002b). The expression of nesprin-1α 
had been reported in smooth muscle cells, and it was proposed that the nesprin-1α 
antiparallel dimers interact with both lamin A and emerin, serving as a scaffold at the 
inner nuclear membrane (Mislow et al., 2002a). Nesprin-1 giant, as the name 
suggests, is a ~1000kDa protein that localises to the ONM, and its expression has 
been confirmed in vascular smooth muscle cells (Duong et al., 2014). It forms the 
LINC complex with SUN domain proteins, which is responsible for 
mechanotransduction (Anno et al., 2012, Kim et al., 2015). For example, deletion of 
nesprin-1 altered nuclei positioning, shape, and the expression of biomechanical 
response genes upon mechanical stimulation (Banerjee et al., 2014). 
 
As mentioned previously, SUN 2 was present in the superficial invaginations and the 
entry point of trans-nuclear invaginations identified. Due to the limited sample size, I 
would not assert that SUN2 only targets to the superficial invaginations and the entry 
point of trans-nuclear invaginations, but it is clear that for some reason the distribution 
of the LINC complex formed by nesprin-1 and SUN2 might be restricted to some 
nuclear invaginations or certain sites along the length of a nuclear invagination. They 
perhaps only appear at where the functional LINC complex (i.e. mechanotransduction) 
is required. However, nesprin-1α was shown to co-associate with emerin and lamin A 
as mentioned (Mislow et al., 2002), and it has also been shown to associate with 
RyR1 at the nuclear membrane (Pare et al., 2005a; Pare et al., 2005b). Given that my 
data show that nesprin-1 colocalises with lamin A on the nuclear invaginations, this 
raises the possibility that the RyR1-nesprin-1α-lamin A associations occur within 
nuclear invaginations. 
 
All types of structure defined by relatively high densities of lamin A labelling were also 
identified by dense labelling of emerin, which appears to line the entire inner surface 
of the INM. Emerin may also form protein complexes with nesprin-1α (Mislow et al., 
2002), which links to RyR1(Pare et al., 2005a; Pare et al., 2005b).  Moreover, emerin 
can provide discrete chromatin attachment points along the surface of the INM 
through its co-association with BAF (Berk et al., 2014; Cai et al., 2001; Lee et al., 
2001). It was evident, however, that there were two subpopulations of emerin-positive 
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invaginations, those that were positive and those that were negative for lamin A. In 
short, the molecular complexes that underpin chromatin attachment within different 
nuclear invaginations are heterogeneous in nature. 
 
4.3.4 The inner nuclear membrane of nuclear invaginations is lined by puncta 
of chromatin-anchoring protein complexes. 
Co-labelling for lamin A and H3K9me2, or emerin and BAF confirmed that chromatin 
anchoring NET protein complexes are formed along the length of nuclear 
invaginations. In fact, it was shown that sites of nuclear invaginations often displayed 
electron-dense heterochromatin in close proximity to the inner nuclear membrane 
(Jorgens et al., 2017). More than 90% of nuclear structures defined by dense labelling 
for lamin A exhibited well-defined regions of colocalisation with H3K9me2, including 
blind, superficial and trans-nuclear invaginations. Nuclear invaginations were either 
entirely covered or harboured small discrete puncta of colocalisation with H3K9me2 
(~500 nm in diameter) that were generally separated by 300 nm. In short, while the 
numbers of lamin A positive nuclear invaginations per cell varied markedly, wherever 
they appeared they harboured at least one site of H3K9me2 co-localisation. 
Peripheral ridges and clefts also exhibited relatively large, broad “plaques” of co-
labelling for H3K9me2 of the order of up to several micrometers across. These 
observations are significant because lamin A may facilitate transcriptional 
suppression by binding to the LADs of heterochromatin (Burke and Stewart, 2013), 
anchoring it to the IMN. LADs have been considered as repressive domains that are 
enriched in H3K9me2 (Towbin et al., 2012), and the formation of LADs appears to be 
dependent on H3K9me2/3 (Harr et al., 2015). H3K9me2 is generally considered to be 
a repressive histone mark. High-resolution profiling of histone methylation in the 
human genome has identified a modest correlation between H3K9me2 and gene 
silencing (Barski et al., 2007). However, it is very important to note that H3K9me2 
signals were found on both silent and active genes (Barski et al., 2007). In human T 
cells, H3K9me2 enrichment partially overlapped with active histone signatures 
upstream of transcriptional starting sites (Smith et al., 2009). It predicted that co-
occurrence of epigenetic marks with distinct functions might contribute to the rapid 
and dynamic regulation of changes in gene expression, and this may as well occur 
within nuclear invaginations. Consistently with this view the repressive modification 
H3K9me2 has been shown to spread to enhancers that exhibit transient co-
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enrichment with activating modifications such as H3K27ac during epiblast priming in 
early mouse development (Zylicz et al., 2015). Co-associations with seemingly 
opposing epigenetic marks at enhancers has been proposed to confer 
responsiveness and plasticity of cells, allowing instant and dynamic transcriptional 
regulation in response to transient signals. In short, co-existence of lamin A and 
H3K9me2 is a hallmark of gene suppression, and suggests that the nuclear 
invaginations as well as the peripheral ridges and clefts identified here are sites of 
gene suppression. That this suppression by H3K9me2 may be considered to be 
instant and dynamic, through co-associations with activating histones, indicates that 
its target genes may well subject to modulation by intracellular signals such as 
transmembrane Ca2+ flux. 
 
In contrast to the widespread distribution of H3k9me2, the majority of BAF labelling 
was clearly targeted to nuclear invaginations rather than the perimeter of the nucleus. 
Moreover, greater inter-cell variability was evident with respect to the number of 
emerin-positive nuclear invaginations per cell that co-labelled for BAF. This is 
indicative of greater plasticity of association than observed for lamin A and H3K9me2. 
Once more this observation may be of yet greater significance given the high level of 
plasticity exhibited by nuclear invaginations themselves and the gene-specific actions 
of BAF, which may either repress or activate gene expression (Takama et al., 2013, 
Cox et al., 2011). 
 
Emerin has been shown to provide discrete chromatin attachment points along the 
surface of the INM through its co-association with BAF (Berk et al., 2014, Cai et al., 
2001, Lee et al., 2001). One early study showed that BAF forms dodecamers that 
tightly binds double-stranded DNA in a sequence-independent manner (Zheng et al., 
2000), but more recent studies argue that BAF binding has distinct effects on different 
genes. For example, depletion of BAF reduces Sox2, Oct4, Nanog expression in 
mouse embryonic stem cells(Cox et al., 2011), and BAF facilitates immediate-early 
gene expression in herpes simplex virus (Oh et al., 2015). All the evidence above 
seems to prove that BAF association promotes gene expression. However, in 
LHaCaT psoriasis cells, BAF depletion results in an increased expression of S100A9 
and c-Jun(Takama et al., 2013). It has also been reported that BAF suppresses eef-
1 expression in C. elegans (Margalit et al., 2007). When taken together the evidence 
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above indicates that while emerin-BAF association can modulate gene expression, it 
does not have the same effect on all genes. Moreover, the mode of its action is 
intriguing. BAF is more mobile when compared to its binding partner emerin, and it 
was proposed that BAF binds emerin frequently but transiently during interphase in a 
“touch-and-go” manner (Shimi et al., 2004). This theory is also supported by my data 
that the nuclear invaginations targeted by emerin-BAF complex exhibit a high degree 
of plasticity. Perhaps BAF should be considered as a “dynamic” regulator that is 
constantly associating and disassociating with its targets in response to upstream 
signals. 
 
The sizes of the emerin-BAF and lamin A-H3k9me2 complexes range from 150-600 
nm in diameter. Taking into consideration the spread of fluorescence albeit limited by 
deconvolution, these measurements are likely overestimated. However, it is the 
distances of separation between these puncta that are most revealing in the context 
of my study. In each case the puncta of co-localisation were separated by around 
300-500 nm in all invaginations studied. This is intriguing because this is similar to the 
distances of separation I measured for the hotspots of Ca2+ release supported by 
RyRs within nuclear invaginations (see Chapter 3). This strongly suggests that the 
interactions between lamin A, emerin and their respective binding partners (Burke and 
Stewart, 2013), and the modulation of chromatin re-organisation and ultimately 
transcription, might be coordinated on the nanoscale, at least in part, by Ca2+ flux 
across the ONM.  
4.3.5 Conclusion 
Nuclear invaginations of differentiated PASMCs form a trans-nuclear network of 
nanodomains, to which chromatin anchoring NET protein complexes are selectively 
and strategically targeted. Here they form potential chromatin attachment sites for the 
regulation of gene expression. The nano-pattern of the chromatin attachment sites 
suggests that gene expression is perhaps regulated, in part, by Ca2+ signals 




Figure 4.15 Schematic model showing the distribution of NET proteins.  
Predicted distribution of NET proteins in on the inner nuclear membrane and nuclear 

















Chapter 5: Nuclear invaginations are reduced and 
PASMCs are reconfigured during phenotypic switch 
5.1 Introduction 
5.1.1 Vascular smooth muscle cells display remarkable phenotypic plasticity 
Vascular smooth muscle cells are the key components of the vasculature, their 
primary function is to regulate the blood vessel diameter by modulating 
vasoconstriction and dilation, which subsequently control blood flow distribution and 
blood pressure (Owens, 1995). One key feature that distinguishes the smooth muscle 
cells from the cardiac and skeletal smooth muscle cells is that they exhibit extensive 
plasticity as reviewed by Gomez & Owens (Gomez and Owens, 2012). They are not 
terminally differentiated in mature animals, instead, they are able to undergo 
reversible phenotypic switching in response to changes in the environment. The 
consensus is that smooth muscle cells can switch from the differentiated contractile 
phenotype to a synthetic, migratory and proliferative phenotype. In fact, the 
differentiated smooth muscle cells in adult blood vessels exhibit an extremely low 
proliferation rate (Hungerford and Little, 1999). They are nonmigratory and they 
synthesise very limited amounts of extracellular matrix components, because their 
primary function is contraction. However, in response to changes of the local 
environment, for example the occurrence of vascular injury, the differentiated smooth 
muscle cells switch to a synthetic, proliferative phenotype transiently during the 
healing process and switch back to the contractile phenotype once the tissues are 
repaired (Owens et al., 2004). Another example of the phenotypic switch is the 
proliferation of pulmonary arterial smooth muscle cells (PASMCs) in the pulmonary 
vasculature of patients with pulmonary arterial hypertension. The PASMCs of these 
patients exhibit the proliferative phenotype, which contributes to the thickening of the 
artery walls. The hypertrophy eventually leads to the elevation of pulmonary arterial 
pressure, which jeopardises the well-being of the patients (Wilson et al., 2015). 
 
5.1.2 Smooth muscle cell phenotypic switch is underpinned by changes in gene 
expression 
It is generally accepted that the phenotypic switch of the smooth muscle cell from the 
contractile state to the proliferative phenotype is underpinned by the down regulation 
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of differentiation/contractile markers and the upregulation of the proliferation markers 
(Owens et al., 2004, Gomez and Owens, 2012). A number of smooth muscle specific 
proteins and proteins that are selective for smooth muscle cells have been identified 
as smooth muscle markers or differentiation markers. For example, the α-actin has 
been shown to specifically express in vascular smooth muscle cells (Gabbiani et al., 
1981); h1-calponin and SM 22α were used as a differentiation marker of smooth 
muscle cells in early research (Duband et al., 1993); smoothelin also identifies 
differentiated smooth muscles in human blood vessels (van der Loop et al., 1997). 
However, the most specific marker of the differentiated smooth muscle cells is 
perhaps the myosin heavy chain (MHC). It was shown by in situ hybridization that the 
expression of smooth muscle MHC was observed throughout the development and 
maturation of whole mouse embryos, and this protein was not expressed in any other 
cell types but smooth muscles (Miano et al., 1994). This observation is confirmed by 
other studies (Regan et al., 2000, Sartore et al., 1994), and MHC has been considered 
as one of the most reliable markers of smooth muscle cells (Rensen et al., 2007). 
 
During the phenotypic switch from the contractile phenotype to the proliferative 
phenotype, the expression of the differentiated smooth muscle cell markers is 
gradually reduced, and the extent to which the expression is downregulated correlates 
to the degree of proliferation (Christen et al., 1999). Meanwhile, the expression of the 
proliferation markers, such as PDGF-A, CRBP-1 and Smemb is upregulated as 
reviewed by  Rensen et al (Rensen et al., 2007). The changes in the protein 
expression eventually lead to the loss of the contractile apparatus, and proliferative 
smooth muscle cells gained the ability to migrate and increase synthesis.  
 
5.1.3 Smooth muscle proliferation and Ca2+ signalling 
Accompanied by changes in gene expression, the intracellular Ca2+ handling in 
proliferating smooth muscle cells is altered. It was reported that the smooth muscle 
proliferation is reliant on IP3R dependent Ca2+ signalling (Wilkerson et al., 2006).  
Consistent with the view, it was shown that expression of RyR3 is reduced (Vallot et 
al., 2000), whereas the expression of all three IP3R isoforms are augmented in 
proliferating smooth muscle cells compared to differentiated smooth muscle cells 
(Berra-Romani et al., 2008). Therefore, it is possible that this altered Ca2+ handling 
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contributes to the changes in gene expression. 
 
5.1.4 Aim 
The nuclear invaginations/nucleoplasmic reticulum was observed in tumorous cells 
(Fischer et al., 2003), and it was stated that increased nucleoplasmic reticulum is 
common in tumour cells (Malhas et al., 2011).  Moreover, it was shown that the 
nucleoplasmic Ca2+ is required for cell proliferation (Rodrigues et al., 2007). Based on 
these facts, it was proposed that the nuclear invaginations could provide further 
specificity to cell proliferation by allowing the focal delivery of Ca2+ to particular sites 
within the nucleus (Resende et al., 2013). Therefore, I decided to study nuclear 
invaginations and nuclear Ca2+ signalling in proliferating PASMCs. 
 
Moreover, given that the phenotypic switch of the smooth muscle cells is underpinned 
by changes in gene expression, I also decided to study the regulation of chromatin 



















5.2.1 Nuclear invaginations disassemble, and Ca2+ handling is altered during 
the phenotypic switch from contractile to proliferating myocytes 
 
5.2.1.1 Day 7 cultured PASMCs switched from the contractile phenotype to a 
proliferative phenotype. 
Consistent with previous publications on vascular smooth muscle cells (Zhang et al., 
2016, Zhang et al., 2017), we observed phenotypic switch of the arterial smooth 
muscle cells (n=358) from the contractile phenotype to a proliferative phenotype 
induced by culture in the presence of serum containing growth factors. Smooth 
muscle cells were identified by myosin heavy chain (MHC) staining, which was proved 
to be an effective marker for smooth muscle cells up to and including the 7th day of 
culture (Liu et al., 2013, Peng et al., 2017). The acutely isolated (i), day 1 cultured (ii), 
day 4 cultured (iii) and day 7 cultured (iv) PASMCs were identified in the bright field 
images by labelling the nuclei with Dapi (blue, Figure 5.1 A) and the myofilaments 
were identified with a sequence-specific antibody against MHC (green) as Figure 5.1B 
shows. One example cell of each group is magnified and shown with both the MHC 
(green) and Dapi (blue) staining in Figure 5.1 C. It was confirmed that 99% of the cells 
acutely isolated from the pulmonary arteries were smooth muscle cells (Figure 5.1 Bi), 
because they were MHC positive, and they were in an elongated, oval shape, which 
is typical for the contractile smooth muscle cells (Figure 5.1 Ci)(Rzucidlo et al., 2007). 
The good isolation efficiency guarantees that the cells that had been used for culture 
are almost pure population of smooth muscle cells.  
 
In response to stimulation with growth factors, the morphology of PASMCs changed 
in culture (medium containing 10% of fetal bovine serum). The spindle-like PASMCs 
developed protrusions (indicated with arrow head) that were similar to filopodia and 
lamellipodia (Figure 5.1 Cii). However, 91% percent of the cells were still positive for 
MHC. After 4 days of culture with 10% serum, the cells developed spreading, 
epithelioid/rhomboid-like shapes (Figure 5.1 Cii), which is the typical morphology of 
the proliferative smooth muscle cells (Thakar et al., 2009). In contrast with acutely 
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isolated PASMCs, only 63% of the day 4 cultured PASMCs were labelled by MHC 
(Figure 5.1 Biii), suggesting a gradual loss of the contractile apparatus. The day 7 
cultured cells were in similar morphology to the day 4 cultured cells (Figure 5.1 Civ), 
although at this stage 42% of the cells were MHC negative (Figure 5.1 Biv) perhaps 
due to the total loss of the contractile apparatus. Therefore, the proliferation has been 
initiated following 7 days of culture. 
 
 
Figure 5.1 Smooth muscle cells were identified by MHC labelling  
 
(A) Bright field images of (i) acutely isolated PASMCs, (ii) Day 1 cultured PASMCs, 
(iii) Day 4 cultured PASMCs and (iv) Day 7 cultured PASMCs are shown with the 
nuclei labelled by Dapi (blue). 
(B) As for (A), but showing the immunostaining of myosin heavy chain (MHC) in green. 
(C) Higher magnification images showing (i) a single acutely isolated PASMC, (ii) a 
single day 1 cultured PASMC, (iii) one day 4 cultured PASMC and (iv) two day 7 






5.2.1.2 Nuclear invaginations are lost in the majority of proliferating PASMCs 
Day 7 cultured proliferating PASMCs were loaded with the Ca2+ indicator Fluo-4, the 
ER/OMN indicator ER-tracker, and Draq 5 which identifies the nucleoplasm. Z stacks 
through the nuclei of the labelled cells were taken at an interval of 0.2 µm. One 
example is shown in Figure 5.2. Z sections showing the bottom of the nucleus (i), the 
middle of the nucleus (ii, iii), and the top of the nucleus (iv) are displayed in Figure 5.2 
A, B, C&D. Figure 5.2 Ai-iv show the confocal Z sections of the cell labelled by ER-
tracker (orange) at the four positions (i-iv). In Figure 5.2 Bi-iv, Draq 5 labelling (blue) 
was merged on top of the images shown in Figure 5.2 A. With the Draq 5 identifying 
the nucleoplasm, it was observed that the ER-tracker identified the network of ER and 
ONM, the ONM was identified because it outlined the nucleoplasm in blue. 
Interestingly, the two sections through the middle of the nucleus reveal no nuclear 
invagination (Figure 5.2 A ii&iii). In fact, in all the day 7 cultured proliferating PASMCs 
studied so far (ER-tracker labelled), 80% of the cells showed no sign of nuclear 
invaginations, regardless of the depth of scanning into the nucleoplasm (n=25).  
 
This representative cell was also loaded with the Ca2+ indicator Fluo-4, and the Z 
sections scanned at 3 positions (i-iii) as shown in Figure 5.2 A&B are displayed with 
the Fluo-4 intensity alone (green, Figure 5.2 Ci-iii) or Fluo-4 intensity together with the 
ER-tracker labelling (Figure 5.2 Di-iii). Based on the ER-tracker labelling, the 
cytoplasm and nucleoplasm can be distinguished, and it can be seen that the Fluo-4 
intensity within the nucleoplasm appears to be lower than the cytoplasmic Fluo-4 
intensity (which is confirmed by quantitative assessment in section 5.2.1.3&4). 
Judging by the intracellular distribution of free Ca2+ indicated by Fluo-4, no apparent 
tubular/linear structures were revealed by high Ca2+ concentrations as was commonly 
seen in acutely isolated cells; in other words, no nuclear invagination was identified 









Figure 5.2 The nuclear invaginations are lost in proliferating PASMCs.  
(A) A series of confocal z sections through a day 7 cultured PASMC with the ER/SR 
and nuclear membrane identified by ER-tracker (orange). 
(B) As for (A), and also shows Draq 5 (blue) identified nucleoplasm. 
(C) As for (A), but showing the Fluo-4 loading. 












5.2.1.3 Nuclear invaginations were infrequently observed in proliferating PASMCs, 
they did not retain higher levels of Ca2+ at rest comparing to the nucleoplasm. 
Only 20% of the studied cells exhibited nuclear invaginations, and 1.8 ± 0.3741 
nuclear invaginations were identified per cell (Appendix 3, Table 5.1). One example 
of such cells is shown in Figure 5.3. Confocal scans through the middle of the ER-
tracker and Fluo-4 co-labelled proliferating PASMC are shown in Figure 5.3 Ai,ii&Bi. 
As Figure 5.3 Ai shows, apart from the ER and ONM, a very small, single dot in the 
middle of the nucleoplasm was revealed by the ER-tracker labelling (as indicated by 
the white arrow). It was easily neglected, even after magnification (Figure 5.3 Bi) it 
was still not very obvious. However, this dot at the same position appeared in every 
scan through the middle of the nucleus, suggesting that it might be the cross section 
of one nuclear invagination.  
 
In terms of the distribution of intracellular Ca2+, Fluo-4 loading (green) of the same 
confocal Z section indicates that the cytoplasm contained higher levels of free Ca2+ 
compared to the nucleoplasm (Figure 5.3 Aii). Interestingly, the analysis of the Fluo-
4 fluorescence signal did not reveal this ER-tracker identified structure, although it 
appeared to represent a trans-nuclear invagination. To confirm this, a blue dotted line 
was drawn across the cytoplasm, nucleoplasm and this nuclear invagination-like 
structure as shown in Figure 5.3Aii, and the fluorescent intensities of both the ER-
tracker and Fluo-4 along this line were plotted against distance as shown in Figure 
5.3 Aiii. The regions of interest are indicated on the grey bar (C for cytoplasm, N for 
nucleus, I for nuclear invagination). The ER-tracker intensity (orange) along the line 
identifies from left to right the perinuclear cytoplasm (C) which contains perinuclear 
ER, the nucleoplasm (N) that was not labelled by the ER-tracker, and the cross-
section of a nuclear invagination (I) that was evidently labelled by ER-tracker. The 
Fluo-4 intensity along the same line indicated that the perinuclear cytoplasm held 
higher levels of free Ca2+ than the nucleoplasm, whereas the Ca2+ level in the 
nucleoplasm was similar to that of the lumen of the nuclear invagination. 
 
The confocal Z section shown in Figure 5.3 Ai and Aii were merged and magnified as 
Figure 5.3 Bi shows, and the dot that seems to be a nuclear invagination is indicated 
by a white arrow. To prove that it is indeed the cross section of a nuclear invagination, 
the cellular region containing the nuclear invagination was defined by two white dotted 
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lines, and the 3D reconstructed model of the cell was sectioned to show only this 
region. The sectioned 3D model was rotated 90 degrees upward to show the nuclear 
invagination from the side (Figure 5.3 Bii, iii&iv). Figure 5.3 Bii shows this sectioned 
3D model built with the ER-tracker labelling, within which it is evident that one nuclear 
invagination traversing the nucleus was identified as the white arrow indicated; 
consistent with my prediction concerning the nature of the ER-tracker density 
observed in Figure 5.3 A. By contrast, the sectioned 3D model built with Fluo-4 loading 
shows that at no point along the entire length of the nuclear invaginations, did the 
Fluo-4 fluorescence intensity within the lumen of the nuclear invagination differ from 
that of the nucleoplasm.  
  
Figure 5.3 The lumen of nuclear invaginations in proliferating PASMCs does not 
retain high levels of free Ca2+ at rest. 
(A) A confocal scan through the middle of a day 7 cultured PASMC labelled by ER-
tracker (i, orange) or loaded with Fluo-4 (ii, green) is shown. A blue dotted line was 
drawn across the cell by passing the cytoplasm, nucleus and a nuclear invagination, 
the nuclear invagination is indicated by a white arrow. (iii) The fluorescence intensity 
along the line was plotted against distance, the ER-tracker intensity is shown in 
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orange and Fluo-4 intensity is shown in green. Regions of interest are indicated in the 
grey bar, C for cytoplasm, N for nucleus and I for invagination. 
(Bi) The same confocal scan showed in (A) is displayed with the ER-tracker labelling 
in orange and Fluo-4 loading in green. The nuclear invagination is indicated by a white 
arrow. A region of the cell is defined by two dotted white lines. (ii) A 3D model of the 
cell was reconstructed based on confocal Z stacks, and the section of the cell 
indicated in (i) by the white dotted lines was cut out and turned 90 degrees upwards 
to show the view from the side of the section. The 3D model of the section with the 
ER-tracker labelling is shown. (iii) As for (ii), but showing the 3D model of the section 
with the Fluo-4 loading. (iv) As for (ii), but showing the 3D model of the section with 




5.2.1.4 RyR1 agonist cannot induce Ca2+ signals within either the nuclear 
invaginations or the cytoplasm of proliferating PASMCs 
 
It was reported in Chapter 3 that the nuclear invaginations in acutely isolated PASMCs 
are able to generate spatially restricted Ca2+ signals within their lumen in response to 
the RyR1 agonist maurocalcine. Therefore, I decided to examine whether the nuclear 
invaginations in the proliferating PASMCs can generate such Ca2+ signals.  
 
The nuclear invaginations in acutely isolated PASMCs can be identified by Fluo-4 
intensity, because they can effectively restrict Ca2+ diffusion at rest. By contrast, the 
nuclear invaginations in proliferating PASMCs cannot be identified by Fluo-4 intensity, 
and the identification of those nuclear invaginations relied on the ER-tracker labelling. 
However, as the ER-tracker is toxic to live cells (see product safety sheet, ER-
Tracker™ Blue-White DPX, ThermoFisher Scientific) and fast photobleaching of the 
ER-tracker signal was observed within 3 minutes. It was not recommended to apply 
ER-tracker in time course experiments that lasted longer than 3 minutes. Hence, the 
confocal time course experiments were conducted with proliferating PASMCs loaded 
with Fluo-4 alone. As RyR1 was shown to target the SR and nuclear invaginations of 
acutely isolated PASMCs (see Chapter 3), I hypothesized that RyR1 is also targeted 
to the nuclear invaginations of proliferating PASMCs, and I expected to visualize 
increases in Fluo-4 fluorescence intensity within nuclear invaginations of proliferating 




Live proliferating PASMCs were loaded with Fluo-4 (green) and viewed at a focal 
plane that provides a good view of the nucleoplasm. Extracellular application of 
maurocalcine was used as in Chapter 3 to stimulate the cells, and the cellular 
responses were recorded as time course videos. A series of frames showing several 
significant points of the entire process were selected from one example video and 
shown in Figure 5.4 A. Figure 5.4 Ai-v show the images of the cell at 5 different time 
points. Figure 5.4 Bi-v show the 3D surface plots of the nucleus at these 5 time points. 
Pseudocolour was applied to the 3D surface plots to indicate high Fluo-4 intensity in 
white and low Fluo-4 intensity in black. The index of changes in cytoplasmic (orange) 
or nuclear (blue) Ca2+ concentration versus time was derived from the Fluo-4 
fluorescence ratio (Fx/FC0; C0 = Fluo-4 fluorescence intensity for the cytoplasm at 
time point 0; Fx = fluorescence intensity for the region of interest), and they were 
plotted against time as Figure 5.4 C shows, the selected 5 time points (i-v) were 
indicated by numbers and arrow heads. Images were taken at time point i show the 
Fluo-4 fluorescent intensity within the cell (Figure 5.4 Ai) and the nucleus (Figure 5.5 
Bi) at rest. The Fluo-4 intensity indicates that the cytoplasmic Ca2+ concentration is 
higher than that of the nucleus. On average, the index of cytoplasmic basal Ca2+ was 
1.0±0, which is significantly higher than the index of nuclear basal Ca2+, which 
measured 0.72±0.04 (n=16, p<0.0001, Appendix 3, Table 5.2).  
 
The RyR1 agonist maurocalcine (300nM) was added to the cell as indicated in Figure 
5.4 C. Surprisingly, none of the studied proliferating PASMCs (n=18) responded to 
maurocalcine as Figure 5.4 Aii, Bii &C show. It was presented above that 19% of the 
studied proliferating PASMCs exhibited nuclear invaginations; hence, the chance that 
none of the 18 studied cells harbour any nuclear invagination is very low. Therefore, 
it is very likely that RyR1 expression is largely reduced in proliferating PASMCs, and 
they no longer target the S/ER, nuclear invaginations or any other part of the ONM. 
To examine whether the cells that did not respond to maurocalcine were able to 
generate any Ca2+ signal, 1µM of thapsigargin was added to some of these cells, 
which depletes SR Ca2+ stores supplied by SERCA (Lytton et al., 1991). Consistent 
with the presence of a viable, releasable S/ER Ca2+ store, marked Ca2+ release into 
the cytoplasm and the nucleoplasm was observed as Figure 5.4 Aiii, Biii &C show, 
and the responses in the cytoplasm and the nucleoplasm were synchronized. As 
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Figure 5.4 Aiii and Figure 5.4 C show, the Ca2+ transient in the nucleus is evidently 
larger than that of the cytoplasm. This received support from the fact that the average 
index of the peak change in nuclear Fluo-4 fluorescence is 3.9±0.4, which is 
significantly higher than the average index of the peak change of the cytoplasm 
(2.7±0.26, p< 0.05, n=16, Appendix 3, Table 5.2). When the response peaked, it can 
be observed from both Figure 5.4 Aiii&Biii that the Ca2+ spread homogeneously cross 
the entire nucleus, showing no sign of invagination-restricted Ca2+ signals. This 
indicates that there are no nuclear invaginations that can generate spatially restricted 
Ca2+ signals in any of the 16 cells studied. Moreover, comparison of the effects of 
maurocalcine and thapsigargin on Fluo-4 fluorescence in either the nucleoplasm 
(p<0.0001, Appendix 3, Table 5.2) or the cytoplasm (p<0.0001, Appendix 3, Table 5.2) 
demonstrates that cells were non-responsive to maurocalcine, while they harboured 










Figure 5.4. Maurocalcine fails to induce Ca2+ signal in proliferating PASMCs 
 
(A) Confocal scans through the center of a proliferating pulmonary arterial smooth 
muscle cell loaded (25o C) with Fluo-4 are shown. Images show the same focal plane 
at (from left to right) different time points (i, ii, iii, iv and v) following extracellular 
application of 300 nM maurocalcine, and later on 1 M thapsigargin. 
(B) As in (A), but showing the 3D surface plots of the nucleus with a higher 
magnification, the Fluo-4 fluorescence intensity is indicated by pseudocolour 
representation.  
(C) Fluo-4 fluorescence ratio (Fx/FC0) versus time for each of the identified regions of 
the cytoplasm and nucleoplasm shown in (A) is plotted; FC0 = Fluo-4 fluorescence 
intensity for the perinuclear cytoplasm at time point 0, Fx = fluorescence intensity for 
region of interest). 
(Di) Bar charts show the mean±SEM basal fluorescence within the cytoplasm (orange) 
and nucleoplasm (blue). (ii) Bar charts show the mean±SEM for the peak change in 
fluorescence ratio induced by 300 nM maurocalcine or 1 M thapsigargin ; *=p<0.05, 
**=p<0.01, *** =P<0.001, ****=p< 0.0001, n=16. 
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It is evident from the results that the nuclear invaginations in proliferating PASMCs do 
not support spatially restricted Ca2+ signals in response to either maurocalcine or 
thapsigargin, although there is a slim chance that none of the studied cells harboured 
nuclear invaginations. The difficulty of the experiments lies in the fact that the nuclear 
invaginations in the proliferating PASMCs cannot be identified by Fluo-4 intensity, and 
there are no other means to identify the structure without introducing toxicity. However, 
one surprising finding is that among all the 53 Fluo-4 loaded proliferating PASMCs I 
studied, there was one peculiar cell that showed one nuclear invagination that seemed 
to retain Ca2+ at rest, and thus was identified by Fluo-4 intensity. Similarly, stimuli 
were added to the cell, and the response was recorded by a time course video. 5 
frames showing the cell at 5 significant time points were selected, and the 3D surface 
plots of the nucleus in the 5 frames were produced with the application of 
pseudocolour (Figure 5.5 Ai-v). The index of changes in cytoplasmic (orange), nuclear 
(blue) Ca2+ concentration and Ca2+ concentration in the nuclear invagination (red) 
versus time were derived from the Fluo-4 fluorescence ratio (Fx/FC0; C0 = Fluo-4 
fluorescence intensity for the cytoplasm at time point 0; Fx = fluorescence intensity 
for the region of interest), and they were plotted against time as Figure 5.5 B shows 
with the 5 selected time points indicated by numbers and arrow heads.  
 
At rest one nuclear invagination traversing the nucleus was observed, which 
displayed slightly higher Fluo-4 fluorescence intensity compared to the rest of the 
nucleoplasm (Figure 5.5 Ai&B), but it was lower than the cytoplasmic Fluo-4 intensity 
(Figure 5.5 B). Following the addition of 300 nM maurocalcine, no change was 
observed in the nuclear invagination, nucleus or the cytoplasm (Figure 5.5 Aii&B). By 
depleting the SERCA supplied Ca2+stores, dramatic Ca2+ transients were induced in 
both the nucleoplasm and the cytoplasm as Figure 5.5 Aiii &B show. Importantly, 
Figure 5.5 Aiii&iv show the 3D surface plots of the nucleus when the response peaked, 
and it seems that the nuclear invagination cannot be distinguished from the rest of the 
nucleoplasm. The observation received support from the plot of response shown in 
Figure 5.5C, which revealed that the nuclear invagination was not responsive to 
maurocalcine, despite the existence of releasable Ca2+ store. 
 
These facts confirm that, unlike the nuclear invaginations in acutely isolated PASMCs, 
RyR1 is not targeted to the nuclear invaginations in the proliferating PASMCs. Upon 
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the depletion of thapsigargin-sensitive Ca2+ stores, Ca2+ was released directly into the 
nucleoplasm and cytoplasm but not the cytoplasmic nanodomains enclosed by 
nuclear invaginations. RyR1s are therefore absent from the ONM of nuclear 
invaginations, and these nuclear invaginations do not appear to support spatially 
restricted Ca2+ signalling. 
 
 
Figure 5.5 Nuclear invaginations in proliferating PASMCs are not able to 
generate spatially restricted Ca2+ signals within these nanotubes 
(A) Confocal scans through the center of a day 7 cultured pulmonary arterial smooth 
muscle cell loaded (25o C) with Fluo-4 were selected. Images showing the 3D surface 
plots of the nucleus at (from left to right) different time points (i, ii, iii, iv and v) following 
extracellular application of 300 nM maurocalcine, and later on 1 M thapsigargin. 
Pseudocolour representation was applied to show high fluorescent intensity in white 
and low fluorescent intensity in black.  
(B) Fluo-4 fluorescence ratio (Fx/FC0) versus time for each of the identified regions of 
the cytoplasm, nuclear invaginations, and nucleoplasm is plotted; FC0 = Fluo-4 
fluorescence intensity for the perinuclear cytoplasm at time point 0, Fx = fluorescence 





The observations above showed that the RyR1 agonist failed to induce Ca2+ signal in 
proliferating PASMCs. Next, I investigated whether the physiological stimulation by 
angiotensin II could induce Ca2+ signals in these cells. 30µM angiotensin II was added 
to the proliferating PASMCs and the experiments were recorded by time course 
videos. One example experiment is shown in Figure 5.6. Figure 5.6 Ai-iv show 4 
frames of the time course video at 4 different time points. Figure 5.6 Bi-iv show the 
3D surface plots of the nucleus at these 4 time points, pseudocolour was applied to 
the 3D surface plots to indicate high Fluo-4 fluorescence intensity in white and low 
Fluo-4 fluorescence intensity in black. The index of changes in cytoplasmic or nuclear 
Ca2+ concentration versus time was derived from the Fluo-4 fluorescence ratio (Fx/FC0; 
C0 = Fluo-4 fluorescence intensity for the cytoplasm at time point 0; Fx = fluorescence 
intensity for the region of interest), and they were plotted against time as Figure 5.6 
C shows with the 4 time points (i-v) indicated by numbers and arrow heads. 
 
The Fluo-4 intensity indicates that the cytoplasmic Ca2+ concentration is significantly 
higher than the nuclear Ca2+ concentration at rest as observed in other proliferating 
PASMCs (Figure 5.6 Ai&Di, n=4, p<0.05, Appendix 3, Table 5.3). Following the 
addition of the vasoconstrictor angiotensin II, synchronic Ca2+ transients were induced 
in both the cytoplasm (Figure 5.6 Aii &C) and nucleoplasm (Figure 5.6 Bii &C). The 
increase of Ca2+ was homogeneous across the nucleoplasm (Figure 5.6 Aii&Bii) in all 
the studied cells (n=8), suggesting that nuclear invaginations of proliferating PASMCs 
cannot generate spatially restricted Ca2+signals above the peak response evoked 
within the nucleoplasm by angiotensin II.  
 
The amplitude of the Ca2+ transient induced in the nucleoplasm is significantly larger 
than that in the cytoplasm (n=4, Figure 5.6 Dii, p<0.0005, Appendix 3, Table 5.3), 
quite unlike outcomes for acutely isolated cells. Interestingly, as the bar charts in 
Figure 5.6 Dii shows, angiotensin II induced Ca2+ signals were not blocked by 
preincubating the cells with the non-selective RyR inhibitor tetracaine (1 mM TTC, 
n=4, Appendix 3, Table 5.4). However, the angiotensin II induced Ca2+ signals were 
abolished following the depletion of S/ER stores by SERCA inhibition using 
thapsigargin (1µM, n=4, Appendix 3, Table 5.4), indicating that while these stores 
support the angiotensin II induced Ca2+ release they do so by alternative means. 
Consistent with this view, angiotensin II induced Ca2+ signals were abolished by 
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preincubating the cells with either 50 µM 2-APB (2-Aminoethoxydiphenyl borate, n=4, 
Appendix 3, Table 5.4) or 3 µM U73122 (n=4, Appendix 3, Table 5.4). 2-APB is a 
membrane permeable antagonist of Ins(1,4,5)P3 receptors and transient receptor 
potential cation channels (Maruyama et al., 1997, Togashi et al., 2008), whereas 
U73122 is a phospholipase C inhibitor that can effectively inhibit the production of 
Ins(1,4,5)P3 (Bleasdale et al., 1990). When these facts are taken together, it can be 
concluded that in proliferating PASMCs the vasoconstrictor angiotensin II induces 
Ca2+ release from SERCA supplied Ca2+ store (i.e.S/ER) into the nucleoplasm and 






Figure 5.6 Angiotensin II induces Ca2+ signals in both the nucleoplasm and the 
cytoplasm of proliferating pulmonary arterial myocytes via IP3Rs but not RyRs 
(A) Confocal scans through the middle of a proliferating pulmonary arterial smooth 
muscle cell loaded (25o C) with Fluo-4 are shown. Images show the same focal plane 
at (from left to right) different time points (i, ii, iii, and iv) following extracellular 
application of the vasoconstrictor angiotensin II (30 M). 
(B) As in (A), but showing the 3D surface plots of the nucleus at a higher magnification 
with the fluorescence intensity indicated by pseudocolour representation.  
(C) Fluo-4 fluorescence ratio (Fx/FC0) versus time for each of the identified regions of 
the cytoplasm and nucleoplasm shown in (A) is plotted; FC0 = Fluo-4 fluorescence 
intensity for the perinuclear cytoplasm at time point 0, Fx = fluorescence intensity for 
region of interest). 
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(D) Bar charts show the mean±SEM basal fluorescence within the cytoplasm (orange) 
and nucleoplasm (blue), and for the peak change in fluorescence ratio induced by 
angiotensin II (30 M) in the absence and presence of 1 mM tetracaine (TTC, 4h pre-
incubation), 1 M thapsigargin (TG, 1h pre-incubation), 50 M 2APB (30 minutes 





5.2.2 Components of the chromatin anchoring NET protein complex are 
reconfigured in proliferating PASMCs 
 
As previously mentioned, the nuclear invaginations were absent from the majority of 
proliferating PASMCs, while the remaining 19% of cells incorporated 1-2 nuclear 
invaginations per cell. Either way, when present they do not appear to support Ca2+ 
signalling in response to any stimulus applied here. This observation led to the next 
question: are the components of the chromatin anchoring NET protein complex that 
lines nuclear invaginations of acutely isolated PASMCs reconfigured in proliferating 
cells? 
 
5.2.2.1 Reconfiguration of lamin A in proliferating PASMCs 
Proliferating PASMCs were labelled for lamin A, and one example cell is shown in 
Figure 5.7. The 3D reconstruction of the lamin A (red) labelled nucleus is shown in 
Figure 5.7 A with Dapi (blue) indicating the nucleoplasm. The lamin A labelling alone 
is shown in Figure 5.7 B. Surprisingly, not only did lamin A labelling fail to identify 
nuclear invaginations in 100% of cells studied, but also revealed that the peripheral 
ridges or clefts seen in acutely isolated cells were absent from the nuclear membrane 
of proliferating PASMCs (n=20). However, it is very clear that the density of lamin A 
labelling is not uniform across the inner surface of the INM (Figure 5.7 C). Quite unlike 
the structure observed in acutely isolated PASMCs, lamin A labelling formed a dense 
mesh-like pattern across the entire surface of the INM. This indicates that sites for 
chromatin attachment and gene repression are massively reconfigured during 
proliferation. Furthermore, Figure 5.7 D shows the rotated section of the 3D 
reconstructed lamin A labelling, which reveals the nuclear interior of the exemplary 
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proliferating PASMC. it confirms that no nuclear invagination was identified by lamin 
A labelling, which is true across all the cells studied thus far (n=20, Figure 5.8A). In 
short, when present nuclear invaginations of proliferating cells are not lined by lamin 
A and do not support Ca2+ signalling. This further suggests that chromatin attachment 






Figure 5.7 Lamin A forms a meshwork across the surface of the INM of 
proliferating PASMCs 
The nucleus of a PASMC was labelled for lamin A (red) with (A) or without (B) Dapi 
(blue) identifying the nucleus. 3D reconstruction of the nucleus (C) was sectioned (D, 




In acutely isolated PASMCs, peripheral ridges and clefts were revealed by raising the 
detection threshold of lamin A labelling. To study the peripheral structures on the 
nuclear surface of proliferating PASMCs, the 3D reconstructions were processed in 
the same way. As Figure 5.8 A shows, the 3D reconstruction of a lamin A (red) labelled 
nucleus is displayed with Dapi (blue) indicating the nucleoplasm. The lamin A labelling 
alone is shown in Figure 5.8 B, but the detection threshold was set to reveal only the 
density of lamin A by removing the surrounding lamina. It is clear following the 
application of the digital skin that the lamin A densities on the nuclear surface are 
segregated pieces (Figure 5.8 C&D), by sectioning, magnifying and rotating it can be 
confirmed that these densities of lamin A do not form linear structures like the 






Figure 5.8 Lamin A does not identify peripheral ridges or clefts in proliferating 
PASMCs 
The nucleus of a PASMC was labelled for lamin A (red) under high detection threshold 
with (A) or without (B) Dapi (blue) identifying the nucleus. 3D reconstruction of the 
nucleus (C) was sectioned (D, left hand panel) and then displayed at higher 
magnification (D, right hand panel). Dr. Jorge Navarro-Dorado conducted experiment 




The nuclei of the acutely isolated (differentiated) and proliferating PASMCs also 
differed in respect of the surface area to volume ratio for lamin A labelling (Figure 5.9 
A). For proliferating PASMCs this is reduced to 2.0±0.4 µm2/ µm3, which is significantly 
lower than the values for differentiated PASMCs (5.0±0.8, Figure 5.9 B, n=4, p<0.005, 
Appendix 3, Table 5.5). The significance of this finding lies in the fact that lamin A is 
the key component of the chromatin anchoring nuclear envelope transmembrane 
(NET) protein complexes. This indicates that the number of sites / relative area for 





Figure 5.9 Lamin A does not identify nuclear invaginations and the surface to 
volume ratio of for lamin A is reduced in proliferating PASMCs  
(A) Number of invaginations per cell in acutely isolated PASMCs (black) and day 7 
cultured PASMCs (red) identified by lamin A are shown. Data are presented as 
mean±SEM;  ****=p< 0.0001, n=4 





5.2.2.2 The chromatin anchoring protein complexes formed via lamin A are 
redistributed in proliferating PASMCs, lamin A and H3K9me2 association at the 
periphery of the nuclei are reduced in proliferating PASMCs  
Next, I investigated the distribution of the lamin A-H3K9me2 association, considering 
that lamin A can promote transcriptional suppression by binding to the lamina-
associated domain (LAD) of heterochromatin (Burke and Stewart, 2013), in a manner 
facilitated by co-association with histones such as H3K9me2/3(Harr et al., 2015). 
Proliferating PASMCs were co-labelled for lamin A (red) and H3K9me2 (green). Z 
stacks through the nuclei of the labelled cells were taken at 0.2 µm intervals. One 
example is shown in Figure 5.10. Z sections showing the top of the nucleus (i), the 
middle of the nucleus (ii, iii, iv), and the bottom of the nucleus (v) are displayed in 
Figure 5.10 with different labelling. Figure 5.10 shows the confocal Z sections of the 
cell labelled for lamin A at low detection threshold with (A) and without (B) Dapi (blue) 
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indicating the nucleoplasm. Figure 5.10 C shows the H3K9me2 labelling at low 
threshold. In Figure 5.10 D, the lamin A labelling is merged with the H3K9me2 
labelling. The colocalisation between lamin A and H3K9me2 was calculated and 
displayed in yellow, and merged on top of the lamin A labelling as Figure 5.10 E shows. 
 
It is important to note that the fixation method used in this approach (methanol fixation) 
causes dehydration of the samples and this appeared to result in shrinkage of cells 
and consequent reduction in the separation between the top and bottom of the NE. 
Subsequently, in many cells the separation of the upper and lower nuclear 
membranes was too small to be resolved by confocal microscopy. This is evident in 
Figure 5.10, which does not identify an empty space representative of the nuclear 
interior. However, this did not interfere with my further studies of the inner nuclear 
surface. 
 
Similar to what was reported in Section 5.2.2.1, the series of confocal scans through 
the example nucleus show that lamin A (red) labelling covers the nucleoplasm 
identified by Dapi (blue, Figure 5.10 A). The images of lamin A labelling alone (Figure 
5.17 B) confirmed that lamin A forms a network on the inner nuclear surface. 
H3K9me2 was enriched in the nucleoplasm as Figure 5.10 C shows, and by merging 
the H3K9me2 labelling with the lamin A labelling it was observed that half of the 
H3K9me2 labelling sits in the holes of the lamin A network (Figure 5.10 D), which 
indicates that possible lamin A-H3K9me2 association sites are limited. By 
superimposing the colocalisation of lamin A and H3K9me2 (yellow) onto the lamin A 
labelling as Figure 5.10 E shows, it can be concluded that only part of the lamin A 
labelling colocalised with H3K9me2. 
 
The calculation of percentage of volume of lamin A colocalized with H3K9me2 showed 
that only 35±6% of the lamin A labelling (red dashed bar) colocalised with H3K9me2, 
whereas 40±5% of the H3K9me2 labelling (green dashed bar) colocalized with lamin 
A in the proliferating cells (n=4, Figure 5.11 A, Appendix 3, Table 5.9). In great 
contrast, in the differentiated PASMCs, 59±7% of the lamin A labelling (red bar) 
colocalised with H3K9me2, whereas 48±3% of the H3K9me2 labelling (green dashed 
bar) colocalized with lamin A (n=3, Figure 5.11 A, Appendix 3, Table 5.9). The volume 
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of lamin A colocalised with H3K9me2 drastically reduced in proliferating PASMCs 
(p=0.053). Moreover, the Pearson’s correlation coefficient of the colocalisation in the 
proliferating cells is -0.1±0.03 (dashed grey bar), which is significantly lower than that 
of the differentiated PASMCs (grey bar, 0.1±0.03, p<0.05, n=4, Figure 5.11 B, 
Appendix 3, Table 5.9). Taking these facts together, it is very likely that the lamin A-
H3K9me2 association is reduced in proliferating PASMCs. In fact, in differentiated 
PASMCs, the lamin A-H3K9me2 association lines almost all the nuclear invaginations 
and peripheral structures. Here the nuclear invaginations are not lined by the 
association, and it only targets to parts of the lamin A network. These facts show that 
the chromatin attachment machinery for gene suppression are redistributed and 









Figure 5.10 Lamin A and H3K9me2 colocalise at the nuclear periphery in 
proliferating PASMCs 
(A) A series of confocal Z sections through a day 7 cultured PASMC labelled by lamin 
A (red), the nucleoplasm was identified by Dapi (blue). 
(B) As for (A), but labelled for lamin A alone. 
(C) As for (A), but labelled for H3K9me2 (green). 
(D) As for (A), but showing the merged images. 
(E) As for (A), but showing the colocalisation of lamin A and H3K9me2 in yellow, with 









Figure 5.11 Lamin A and H3K9me2 colocalisation is reduced in proliferating 
PASMCs 
(A) Percentage of volume of H3K9me2 (green) or lamin A (red) colocalised with the 
other channel (lamin A or H3K9me2 respectively) in acutely isolated cells or day 7 
cultured cells (dashed) are shown in bar charts. Data are shown as mean±SEM, n=4. 
(B) Colocalisation between lamin A and H3K9me2 labelling in acutely isolated cells 
or day 7 cultured cells were calculated, the Pearson’s correlation coefficient was 




5.2.2.3 Lamin A and emerin form two meshworks that are not fully aligned 
Both lamin A and emerin can direct chromatin attachment but through distinct 
mechanisms. As discussed above, lamin A-H3K9me2 association indicates gene 
suppression. By contrast, emerin provides discrete chromatin attachment points along 
the surface of the INM through its co-association with BAF (barrier to auto-integration 
factor)(Berk et al., 2014, Cai et al., 2001, Lee et al., 2001), which binds DNA (Zheng 
et al., 2000) and may thus either repress or enhance gene expression (Takama et al., 
2013, Cox et al., 2011). Furthermore, lamin A and emerin define two subsets of 
nuclear invaginations in differentiated PASMCs. Therefore, I decided to study the 
distribution of emerin in relation to lamin A in proliferating PASMCs and the possible 




Proliferating PASMCs were co-labelled for lamin A (red) and emerin (cyan). Z stacks 
through the nuclei of the labelled cells were taken at 0.2 µm intervals, and one 
example is shown in Figure 5.12. Z sections showing the top of the nucleus (i), the 
middle of the nucleus (ii, iii), and the bottom of the nucleus (iv) are displayed in Figure 
5.12. Figure 5.12 Ai-iv show the confocal Z sections of the cell labelled for emerin at 
low detection threshold, and Figure 5.12 Bi-iv show the lamin A labelling at low 
threshold. In Figure 5.12 C, the emerin labelling is merged with the lamin A labelling. 
The colocalisation between emerin and lamin A was calculated and displayed in 
yellow as Figure 5.12 D shows. 
 
Consistent with my findings for lamin A, no nuclear invagination was identified in the 
emerin labelled nuclei (n=10). Moreover, like the lamin A labelling in proliferating cells, 
the density of emerin labelling did not identify peripheral ridges or cleft on the nuclear 
surface. The series of scans through the co-labelled nucleus at low detection 
threshold show that emerin labelling forms a dense meshwork on the inner nuclear 
surface (Figure 5.12 Ai, ii, iii&iv). The scans at the same focal planes show that the 
lamin A labelling also forms a meshwork covering the inner nuclear surface (Figure 
5.12 B i, ii, iii&iv). However, by merging the two it was observed that their meshworks 
do not fully overlap, the emerin meshwork seeming to cover large areas that were 
entirely lamin A free (Figure 5.12 Aii Vs Figure 5.12 Bii, Figure 5.12 Aiii Vs Figure 5.13 
Biii). Moreover, lamin A appears to occupy the holes in the emerin meshwork (Figure 
5.12 C).  
 
To confirm this, the colocalisation between the lamin A and emerin labelling was 
calculated and showed in Figure 5.12 D (yellow). It was particularly obvious when 
comparing the colocalisation in Figure 5.12 Dii&iii with the emerin labelling in Figure 
5.12 Aii&iii and the lamin A labelling in Figure 5.12 Bii&iii, only part of the lamin A or 
emerin labelling colocalised with the other, and they do form meshworks that are not 
fully overlapped. 
 
Despite the fact that in differentiated PASMCs the percentage of volume of the emerin 
(57±5%, n=4, Appendix 3, Table 5.6) and lamin A (55±8%, n=3, Appendix 3, Table 
5.7) labelling colocalised with the other are similar to the measurements of emerin 
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(48±2%, n=4) and lamin A (60±2%, n=3, Appendix 3, Table 5.7) in proliferating 
PASMCs (Figure 5.13 A, p=0.17 and p=0.62 respectively, Appendix 3, Table 5.7), the 
Pearson’s correlation coefficient of colocalisation is significantly reduced in 
proliferating PASMCs (0.05±0.01, n=3, Figure 5.14 B, dashed grey bar, Appendix 3, 
Table 5.7) compared to differentiated PASMCs (0.3±0.01, n=4, p<0.05, Figure 5.13 
B, grey bar, Appendix 3, Table 5.7). The fact that the Pearson’s correlation coefficient 
of the colocalsation dropped to below 0.1 suggests that lamin A and emerin may form 
two meshworks that are mostly separated but retain some points of contact, at least 
at the resolution of the present experiments. The significance of this finding is that 
both lamin A and emerin can direct chromatin attachment but through distinct 
mechanisms. Therefore, it is plausible that lamin A and emerin form partially 




Figure 5.12 Lamin A forms a meshwork that only partially overlaps with the 
emerin meshwork in proliferating PASMCs 
(A) A series of confocal z sections through a proliferating PASMC labelled for emerin 
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(cyan) with low detection threshold. 
(B) As for (A), but labelled for lamin A (red) 
(C) As for (A), but showing the merged images. 





Figure 5.13 Lamin A and emerin colocalisation is reduced in proliferating 
PASMCs 
(A) Percentage of volume of emerin (cyan) or lamin A (red) labelling colocalised with 
the other (lamin A or emerin respectively) in acutely isolated cells or day 7 cultured 
cells (dashed) are shown in bar charts. Data are shown as mean±SEM.  
(B) Colocalisation between lamin A and emerin labelling in acutely isolated cells or 
day 7 cultured cells (dashed) were calculated, the Pearson’s correlation coefficient 








5.2.2.4 Emerin and BAF associate at the periphery of proliferating PASMCs, 
providing a greater abundance of sites for chromatin attachment than observed in 
differentiated PASMCs 
Proliferating PASMCs were co-labelled for emerin (cyan) and BAF (purple). Z stacks 
scanning through the nuclei of the labelled cells were taken at the step interval of 0.2 
µm, and one example is shown in Figure 5.14. Z sections showing the top of the 
nucleus (i), the middle of the nucleus (ii, iii, iv), and the bottom of the nucleus (v) are 
displayed in Figure 5.14. Figure 5.14 i-v show the confocal Z sections of the cell 
labelled for emerin at low detection threshold with (A) and without (B) Dapi (blue) 
indicating the nucleoplasm, and Figure 5.14 Ci-v show the BAF labelling with a low 
threshold. In Figure 5.14 D, the emerin labelling is merged with the BAF labelling. The 
colocalisation between emerin and BAF was calculated and displayed in yellow, and 
merged on top of the emerin labelling as Figure 5.14 E shows. 
 
As Figure 5.14 A shows, the emerin (cyan) labelling covers the entire perimeter of the 
nucleoplasm identified by Dapi (blue). The images of emerin labelling alone (Figure 
5.14 B) confirmed that emerin forms a meshwork on the inner nuclear surface. On the 
other hand, BAF was identified in the nucleoplasm as Figure 5.14 C shows, and by 
merging the BAF labelling with the emerin labelling it can be seen that some of the 
BAF sits in the hole of the emerin meshwork, and it does not appear to always 
colocalise with emerin. Indeed, the colocalisation of emerin and BAF (yellow) was 
superimposed onto the emerin labelling as Figure 5.14 E shows, and it can be 
concluded that only part of the emerin colocalised with BAF. 
 
This observation received support from the calculation of percentage of volume of 
emerin or BAF colocalized with each other. In proliferating PASMCs, 43±5% of the 
emerin labelling (cyan, dashed) and 59±9% of the BAF labelling (purple, dashed) 
colocalized with the other (Figure 5.15, n=4, Appendix 3, Table 5.8). This shows that 
around half of the emerin identified colocalised with BAF. However, in differentiated 
PASMCs, only 10±2% of the emerin labelling (cyan) and 25±4% of the BAF labelling 
(purple) colocalized with the other protein (Figure 5.15, n=10, Appendix 3, Table 5.8). 
The volumes of both emerin or BAF colocalised with each other were significantly 
increased in the proliferating PASMCs (p<0.0005). Moreover, the Pearson’s 
correlation coefficient of the colocalisation increased significantly in the proliferating 
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PASMCs (0.005±0.01, Figure 5.15, grey bar, Appendix 3, Table 5.8) compared to the 
differentiated PASMCs (-0.080.05±0.02, n=10, Figure 5.16, dashed grey bar, p<0.001, 
Appendix 3, Table 5.8). Given the above, it can be postulated that perhaps the 
chromatin attachment governed by emerin-BAF association is more pronounced in 
the proliferating cells compared to the differentiated PASMCs. 
 
Figure 5.14 Emerin and BAF colocalise at the periphery of the nucleus in 
proliferating PASMCs 
(A) A series of confocal z sections through a day 7 cultured PASMC labelled by 
emerin (cyan) with low detection threshold, the nucleoplasm was identified by Dapi 
(blue). 
(B) As for (A), but labelled for emerin alone. 
(C) As for (A), but labelled for BAF (purple). 
(D) As for (A), but showing the merged images. 
(E) As for (A), but showing the colocalization of emerin and BAF in yellow, with emerin 





Figure 5.15 Emerin and BAF colocalisation is increased in proliferating 
PASMCs 
(A) Percentage of volume of emerin (cyan) or BAF (purple) labelling colocalised with 
the other (BAF or emerin respectively) in acutely isolated cells or day 7 cultured cells 
(dashed) are shown in bar chart. Data are shown in mean±SEM, *** =P<0.001, n=10 
for differenciated cells, n=4 for proliferating cells. 
(B) Colocalisation between BAF and emerin labelling in acutely isolated cells or day 
7 cultured cells (dashed) were calculated, the Pearson’s correlation coefficient was 
calculated and shown in the bar chart. Data are shown in mean±SEM, **=p<0.01, 





5.2.2.5 The distribution the LINC complex is reconfigured in proliferating PASMCs, 
components of the LINC exhibit a punctate distribution across the periphery of the 
nuclei. 
 
Both emerin and lamin A are shown to bind to nesprin-1α or the LINC complex, 
allowing the signal transduction from the cytoplasm to the nucleoplasm. Following this 
lead, proliferating PASMCs were labelled for nesprin-1 (magenta) and SUN 2 (green), 
and Z stacks were taken through the nuclei of labelled cells at 0.2 µm intervals, (Figure 
5.16). Z sections showing the top of the nucleus (i), the middle of the nucleus (ii, iii), 
and the bottom of the nucleus (iv) are displayed in Figure 5.16. Figure 5.16 Ai-iv 
shows the confocal Z sections of the cell labelled for nesprin-1 at low detection 
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threshold. Figure 5.16 Bi-iv show the SUN 2 labelling at the same focal planes. In 
Figure 5.16 C, nesprin-1 labelling is merged with the SUN 2 labelling. The 
colocalisation between nesprin-1 and SUN 2 was calculated and displayed in yellow 
as Figure 5.16 D shows. 
 
The confocal scans through the nesprin-1 (magenta) labelled nucleus (Figure 5.16 Ai, 
ii, iii&iv) show that nesprin-1 labelled the entire inner nuclear surface in a very 
punctate manner. Similarly, the images showing SUN 2 labelling acquired at the same 
scanning planes (Figure 5.16 Bi, ii, iii&iv) show that SUN 2 was also present across 
the entire inner nuclear surface. In each case the labelling was very punctate. By 
merging the nesprin-1 and SUN 2 labelling it can be observed that, although labelling 
for both proteins was quite abundant, the two proteins seem to sit on two separated 
networks, and this was consistently observed across the four scans acquired at 
distinct focal planes (Figure 5.16 Ci, ii, iii&iv) and all other cells studied. This 
observation received support from the fact that very limited colocalisation (yellow) was 
observed Figure 5.16 D.  
 
Moreover, the degree of colocalisation between nesprin-1 and SUN 2 is evidently 
reduced in proliferating PASMCs compared to the acutely isolated, fully differentiated 
PASMCs. As shown in the bar charts in Figure 5.17 A, the percentage of volume of 
nesprin-1 colocalised with SUN 2 is 50±3% in the differentiated PASMCs, which is 
similar to that of the proliferating PASMCs (53±11%, n=3, p=0.75, Appendix 3, Table 
5.6). The percentage of volume of SUN 2 colocalised with nesprin-1 is 40±7% in the 
differentiated PASMCs, which is also similar to that of the proliferating PASMCs 
(32±10%, n=3, p=0.57, Appendix 3, Table 5.6). However, in the proliferating PASMCs, 
the Pearson’s correlation coefficient of the colocalisation (0.12±0.01, Figure 5.17 B) 
is significantly lower than that of the differentiated PASMCs (0.37±0.06, n=3, p<0.05, 
Appendix 3, Table 5.6), suggesting that although there was overlap between nesprin-
1 and SUN2 in the proliferating PASMCs, they are not so closely aligned as in acutely 
isolated cells. This fact further confirmed that the formation LINC complex is reduced 
in the proliferating PASMCs, and it can be concluded that although both nesprin-1 
and SUN 2 are quite abundant on the NE of the proliferating PASMCs, they were 




Figure 5.16 Nesprin-1 and SUN 2 are both abundant on the NE of proliferating 
PASMCs but their degree of colocalisation is reduced 
(A) A series of confocal z sections through a proliferating PASMC labelled for nesprin 
-1 (magenta) with low detection threshold. 
(B) As for (A), but labelled for SUN2 (green) 
(C) As for (A), but showing the merged image. 







Figure 5.17 Colocalisation of nesprin-1 and SUN 2 is reduced in proliferating 
PASMCs  
(A) Percentage of volume of nesprin-1 (magenta) or SUN 2 (green) labelling 
colocalised with the other (SUN2 or nesprin-1 respectively) in acutely isolated cells or 
day 7 cultured cells (dashed) were shown in the bar chart. Data are shown in 
mean±SEM. 
(B) Colocalisation between nesprin-1 and SUN2 labelling in acutely isolated cells or 
day 7 cultured cells (dashed) were calculated, the Pearson’s correlation coefficient 

















5.3.1 Summary of findings 
Chapter 5 shows that the PASMCs undergo phenotypic switch in culture containing 
10% serum. In proliferating PASMCs, synchronized Ca2+ transients are triggered in 
the nucleoplasm and cytoplasm in an IP3R dependent but RyR independent manner. 
This is perhaps caused by the elimination of RyR1s and reduced expression of other 
RyRs. Coinciding with these changes in Ca2+ signalling, NET proteins are also 
reconfigured at the nuclear periphery. Both the lamin A-H3K9me2 association and 
emerin-BAF association are identified on the inner nuclear surface, albeit in a more 
limited fashion than observed in acutely isolated cells. The proportion of lamin A-
H3K9me2 association is also reduced compared to what was observed in the 
differentiated PASMCs, whereas the proportion of emerin-BAF association is 
increased. Moreover, both nesprin-1 and SUN2 are identified on the inner nuclear 
surface, but they are poorly associated.  
 
Among all the cells studied, only 19% of cells still harbour nuclear invaginations. The 
number of nuclear invaginations per cell is reduced, and the remaining nuclear 
invaginations lost the capacity to generate spatially restricted Ca2+ signals, while they 
no longer harbour any chromatin attachment sites constituted by NET proteins. 
 
5.3.2 Intracellular Ca2+ handling in PASMCs is altered following phenotypic 
switching from a contractile to proliferative state 
Consistent with the studies that stated that the proliferation of smooth muscle cells 
can be induced by serum in culture (Southgate and Newby, 1990, Zhong et al., 2014), 
I observed the initiation of proliferation in PASMCs following 7 days of culture in 10% 
of serum. The change of cell shape to the typical morphology of proliferating smooth 
muscle cells (Thakar et al., 2009), and the gradual loss of the smooth muscle specific 
marker MHC confirmed that the proliferation process was initiated. 
 
Accompanied by the phenotypic switch, I observed changes in intracellular Ca2+ 
handling. Induced Ca2+ transients occurred synchronously within the cytoplasm and 
the nucleoplasm, indicating that there was no buffer barrier nor segregated Ca2+ signal 
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within nuclear invaginations. This was accompanied by a global alteration of SR 
targeted Ca2+ releasing channels. The RyR1 agonist that can effectively induce Ca2+ 
release in the differentiated PASMCs (see Chapter 3) failed to induce any Ca2+ signal 
in proliferating PASMCs, despite the fact that Ca2+ release can be triggered by 
depleting the thapsigargin-sensitive Ca2+ stores in these cells. This indicates that the 
expression of RyR1 is eliminated in proliferating PASMCs, and the Ca2+ release from 
the SR must rely on other receptors. 
 
Consistent with this view, I show that angiotensin II induced dramatic Ca2+ release in 
the nucleoplasm and the cytoplasm of proliferating PASMCs. The Ca2+ originated 
from the SERCA fed stores (i.e. SR and the connected NR) because the Ca2+ release 
was blocked by thapsigargin (Lytton et al., 1991). This shows that activation of SR 
targeted Ca2+ release channels are responsible for the observed Ca2+ transients. 
Interestingly, however, my data show that blocking all subtypes of RyRs with 
tetracaine did not abolish the angiotensin II induced Ca2+ release. By contrast to 
findings for acutely isolated PASMCs, angiotensin II evoked release was abolished 
following blocking the IP3Rs with 2APB (Maruyama et al., 1997) or suppressing IP3 
production by U73122 (Bleasdale et al., 1990). This strongly suggests that 
angiotensin II evoked Ca2+ signals arise preferentially via ER/SR targeted IP3Rs but 
not RyRs. 
 
This finding is consistent with earlier studies of others that showed that while RyR3, 
SERCA 2a and 2b, and IP3R1 were present in freshly isolated rat aortic smooth 
muscle cells (ASMCs), following the induction of ASMC proliferation in culture for 5 
days, the protein expression of RyR3 and SERCA2a were diminished, whereas the 
expression of SERCA 2b and IP3Rs remained unchanged (Vallot et al., 2000). In 
arterial smooth muscle cells, the expression of all three IP3R isoforms and SERCA2b 
were augmented in cultured, proliferating ASMCs compared to the freshly dissociated 
arterial myocytes (Berra-Romani et al., 2008). In short, in proliferating smooth muscle 
cells, IP3Rs, not RyRs, are more likely to be the predominant Ca2+ release channel. 
This is consistent with the proposal that IP3Rs and IP3 induced Ca2+ waves are 
required for arterial smooth muscle proliferation, because proliferation was inhibited 
by a IP3R antagonist (Wilkerson et al., 2006). Given the above, it can be postulated 
that the expression of RyRs is possibly reduced in the proliferating PASMCs, and that 
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IP3Rs are the dominant Ca2+ release channel that is relied on during PASMC 
proliferation. Considering that synchronized Ca2+ transients were observed in both the 
nucleoplasm and cytoplasm, it can be inferred that the IP3Rs are perhaps targeted to 
both the ER/SR and the INM of the nucleoplasmic reticulum of the proliferating 
PASMCs. They direct Ca2+ release from the ER/SR to the cytoplasm, and from the 
nucleoplasmic reticulum to the nucleoplasm.  
 
5.3.3 The inner nuclear surface of the proliferating PASMCs is reconfigured 
compared to the differentiated PASMCs 
Coinciding with the alteration in Ca2+ handling, the chromatin-anchoring NET protein 
complexes on the inner nuclear surface are reconfigured. Lamin A and emerin 
labelled the entire inner nuclear surface in differentiated PASMCs. However, their 
densities no longer depict ridges and clefts in proliferating PASMCs. Instead, they 
form meshworks that only partially overlap on the inner nuclear surface. As mentioned 
previously, both lamin A and emerin can direct chromatin attachment but through 
distinct mechanisms. Lamin A can promote transcriptional suppression by binding to 
the lamina-associated domain (LAD) of heterochromatin(Burke and Stewart, 2013), 
in a manner facilitated by co-association with histones such as H3K9me2/3(Harr et 
al., 2015). By contrast, emerin has been shown to provide discrete chromatin 
attachment points along the surface of the INM through its co-association with BAF 
(barrier to auto-integration factor)(Berk et al., 2014, Cai et al., 2001, Lee et al., 2001), 
which binds DNA (Zheng et al., 2000) and may thus either repress or enhance gene 
expression (Takama et al., 2013, Cox et al., 2011). Here, both the lamin A-H3K9me2 
and emerin-BAF associations were observed on the inner nuclear surface. However, 
the lamin A-H3K9me2 association is largely reduced judging by the decreased 
Pearson’s correlation coefficient. This indicates that in the proliferating PASMCs, the 
suppression of gene expression via lamin-associated domains is reduced. By contrast, 
and although their expression may be reduced, the degree of emerin-BAF association 
may be promoted in proliferating PASMCs judging by the increased Pearson’s 
correlation coefficient, but the effect on global gene expression is unclear because 
BAF has distinct effects on different genes. Interestingly, one paper has shown that 
when the proliferation of vascular smooth muscle cells is promoted, the expression of 
lamin A and emerin is repressed. In addition, overexpressing emerin and lamin A in 
vascular smooth muscle can reverse stretch-induced proliferation (Qi et al., 2016). 
These findings support my conclusion that during PASMC phenotypic switching, the 
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chromatin anchoring NET protein complexes are reconfigured in a way that supports 
less gene suppression, favouring PASMC proliferation. 
 
Moreover, the expression of nesprin-1 and SUN2, as well as their associations are 
also reduced in proliferating PASMCs. This shows that the formation of the LINC 
complex is reduced. The LINC complex associates with the cytoskeletons and is 
responsible for the transduction of mechano-forces (Anno et al., 2012, Kim et al., 2015, 
Chang et al., 2015). It is therefore possible that the reconfiguration of NET proteins in 
the proliferating PASMC affects multiple aspects of the cellular function, which 
requires further investigation. 
 
5.3.4 Nuclear invaginations in proliferating PASMCs are reduced and 
remodelled.  
Only 19% of the proliferating PASMCs display nuclear invaginations, and each of 
them only constitutes 1.8 nuclear invaginations on average. Notably, when observed 
the nuclear invaginations of proliferating PASMCs do not seem to demarcate 
nanocourses for Ca2+ signalling. Coinciding with the loss of the ability to generate 
spatially restricted Ca2+ signals, the nuclear invaginations in proliferating PAMSCs 
also lost their ability to modulate chromatin attachment.  This is evident from the fact 
that none of the NET proteins (including lamin A, emerin, nesprin-1, SUN2 and BAF) 
labelled these nuclear invaginations. Therefore, the small number of nuclear 
invaginations remaining in this subpopulation (19%) of proliferating PASMCs no 
longer provide sites for chromatin attachment and thus gene suppression (Zheng et 
al., 2000, Harr and Reddy, 2016). This provides indirect support for my proposal that 
the generation of Ca2+ signals within the nuclear invaginations is related to the 
modulation of chromatin attachment, since the two functions of the nuclear 
invagination are either both observed in one phenotype (contractile) and are both 
absent from the other phenotype (proliferative). 
 
One limitation of my study is that the cells can only be labelled for either the 
ER/SR/ONM (in live cells) or NET proteins (in fixed cells) because ER-tracker signal 
cannot be retained following immunocytochemistry. Due to this fact I cannot provide 
direct evidence to show that the ER-tracker labelled nuclear invaginations are not 
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lined by the NET proteins, although the fact that each label independently 
demonstrates the loss of invaginations strongly supports my conclusions. 
Nevertheless, it would be beneficial to receive further confirmation from co-labelling 
of the ONM and NET proteins, if it is possible in the future. 
 
5.3.4 Conclusion 
During the phenotypic switch of PASMCs, the intracellular Ca2+ handling is altered to 
an IP3R-dependent, RyR-independent pathway (Figure 5.19). This is accompanied by 
the remodelling of the distribution of NET proteins on the inner nuclear surface. Here 
lamin A and emerin form partially overlapping meshworks, and the chromatin 
anchoring protein complexes formed via either lamin A or emerin are rearranged. In 
particular, the lamin A-H3K9me2 association is reduced, which perhaps favours 
PASMCs proliferation by reducing gene suppression.  Moreover, the number of 
nuclear invaginations in proliferating PASMCs is also greatly reduced, while 
remaining nuclear invaginations lost the ability to generate spatially restricted 
Ca2+signal and the infrastructure to support chromatin attachment. 
 
Figure 5.19 Schematic image showing the difference between differentiated and 
proliferating PASMCs. 
Schematic images showing the nucleus of the differentiated PASMC (left) and the 
proliferating PASMC (right). The outer nuclear membrane (OMN), inner nuclear 
membrane (INM), RyR1, IP3R, SERCAs, BAF-emerin association, lamin A-H3K9me2 




Chapter 6: TPC2 mediates Ca2+ signalling in the lysosome-
SR junction 
6.1 Introduction 
The two-pore segment channels (TPCs) (Ishibashi et al., 2000) were first identified as 
endolysosome targeted, NAADP-gated Ca2+ release channels (Calcraft et al., 2009, 
Schieder et al., 2010, Pitt et al., 2010). TPC1, 2 and 3, of which only TPCN1 and 
TPCN2 genes are present in humans, rats and mice (Calcraft et al., 2009, Zhu et al., 
2010b), are homologous with and represent an evolutionary intermediate between 
Ca2+-permeable TRPCs and voltage-gated Ca2+ channels (CaV), with an intermediate 
two-domain structure of subunits which likely assemble as homodimers (Zhu et al., 
2010a).  
 
Lysosome-SR nanojunctions have been identified in pulmonary arterial smooth 
muscle cells (Fameli et al., 2014). They were proposed to form a trigger zone for 
NAADP evoked Ca2+ bursts from the lysosomes (Kinnear et al., 2004). Lysosome 
targeted two-pore segmented channels have been proposed to support the 
generation of such Ca2+ bursts (Calcraft et al., 2009). However, significant controversy 
surrounds the capacity of TPC2 to support an NAADP-gated Ca2+ conductance, given 
that detailed investigations by others have demonstrated that stable expression of 
human TPC2 in several different mammalian cell types confers a phosphatidylinositol 
3,5-bisphosphate [PI(3,5)P2-gated, Na+-selective channel that is entirely insensitive 
to NAADP (Cang et al., 2013, Guo et al., 2017, Wang et al., 2012). Countering this, 
more recent studies suggest that PI(3,5)P2-mediated cation currents are observed in 
cells derived from Tpcn1 and Tpcn2 null mice while NAADP-gated Ca2+ currents are 
not. Moreover, NAADP-dependent Ca2+ currents are rescued in Tpcn1 and Tpcn2 null 
cells by overexpression of wild-type TPC2(Ruas et al., 2015). It is more intriguing that 
TPC2 has been shown to support a Na+ conductance that is gated by dissociation of 
mechanistic Target of Rapamycin (mTOR) from the cytoplasmic domain of TPC2 
(Cang et al., 2013).  
 
Given the above, I sought to determine whether or not TPC2 is a pre-requisite for the 
induction of lysosomal Ca2+ signals in pulmonary arterial myocytes and the role of 
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mTOR in these processes.  
6.2 Results 
6.2.1 Rapamycin induces Ca2+ signals via acidic stores in an mTOR- and TPC2-
dependent manner in pulmonary arterial myocytes 
The work of my colleague Dr. Oluseye Ogunbayo showed that extracellular 
application of the mTOR inhibitor rapamycin (30 mol/L) induced Ca2+ transients in 
freshly isolated PASMCs (Ogunbayo et al., 2018). Figure 6.1 Ai-Di shows 4 different 
PASMCs loaded with the Ca2+ indicator Fura-2, the bright field images of cells are 
displayed on the left hand side, followed from left to right by a series of pseudocolour 
images representing the changes in Fura-2 fluorescence intensity in response to 
rapamycin; blue indicates low Ca2+concentration whereas high Ca2+ concentrations 
are shown in red. The Fura-2 fluorescence ratio (F340 / F380) was calculated and 
plotted against time as the records in Figure 6.1 Aii-Dii show. Rapamycin induced 
pronounced Ca2+ transients in PASMCs, and the responses were mostly biphasic, 
characterized by a single rapid, global Ca2+ transient which was superimposed on an 
underlying, slower transient (black, Figure 6.1 Ai, Ci &Di). Occasionally the initial, fast 
Ca2+ transient was followed by multiple smaller transients, which were all 
superimposed on the slower underlying Ca2+ signal (black, Figure 6.1 Bi). Assessment 
of this response based on the peak of the first Ca2+ transient triggered by rapamycin 
demonstrated that the Fura-2 fluorescence ratio (F340 / F380) of the peak change is 
1.2±0.14 (black, n=32, Figure 6.1 Ei, Appendix 4, Table 6.1). The Area Under Curve 
(AUC) was also calculated, and AUC of the response induced by rapamycin was 
60±11.77 (black, n=56, Figure 6.1 Eii, Appendix 4, Table 6.1). To confirm that the 
response was truly induced by rapamycin, the effect of the drug vehicle was tested. 
Figure 6.1 Aii shows a record (green) which illustrates that the drug vehicle (DMSO) 
did not induce any response, the peak change and AUC of the DMSO responses were 
0.03±0.007 (green, n=35, Figure 6.1 Ei, Appendix 4, Table 6.2) and 3.0±0.23 (green, 
n=35, Figure 6.2 Eii, Appendix 4, Table 6.2), respectively, which is significantly 
smaller than the peak change and AUC of the rapamycin response (p<0.0001). 
 
Outcomes for pharmacological interventions against rapamycin-induced Ca2+ signals 
in pulmonary arterial myocytes are illustrated in Figure 6.1. The red record in Figure 
6.1 Aii shows that rapamycin-evoked Ca2+ transients were blocked by prior depletion 
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of acidic Ca2+ stores with bafilomycin-A1 (1 mol/L; n = 12, Figure 6.1 Bii). The peak 
change and AUC were 0.07±0.01 (red, n=12, Figure 6.1 Ei) and 13±3.5 (red, n=12, 
Figure 6.1 Eii), respectively, which were significantly reduced compared to that of the 
rapamycin responses obtained under control conditions (p<0.001). The Ca2+ 
transients induced by rapamycin were attenuated by depleting the SR Ca2+ stores 
with thapsigargin (1 M ；n = 15, P<0.0001; Figure 6.1 Cii), the peak change and 
AUC were reduced to 0.24±0.05 (red, n=15, Figure 6.1 Ei) and 10.7±1.90 (red, n=15, 
Figure 6.1 Eii) respectively (p<0.001). Following block of RyRs with ryanodine at 
micromolar concentrations (100 M), rapamycin-induced Ca2+ transients were also 
attenuated (n = 24, P<0.001; Figure 6.1 Cii) with the peak change and AUC reduced 
to 0.27±0.14 (red, n=8, Figure 6.1 Ei) and 23±10.15 (red, n=8, Figure 6.1 Eii) 
respectively (p<0.001). Moreover, the rapamycin induced response was abolished by 
pre-incubation with the L-type voltage-gated Ca2+ channel blocker nifedipine (10 
mol/L; n = 24; Figure 6.1 Di). The peak change and AUC were 0.12±0.01 (red, n=12, 
Figure 6.1 Ei) and 3.72±0.44 (red, n=12, Figure 6.1 Eii), and they both were 
significantly reduced compared to the rapamycin response. 
 
The Ca2+ transients were blocked upon the depletion of bafilomycin-A1 sensitive Ca2+ 
store, suggesting that the Ca2+ is likely released from the lysosomal Ca2+ store 
(Ogunbayo et al., 2018). Moreover, the rapamycin-induced and NAADP-induced (not 
shown) Ca2+ transients were abolished by the VGCC blocker nifedipine, indicating 
that dihydropyridines block TPC2. Interestingly, the rapamycin induced Ca2+ 
transients were attenuated following the depletion of SR Ca2+ store and the blocking 
of RyRs. This is consistent with the view that the lysosome-SR junction forms a trigger 






Figure 6.1  Rapamycin induces Ca2+ transients in pulmonary arterial myocytes, 
and the Ca2+ transients can be blocked by bafilomycin A1 and nifedipine 
(Ai) The bright field image (BF) of an acutely isolated rat pulmonary arterial myocyte 
and a series of pseudocolour images of F340/F380 recorded in the same cell during 
extracellular application of 30μmol/L rapamycina are shown. (ii) Corresponding record 
(black) of F340/F380 ratio against time; the timepoints at which pseudocolour images 
were acquired are indicated by the numbered lines. The green record shows the effect 
of DMSO (vehicle control) in a different cell. 
(B) As in (A) but with a red record showing the effect of rapamycin after pre-incubation 
(≥50 min) of a myocyte with 1 μmol/L bafilomycin A1. 
(C) As in (A) but with an orange record showing the effect of rapamycin after pre-
incubation (≥50 min) of a cell with 1 μmol/L thapsigargin. 
(D) As in (A) but with a magenta record showing the effect of rapamycin after pre-
incubation (≥50 min) of a myocyte with 10 μmol/L nifedipine, and a record in gold of 
the effect of rapamycin after pre-incubation (≥50 min) of a myocyte with 10 μmol/L 
ryanodine. 
(Ei) Bar chart compares, under all conditions studied (see key), the mean ± SEM for 
the peak change in Rat PASMC with DMSO, n = 35; rapamycin, n = 32;  rapamycin 
with bafilomycin-A1 preincubation, n = 12; rapamycin with thapsigargin preincubation, 
n = 15; rapamycin with ryanodine preincubation, n = 8; rapamycin with nifedipine 
preincubation n = 24. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, *****P < 
0.00001. (ii) as in (i) but for area under the curve. 
Figure adapted from “mTORC1 controls lysosomal Ca(2+) release through the two-




Moreover, Dr. Oluseye Ogunbayo also showed that rapamycin (30 µM) failed to 
induce measurable Ca2+ transients in pulmonary arterial myocytes derived from 
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Tpcn2 knockout mice as Figure 6.2 shows, the F340 / F380 ratio increasing marginally, 
from 0.40±0.03 to 0.45±0.03 (Figure 5A-B, n=18, P<0.00001 compared to wild type). 
This shows that rapamycin induces Ca2+ signals in an mTOR-and TPC2-dependent 
manner (Ogunbayo et al., 2018). 
 
 
Figure 6.2 Rapamycin-induced Ca2+ transients in pulmonary arterial myocytes 
are blocked by deletion of TPC2 
(A) Upper panel shows a bright field image (BF) of a wild type (WT) mouse PASMC, 
and a series of pseudocolour images of the Fura-2 fluorescence ratio (F340/F380) 
recorded in the same cell during extracellular application of 30 µmol/L rapamycin. 
Lower panel, corresponding record (black) of F340/F380 ratio against time; the time 
points at which pseudocolour images were acquired are indicated by the numbered 
lines. The red record shows the response to 30 µmol/L rapamycin of a myocyte 
isolated from a Tpcn2 knockout (Tpcn2KO) mouse.  
(B) Bar charts show the mean ± SEM for (i) the peak change in F340/F380 during the 
1st transient recorded and (ii) the area under the curve during the response of each 
cell to rapamycin: WT PASMC + 30µM rapamycin, n = 5; Tpcn2KO PASMC + 30µM 
rapamycin, n = 18. *****P  <  0.00001. 
Figure adapted from “mTORC1 controls lysosomal Ca(2+) release through the two-









6.2.2 HEK293 cells that stably overexpress GCaMP5-TPC2 reveal that 
rapamycin evokes bafilomycin- and nifedipine-sensitive Ca2+ signals proximal 
to TPC2 
To determine whether or not rapamycin-evoked Ca2+ signals were indeed elicited from 
lysosomes in a manner supported by TPC2, HEK293 cells that stably over-expressed 
GCaMP5-hTPC2 were used (generated and supplied by Dr. M.X. Zhu, University of 
Texas Medical School at Houston). In these cells the genetically encoded Ca2+ 
indicator GCaMP5 was fused to the cytoplasmic N-terminus of TPC2, allowing 
detection of Ca2+ signals arising proximal to TPC2. In order to confirm the localisation 
of GCaMP5-TPC2, HEK293 cells were co-labelled with Lysotracker Red (Figure 6.3). 
An exemplary HEK293 cell is shown in Figure 6.3A, with GCaMP5 fluorescence in 
green (left panel), the Lysotracker Red labelling in red (middle panel) and the two 
images merged to show co-localisation in yellow (right panel). Lysotracker Red 
labelled small vesicles, and some of the vesicles formed a big static cluster. Moreover, 
the merged image shows that GCaMP5-hTPC2 specifically labelled Lysotracker Red 
positive vesicles. To confirm this, the region of the cluster was magnified as Figure 
6.3B shows. Indeed, by merging the GCaMP5 fluorescence (green, left panel) and 
the Lysotracker Red fluorescence (red, middle panel) it can be observed that the 
GCaMP5 tagged TPC2s were mostly colocalized with Lysotracker identified 
lysosomes (Pearson’s correlation coefficient=0.56), suggesting that the TPC2s were 
specifically targeted to lysosomes. One example vesicle was selected and shown in 
Figure 6.3C. A digital skin was applied to the GCaMP5 and Lysotracker Red 
fluorescence, and a 3D model of the vesicle was rendered. The 3D model was 
sectioned through the middle, with half of it shown in Figure 6.3 C. It is obvious that 
the lysosome (red, middle panel) was lined by GCamP5 fluorescence (green, left 
panel) on the extracellular surface, consistent with the prediction that the TPC2s are 







Figure 6.3 TPC2s were specifically targeted to lysosomes in HEK293 cells that 
stably over-express GCaMP5-TPC2. 
(A) Deconvolved confocal images show a 3D reconstruction, from left to right, of a 
single HEK293 cell stably expressing GCaMP5-hTPC2 (green), the distribution of 
Lysotracker-red (red) labelling within the same cell and a merged image depicting 
regions of colocalisation (yellow).  
(B) As for (A), but showing one identified cluster.  
(C) As for (A), but showing half of an identified vesicle coated with digital skin. 
Figure adapted from “mTORC1 controls lysosomal Ca(2+) release through the two-








Using confocal microscopy, I next investigated the effect of mTOR inhibition by 
rapamycin on GCaMP5-hTPC2 fluorescence intensity.  Extracellular application of 
rapamycin induced pronounced increases in GCaMP5-hTPC2 fluorescence. Figure 
6.4 A upper panels, show a series of pseudolour images that depict the time-
dependent increase in GCaMP5 fluorescence after application of 30 M rapamycin in 
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one examplary cell, the record of fluorescenc intensity versus time is shown in the 
lower panel. It is clear that extracellular application of rapamycin induced slowly 
developing increase in fluorescence that arose and decayed over the course of 60-
120s (black record, Figure 6.4 A lower panel; n=11), and this was restricted to the 
vicinity of a static cluster of TPC2 positive lysosomes. The green record in Figure 6.4 
A, lower panel shows the response to the vehicle control (DMSO; 1:1000), which 
confirms that vehicle alone failed to induce increases in GcAMP5 fluorescence at the 
concentration used. The peak change and AUC of the rapamycin response reached 
276±61AU (black, n=11, Figure 6.4 Ci, Appendix 4, Table 6.3) and 299444±59487 
(relative area, black, n=11, Figure 6.4 Cii, Appendix 4, Table 6.3) respectively, which 
is significantly higher than the peak change and AUC of the response to DMSO, which 
measured 57±15AU and 102395±13996 respectively (n=8, Appendix 4, Table 6.4, 
p<0.001). 
 
Interestingly, following depletion of the thapsigargin-sensitive SR Ca2+ stores, 
rapamycin-induced increases in GCaMP5 fluorescence were similar to controls (black, 
Figure 6.4 B lower panel). The Peak change and AUC of the thapsigargin-insensitive 
signals were 229±15 AU (blue, n=5, Figure 6.4 Ci, Appendix 4, Table 6.5) and 
333100±80628 (relative area, blue, n=5, Figure 6.2 Cii Appendix 4, Table 6.5) 
respectively, which are not statistically different from the measurements of the 
rapamycin response under control conditions. Importantly, outcomes for 
pharmacological interventions against rapamycin-induced increases in GCaMP5 
fluorescence were consistent with what was shown in PASMCs. Rapamycin-induced 
increases in GCaMP5 fluorescence were blocked by prior depletion of acidic stores 
by bafilomycin (1 µmol/L, magenta, Figure 6.4 B lower panel), the peak change and 
AUC were reduced to 81±15 AU (magenta, n=10, Figure 6.4 Ci, Appendix 4, Table 
6.6) and 167351±16636 (relative area, magenta, n=9, Figure 6.4 Cii, Appendix 4, 
Table 6.6) respectively (p<0.001). Furthermore, the response was also blocked by 
pre-incubation with nifedipine (10 µmol/L, red, Figure 6.4 B lower panel), the peak 
change and AUC were reduced to 71±8 AU (red, n=6, Figure 6.4 Ci Appendix 4, Table 
6.7) and 97296±13875 (relative area, red, n=6, Figure 6.4 Cii Appendix 4, Table 6.7) 
respectively (p<0.001). 
 
Therefore, I conclude that the inhibition of mTOR by rapamycin can trigger Ca2+ 
release lysosomal Ca2+ stores in a TPC2-dependent manner, due to the facts that 
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increases in GCaMP5-TPC2 fluorescence were abolished by either depleting 
lysosomal Ca2+ stores using bafilomycin or by blocking TPC2s with the VGCC blocker 
nifedipine (Ogunbayo et al., 2018). That increases in GCaMP5-TPC2 fluorescence in 
the vicinity of lysosomes was not affected by depleting the thapsigargin sensitive SR 
Ca2+ store suggest that the initial Ca2+ release was indeed from the lysosome targeted 
TPCs, which is subsequently amplified by CICR via RyRs at lysosome-SR 
nanojunctions in pulmonary arterial myocytes. Therefore, my data also indicate that 
the slow, relatively sustained increase in cytoplasmic concentration triggered by 
rapamycin observed in PASMCs is supported by Ca2+ release from lysosomal Ca2+ 
stores, while the fast Ca2+ transients superimposed upon this phase may result from 
cycles of SR Ca2+ release triggered by CICR; these are likely too fast to be resolved 
by confocal microscopy used for the GCaMP5 experiments.  
 
The experiment is done in collaboration with Dr. Oluseye Ogunbayo, who maintained 





Figure 6.3 Rapamycin induces bafilomycin and nifedipine-sensitive Ca2+ signals 
proximal to lysosomes in HEK293 cells that stably over-express GCaMP5-TPC2. 
(A) Upper panels show confocal images of an HEK293 cell overexpressing GCaMP5-
hTPC2 (Green) during extracellular application of 30 μmol/L rapamycin. Lower panel, 
corresponding record (black) of fluorescence intensity (arbitrary unit, AU) against time; 
the time points at which confocal images were acquired are indicated by the 
numbered lines. The green record shows the effect of DMSO (vehicle control) in a 
different cell. 
(B) As in B but showing the response of a thapsigargin (1µM) preincubated cell to 30 
μmol/L rapamycin (black), and the effect of preincubation with bafilomycin A1 (1µM, 
red) and nifedipine (10µM, pink) on basal fluctuations in GCaMP5-hTPC2 
fluorescence and the response of these cells to 30 μmol/L rapamycin. 
(C) Bar charts show the mean ± SEM for (i) the peak change in GCaMP-5 
fluorescence intensity (arbitrary unit, AU) and (ii) the area under the curve during the 
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response to rapamycin: GCaMP5-hTPC2 + DMSO, green, n = 8; GCaMP5-hTPC2 + 
rapamycin, black, n = 11; GCaMP5-hTPC2 + bafilomycin-A1 + rapamycin, red, n = 9; 
GCaMP5-hTPC2 + thapsigargin + rapamycin, blue, n =5; GCaMP5-hTPC2 + 
nifedipine + rapamycin, pink, n = 6). *P < 0.05, **P < 0.01, ***P < 0.001. 
Figure adapted from “mTORC1 controls lysosomal Ca(2+) release through the two-






The role of TPC2 in lysosomal Ca2+ signalling was examined by using fully 
differentiated, acutely isolated pulmonary arterial myocytes to examine the (Fameli et 
al., 2014, Kinnear et al., 2004, Kinnear et al., 2008)  in combination with HEK293 cell 
lines stably over-expressing human TPC2 and Tpcn2 knockout mouse line, and the 
results showed that TPC2 is a pre-requisite for global Ca2+ transients in response to 
the mTOR inhibitor rapamycin (Ogunbayo et al., 2018). 
 
We found that rapamycin, the mTOR inhibitor (Ballou and Lin, 2008), can effectively 
induce Ca2+ signals in rat PASMCs, and the Ca2+signal was abolished following the 
preincubation with bafilomycin A1 (Ogunbayo et al., 2018). Bafilomycin A1 is a 
specific inhibitor of Vacuolar-type H+-ATPase (Yoshimori et al., 1991), it was shown 
to increase lysosome PH and decrease lysosomal Ca2+ concentration by mobilising 
the lysosomal Ca2+ into the cytoplasm (Christensen et al., 2002). This suggests that 
the rapamycin induced Ca2+ release arose from the lysosomal Ca2+ store. Moreover, 
the rapamycin induced Ca2+ release was attenuated following the depletion of 
thapsigargin or ryanodine sensitive Ca2+ store. Thapsigargin blocks SERCAs that 
feed the ER/SR (Lytton et al., 1991), whereas the preincubation with ryanodine 
receptor at micro molar level inhibits the ryanodine receptors (Zhang and Zhu, 1997). 
Similar to NAADP induced Ca2+ signals, the rapamycin induced Ca2+ was attenuated 
following the depletion of the ER/SR Ca2+ store or blocking the ryanodine receptors, 
this indicates that the rapamycin induced Ca2+release is possibly amplified by CICR 





Furthermore, the NAADP induced Ca2+ release via TPC2 was inhibited by VGCC 
blockers (Genazzani et al., 1997), and here the rapamycin induced Ca2+ transient was 
also abolished by the VGCC blocker nifedipine. This finding led to the consideration 
that rapamycin my induced Ca2+release via the TPC2s targeted to the lysosomes. To 
test this, Tpcn2 knockout mice were generated, and rapamycin failed to induce 
measurable Ca2+ transients in myocytes derived from Tpcn2 knockout mice. This 
shows that rapamycin induces Ca2+ in a TPC2-dependent manner. 
 
This conclusion received further support from HEK293 cells that stably over-
expressed GCaMP5-hTPC2. Our results showed that rapamycin can effectively 
induce Ca2+ release via the lysosome targeted TPC2s. This Ca2+ signal was not 
affected by depleting the thapsigargin sensitive Ca2+ stores, but is abolished following 
the depletion of the lysosomal Ca2+ store and the VGCC blocker nifedipine. Given 
above, it can be pustulated that the mTOR inhibitor rapamycin induces Ca2+ release 
from the lysosomal Ca2+ store mediated by the TPC2. 
 
We conclude, albeit small when compared to their estimated Na+ permeability, it 
would appear that endogenous TPC2 may support Ca2+ signalling via lysosome-SR 
nanojunctions in pulmonary arterial myocytes and other cell types, and in a manner 
that may be triggered by inhibition of mTOR (Fameli et al., 2014, Kinnear et al., 2004, 
Kinnear et al., 2008, Ogunbayo et al., 2018), as has recently been suggested by 
computer simulations (Fameli et al., 2014) and electrophysiological investigations on 
the ion selectivity conferred by the filter sequence of the human TPC2 channel pore 
(Guo et al., 2017). This is not entirelyl inconsistent with the findings of others which 
suggest that mTOR is an endogenous inhibitor of PI(3,5)P2-gated Na+ currents 
carried by TPC2 (Cang et al., 2013). The significance of this observation may lie in 
the fact that mTOR-dependent autophagic flux has been implicated in the progression 
of pulmonary hypertension, for which current therapies are poor (Goncharov et al., 
2014). TPC2 may therefore represent a novel therapeutic target for interventions 
against idiopathic pulmonary hypertension and pulmonary hypertension secondary to, 
for example, lysosomal dysfunction associated with Pompe and Gaucher disease 








































Chapter 7: General Discussion  
7.1 Summary of Findings 
Nanocourses of the SR are observed in the PASMCs, they form a cell-wide web for 
Ca2+ signalling underpinned by strategic positioning of RyRs. RyR1 is preferentially 
targeted to the subplasmalemmal nanocourses and nuclear invaginations, whereas 
the RyR 2& 3 may target to the extraperinuclear and perinuclear region as reported 
before. As the result, the Ca2+ signalling generated from different cytoplasmic 
nanocourses appear to support different smooth muscle functions. I show that the 
Ca2+ signals in the subplasmalemmal nanocourses triggered PASMC relaxation 
whereas the Ca2+ signals in the perinuclear and extraperinuclear nanocourses led to 
PASMC contraction. 
 
Among the intracellular nanocourses, nuclear invaginations of the arterial myocytes 
are the most intriguing structure because they may demarcate site-and function-
specific Ca2+ signalling in support of the transcriptional regulation. Invaginations of the 
outer nuclear membrane form a trans-nuclear network of cytoplasmic nanotubes in 
pulmonary arterial smooth muscle cells. Ca2+ pumps (SERCA1) and release channels 
(RyR1) are strategically positioned in the nuclear invaginations for the generation of 
Ca2+ signals arisen from the NR. Moreover, nuclear invaginations provide sites for 
transcriptional suppression, because lamin A and/or emerin line the entire surface of 
their inner nuclear membranes and co-localise with nesprin-1 positive puncta. 
Moreover, a subpopulation of these nuclear invaginations harboured punctate regions 
of colocalisation between lamin A and the suppressive heterochromatin mark 
H3K9me2, while emerin-positive invaginations harboured puncta of BAF co-
localisation and thus an alternative pathway to the regulation of gene expression. 
Therefore, nuclear invaginations form cytoplasmic nanotubes within which nano-
patterning of Ca2+ signals may support stochastic modulation of transcriptional 
regulators.   
 
Chapter 5 shows that the proliferating PASMCs harboured less nuclear invaginations, 
and the remaining nuclear invaginations were reconfigured. In response to growth 
factor, the contractile phenotype PASMCs switched to a proliferating phenotype. 
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Following this change, the expression of RyRs, especially RyR1 seemed to be 
reduced and the Ca2+ release from the SR/NR relies majorly on IP3Rs. The nuclear 
invaginations in the proliferating PASMCs were reduced, and more importantly, they 
were remodelled compared to the nuclear invaginations identified in differentiated 
PASMCs. They were not lined by the NET proteins or protein complex, and therefore 
the chromatin attachment sites. Meanwhile, the remaining nuclear invaginations of 
the proliferating PASMCs lost the ability to generate spatially restricted Ca2+ signals 
due to the loss of RyR1s. Moreover, lamin A and emerin seemed to form two partially 
overlapped meshworks on the nuclear surface. Both the lamin A-H3K9me2 
association and emerin-BAF association were identified on the meshworks albeit 
limited. The lamin A-H3K9me2 association was reduced compared to what is in the 
differentiated PASMCs whereas the emerin-BAF association is increased, and the 
changes perhaps favour less gene suppression that augments PASMC proliferation. 
 
In this chapter, I will further discuss how the results in the thesis add to current 
understanding of intracellular Ca2+ signalling in PASMCs, and the means by which 
the spatially restricted Ca2+ signals demarcate smooth muscle functions. 
 
7.2 Cytoplasmic nanocourses form a cell-wide web for the coordination 
of restricted intracellular Ca2+ signalling 
The existence of multiple releasable SR pools in smooth muscle cell has been 
proposed and reported in multiple studies (Boittin et al., 2002, Clark et al., 2010a, 
Dipp et al., 2001, Yamazawa et al., 1992, Yang et al., 2005). These segregated SR 
Ca2+ pools are fed by different subtypes of SERCAs (Clark et al., 2010a), and the Ca2+ 
release from these segregated SR Ca2+ pools is mediated by different Ca2+ releasing 
channels. For example, IP3Rs and RyRs were reported to be spatially separated and 
non-gated in PASMCs (Boittin et al., 2002) and gallbladder smooth muscle (Morales 
et al., 2005). Moreover, RyR1, 2 and 3 are reported to target different SR 
compartments (Yang et al., 2005, Kinnear et al., 2008) and mediate Ca2+ signalling 
locally. However, it remains unclear that how the Ca2+ signals arisen from the 
segregated SR compartments are separated. 
My data show that the cytoplasmic nanocourses of the SR span from the 
subplasmalemmal region to the nucleoplasm, forming a broad network for segregated 
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and spatially restricted Ca2+ signalling. Ca2+ signals arisen from and restricted within 
different nanocourses direct different smooth muscle functions. The Ca2+ signals in 
the subplasmalemmal nanocourses trigger pulmonary arterial myocytes relaxation 
whereas the Ca2+ signal in the perinuclear and extraperinuclear nanocourses induces 
pulmonary arterial myocytes contraction. The Ca2+ signals in the nuclear invaginations, 
on the other hand, is likely the key to the regulation of chromatin attachment sites. 
Given above, the cytoplasmic nanocourses allow the regulation of a variety of 
physiological processes, from the modulation of blood pressure to gene expression, 
by a single messenger - Ca2+. It was further illustrated that the ability of generating 
differential Ca2+ signals in different nanocourses was conferred by the strategic 
targeting of RyRs subtypes.  
 
7.2.1 Strategic targeting of the RyR subtypes in cytoplasmic nanocourses 
In pulmonary arterial smooth muscle cells, RyR1, RyR2 and RyR3 were targeted to 
different compartments of SR (Clark et al., 2010; Gilbert, Ducret, Marthan, Savineau, 
& Quignard, 2014).  In combination with the published data, I proposed that the RyR1 
are localised to the subplasmalemmal nanocourses where SERCA2b serves as the 
dominant Ca2+ pump. RyR3s are primarily targeted to the perinuclear nanocourses 
where SERCA2a was found majorly. RyR2s are mainly clustered in the 
extraperinuclear nanocourses. In the nucleus, RyR1s are targeted to the NR for the 
generation of Ca2+ signals from this SERCA1 fed store. There is no doubt that the 
sophisticated arrangement of SERCAs and RyRs supports regulation of restricted 
Ca2+ signals in the cytoplasmic nanocourses and thus underpins a variety of 
physiological processes. The question is, what is the logic behind the arrangement of 
the Ca2+ releasing channels and pumps?  
 
To address this issue, the characteristics of the three types of RyRs must be 
understood first. RyR 1 was identified primarily in skeletal muscles (Takeshima et al., 
1989) whereas RyR2 was widely expressed in cardiac muscles (Otsu et al., 1990), 
RyR3 was found originally in the brain (Hakamata, Nakai, Takeshima, & Imoto, 1992). 
As the name indicated, the RyRs can be activated by ryanodine for Ca2+ release but 
only at the nanomolar range. When exposing to ryanodine at 100 micromolar or more, 
RyRs would be locked at a subconductance that inhibits Ca2+ release (Meissner, 
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1986). However, it should be noted that although all the RyR subtypes have similar 
threshold for activation by Ca2+ when cytoplasmic Ca2+ concentration is higher than 
100 nM, each RyR subtypes display different half maximal activation by Ca2+ (EC50) 
and thresholds for inactivation by Ca2+ (Chen, Li, Ebisawa, & Zhang, 1997; Li & Chen, 
2001). The Ca2+ release mediated by RyR3 is unlikely to be compromised considering 
its low sensitivity to inactivation by Ca2+.Therefore, RyR3 can amplify Ca2+ signals by 
Ca2+ induced Ca2+ release, and contribute to the propagation of global Ca2+ waves. 
Moreover, RyR2 is primarily targeted to the extraperinuclear region and therefore the 
extraperinuclear nanocourses with no specific type of SERCA co-localised (Clark et 
al., 2010). Inferring from its low EC50 compared to RyR3 and relatively lower 
sensitivity to inactivation by Ca2+, it was proposed that the RyR2 can be easily 
activated and is capable of carrying propagating Ca2+ waves in a manner that is not 
prone to failure (Evans, 2010, Evans et al., 2016). This role of RyR2 fits my 
observation that the vasoconstrictor triggered Ca2+ wave was initiated from 
extracellular nanocourses and propagated across the cells. In short, it is highly likely 
that RyR2 are majorly targeted to the extraperinuclear nanocourses that occupy the 
major volume of the “bulk cytoplasm”, the RyR2s in the extraperinuclear nanocourses 
that are close to the cell periphery are easily activated, which gives rise to Ca2+ signals 
that are amplified and propagated by neighbouring extraperinuclear nanocourses and 
perinuclear nanocourses, causing a global elevation of Ca2+ concentration which 
eventually leads to smooth muscle contraction.  
 
RyR1, on the other hand, exhibits low IC50 of inhibition by Ca2+, which means RyR1 
is easily closed when exposing to high Ca2+ concentration. When the global Ca2+ wave 
is triggered by the vasoconstrictor, huge Ca2+ influx was induced from both the SR 
and the extracellular space, therefore it is very likely that the RyR1s in the 
subplasmalemmal nanocourses are rapidly inhibited. This explains why there is very 
limited subplasmalemmal Ca2+ increase in response to Angiotensin II. When RyR1 is 
activated alone, it may result in elevation of Ca2+concentration within a range that is 
1) sufficient to breach the threshold for the activation plasma membrane targeted BKca 
channels, and 2) not high enough to inhibit RyR1s in the subplasmalemmal 
nanocourses.   
 
In the nuclear invaginations, the only resource of Ca2+ is the Ca2+ release from the 
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NR, therefore this signal is not readily inhibited, as I showed in Chapter 3. Due to the 
low IC50 of inhibition of RyR1, the Ca2+ transient generated within the nuclear 
invaginations are none propagative. Moreover, the huge Ca2+ waves originated form 
the perinuclear nanocourses are unlikely to diffuse to the nuclear invaginations due 
to their geometry. As the result, the nuclear invaginations can give rise to unique Ca2+ 
signals that are segregated from the perinuclear Ca2+ signals. 
 
The aforementioned hypothesis depicts a simplified picture. In fact, each type of 
nanocourses harbour one major subtype of RyR, but clusters of all 3 types of RyRs 
might be found in one nanocourse. Moreover, the Ca2+ handling in those cytoplasmic 
nanocourses involves more types of Ca2+ channels and transporters, for example the 
BKca in the subplasmalemmal nanocourses as discussed above, and more 
commonly the SR targeted SERCAs and perhaps IP3Rs. 
 
7.2.2 Strategic targeting of the SERCA subtypes in cytoplasmic nanocourses 
Similar to the RyR subtypes, SERCA2a and SERCA2b were strategically targeted to 
functionally segregated SR compartments to support distinct physiological processes 
(Clark et al., 2010). As I proposed in Chapter 3, SERCA2b may target to superficial 
SR, and underpins the functioning of subplasmalemmal nanocourses, which is 
consistent with the proposal that SERCA2b supports the function of PM-SR junction 
(Evans, Fameli, Ogunbayo, Duan, & Navarro-Dorado, 2016). In contrast, SERCA2a 
was proposed to target to central SR and support Ca2+ fluxes which underpins 
vasoconstriction (Clark et al., 2010), therefore it may target to the perinuclear 
nanocourses. SERCA1, is exclusively found in the nuclear region of the PASMCs and 
it targets to the nuclear invaginations and feeds the NR. Here one question was raised, 
what properties of the SERCAs underlie this sophisticated subcellular arrangement? 
 
One early experiment reported that SERCA2b has a higher affinity for Ca2+ (K0.5 
0.17±0.01μM) compared to SERCA2a (K0.5 0.31±0.02μM ) (Verboomen et al., 1992). 
Moreover, SERCA2b displayed lower Vmax compared to SERCA2a (Verboomen et 
al., 1994). Based on those facts it was postulated that SERCA2b might be dominant 
at rest to maintain a low level of the cytoplasmic Ca2+ level near the contractile 
apparatus (Evans et al., 2016, Evans, 2010). When encounter a major influx of Ca2+ 
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that causes contraction, SERCA2b is easily saturated which 1) allows the increase of 
Ca2+ level near the contractile apparatus (Evans et al., 2016, Evans, 2010, Clark et 
al., 2010a), and 2) allow the increase of Ca2+ concentration in the subplasmalemmal 
nanocourses and consequently inhibit RyR1. SERCA2a on the other hand, is able to 
remove Ca2+ quickly due to the high Vmax, it may function to recycle Ca2+ into 
perinuclear SR to support regenerative Ca2+ waves, but it was proposed to be 
dominant only when huge amount of Ca2+ is restricted (Evans et al., 2016), i.e. in the 
nanocourses, and it is perhaps not heavily relied on under quiescent conditions 
considering the low affinity for Ca2+.  
 
SERCA1 was discovered in the fast type skeletal muscle, two isoforms of SERCA 1 
were identified, namely the adult isoform SERCA1a and neonatal isoform SERCA1b 
(Maruyama and MacLennan, 1988). I showed the expression of SERCA1 in the 
nucleus of the PASMCs acutely isolated from rat. Our antibody does not differentiate 
between the two SERCA1 isoforms, but considering that the cells are isolated from 
adult rat, the nuclear SERCA1 we identified are most likely SERCA1a. No clear 
difference between SERCA1a and 1b in terms of their ability to transport Ca2+ and 
affinity for Ca2+ was identified (Maruyama and MacLennan, 1988), however, a 
functional difference between nuclear invagination targeted SERCA1a and 
perinuclear nanocourse targeted SERCA2a has been reported. SERCA2a and 
SERCA1 share similar affinity for Ca2+, which is lower that than of SERCA2b 
(Periasamy and Kalyanasundaram, 2007), therefore SERCA1a facilitates fast 
accumulation of Ca2+ in the nuclear invaginations, which may give rise to fast Ca2+ 
signals when required. However, SERCA1a exhibits the highest pump velocity 
compared to the SERCA2s (Sumbilla et al., 1999, Periasamy and Kalyanasundaram, 
2007), which suggests they can effectively remove Ca2+ from the nuclear 
invaginations when the Ca2+ concentration is too high. This would 1) prevent RyR1 
inhibition by high Ca2+ concentration, and 2) quickly remove the Ca2+ and cease the 
Ca2+ signal. As the result, SERCA1a facilitates the generation of fast and transient 
Ca2+ signals, which may regulate downstream process dynamically. For example, as 
discussed in Chapter 4, the mode of BAF-emerin interaction is in a “touch-and-go” 
manner, and this fast and dynamic interaction must be directed by fast and instant 




7.2.3 IP3Rs may also target to the cytoplasmic nanocourses 
Although not tested, I do not exclude the possibility that IP3Rs are targeted to some 
of the cytoplasmic nanocourses. As the result, some of the spontaneous Ca2+ activity 
may as well be the Ca2+ puffs from IP3Rs. Ca2+ puffs are localised Ca2+ transients that 
arise from the liberation of Ca2+ through the concerted opening of tightly clustered 
IP3Rs from the ER/SR Ca2+ store (Smith and Parker, 2009, Dickinson et al., 2012). 
They are observed and characterized in smooth muscle cells (Boittin et al., 2000). 
Although it is shown that the angiotensin II induced Ca2+ signals in the cytoplasmic 
nanocourses are blocked by the RyR inhibitor tetracaine, one can not assert that IP3 
induced Ca2+ signals are not observed in nanocourses due to the fact that tetracaine 
was reported to inhibit IP3 induced Ca2+ signals in one case (MacMillan et al., 2005). 
More importantly, it was documented that the IP3Rs clustered are separated by 500 
nm or less, which fits with the nano-patterning of the hotspots observed in the  
nanocourses (Smith and Parker, 2009). Therefore, both the RyR clusters and IP3R 
clusters might support Ca2+ signalling within the cytoplasmic nanocourses of PASMCs 
for the coordination of smooth muscle functions, and the role of IP3Rs in the processes 
requires further investigation.  
 
Moreover, it was reported that IP3Rs and RyRs are spatially separated in smooth 
muscle cells (Boittin et al., 2002, Morales et al., 2005), however, the mechanism by 
which they are separated remains unclear. Here, I propose that the cytoplasmic 
nanocourses may provide the physical separation between RyRs, and IP3Rs. As the 
result, the two receptors may give rise to spatially restricted Ca2+ signals that regulate 
different smooth muscle functions (Morales et al., 2005). To conclude, the Ca2+ 
signalling in the cytoplasmic nanocourses may involve multiple SR targeted Ca2+ 
channels and transporters and their strategic positioning, the current model is far more 
simplified, and it surely requires future studies. 
 
7.3 Nuclear invaginations and their proposed function.  
7.3.1 Proposed functions of nuclear invaginations in nuclear Ca2+ signalling in 
literature. 
Nuclear invaginations have been identified in multiple cell types, and the consensus 
was that they are the extension of the NE that invaginate into the nuclear interior. The 
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NE was proposed to serve as a buffer barrier that prevents direct Ca2+ diffusion from 
the cytoplasm to the nucleoplasm in early research (al-Mohanna et al., 1994). 
Contradictory to this view, it was proposed that the formation of invaginations 
increases the surface area of the nuclear envelope, which consequently increased 
the number of nuclear pore complexes which would  accelerate the entry of cytosolic 
Ca2+ into the nucleoplasm (Bootman et al., 2009). Other studies suggested the 
nucleoplasmic reticulum could be a potential releasable Ca2+ store, considering it is 
contiguous with ER, and it may play a fundamental role in nuclear Ca2+ signalling via 
ion channels targeted to the NE (Malhas et al., 2011, Echevarria et al., 2003). The 
nuclear invaginations may bring cytosolic messengers close to the nucleoli or other 
effectors located within the nucleus, and thus assists effective nuclear site-specific 
signalling.  
 
In support of this view, it was reported that the IP3Rs are expressed on the nuclear 
envelope and deep invaginations that form nucleoplasmic reticulum (Avedanian et al., 
2011). Whether IP3Rs are localised to the ONM or INM is still controversial. People 
had visualized the cytoplasmic domain of IP3Rs on the NE of isolated nuclei of Sf9 
cells with electron microscopy, this suggests that IP3Rs are targeted to the ONM 
(Cardenas et al., 2010). However, it was described by other studies that IP3 induces 
Ca2+ release toward the nucleus. IP3 induced intranuclear Ca2+ elevations in isolated 
acinar pancreatic nuclei (Gerasimenko et al., 2003), and SKHep1 cells (Echevarria et 
al., 2003). Moreover, in GH3 pituitary cells, IP3 induced nuclear response is not 
blocked by the addition of cytosolic heparin that selectively blocks cytoplasmic IP3R 
because they cannot pass through the NPCs (Leite et al., 2003). In short, the 
aforementioned evidence supports the argument that IP3Rs are targeted to the NE 
and thus to modulate nuclear Ca2+ signalling. 
 
RyRs were also found on the NE and nuclear invaginations in human vascular smooth 
muscle cells (Avedanian et al., 2011). Nuclear Ca2+ release was achieved by applying 
the RyR agonist cADPR in the intranuclear region, and the Ca2+ signal was blocked 
by RyR inhibitors and inhibitory RyR antibodies (Santella and Kyozuka, 1997). In 
another study, uncaged Ca2+ was placed in the vicinity of the nucleoplasmic reticulum, 
which results in a significant nuclear Ca2+ burst that subsequently spread to the 
cytoplasm. The placement of caged Ca2+ in the nucleoplasm by photorelease also 
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generated a nuclear Ca2+ signal which was followed by an amplified Ca2+ signal that 
spread to the cytoplasm. Furthermore, the observed Ca2+ signals were abolished in 
the presence of dantrolene, a RyR inhibitor (Marius et al., 2006). These facts led to a 
consideration that RyRs might mediate Ca2+signalling within the nucleus, which may 
spread to the cytoplasm. 
 
7.3.2 Concurrent proposals of the role of nuclear Ca2+ signalling in the 
regulation of gene expression 
Nuclear Ca2+ signals may affect gene transcription by manipulating the translocation 
of transcription factors into the nucleus from the cytosolic region. Alternatively, it also 
activates enzymes that are required for the translocation of transcription factors. 
 
Nuclear factor of activated T cells (NFAT) are a group of proteins that activate gene 
transcription. They are majorly localised in the cytosol of quiescent cells.  In response 
to increased cytosolic Ca2+ concentration. NFAT is dephosphorylated by calcineurin, 
a Ca2+-calmodulin-sensitive-phosphatase. The modification enables NFAT 
translocation into the nucleus as well as the exposure of its conserved nuclear 
localization sequence. Increased Ca2+ concentration within the nucleus reinforces the 
association between NFAT and calcineurin while keeping calcineurin activated.  The 
interplay is crucial to NFAT activation because calcineurin competes with kinases that 
re-phosphorylate NFAT which could subsequently export NFAT out of the nucleus 
(Rinne et al., 2009). 
 
Similar regulatory patterns were also found in the activation of cyclic AMP response 
element-binding protein (CREB). Significant increases of cytosolic Ca2+ concentration 
near N-methyl-D-aspartate receptors or L-type Ca2+ channels initiate a signal cascade 
which ultimately leads to the phosphorylation of CREB on Ser133 by Ca2+-calmodulin-
dependent-kinase IV. Nuclear Ca2+ increase is also required for the activation of 
CREB co-activator to achieve gene transcription (Chawla et al., 1998).  
 
Downstream regulatory element antagonist modulator (DREAM) is a transcriptional 
regulator that suppresses the expression of prodynorphin. Four Ca2+ binding EF 
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hands were found on DREAM, which enable it to be manipulated by nuclear Ca2+ 
signals directly. Under low nuclear Ca2+ concentration, DREAM competes with and 
results in the dissociation of transcription activators including CREB to supress gene 
transcription (Ledo et al., 2002). 
 
7.3.3 My results suggest a new model of Ca2+ signalling in nuclear invaginations, 
which may regulate chromatin attachment and therefore gene expression 
Against the views above, I show that the RyR1s are targeted to the ONM of nuclear 
invaginations in differentiated PASMCs. The nuclear invaginations form isolated 
cytoplasmic nanodomains that could effectively restrict Ca2+ signals generated via 
RyR1 from the local NR Ca2+ store. The released Ca2+ is buffered from the 
nucleoplasm, as my data showed no evidence of any propagation to the proximal 
nucleoplasm from these nanotubes in PASMCs, although this may not be true in other 
cell type. 
The nuclear invaginations are selectively lined by the NET proteins and therefore the 
chromatin anchoring NET protein complexes. Not only emerin but also nesprin-1α co-
localised with the nucleoplasmic surface of lamin A labelled nuclear invaginations. 
nesprin-1 α  was shown to interact with RyR 1(Pare et al., 2005a, Pare et al., 2005b). 
As the result, charge redistribution across the NET protein complexes and thus the 
capacity for gene suppression by BAF or the lamin associated domains, could be 
triggered by the gating of RyR1 and further modulated by the subsequent regulation 
of RyR1 gating and/or desensitisation via the nano-scale Ca2+ signalling patterns 
arising along the length of a given nuclear invagination.  
 
Invaginations of the NR form highly plastic and heterogeneous chromatin attachment 
sites that line the cytoplasmic nanotubes, they are demarcated by the strategic 
positioning of specific Ca2+ release channels (RyR1) and Ca2+ transporters (SERCA1), 
with different kinetics, “affinities” for Ca2+ and mechanisms of regulation when 
compared to those targeted to other cytoplasmic nanocourses as discussed in section 
7.2. Here, for example, angiotensin II may evoke Ca2+ signals specific to a given 
invagination and in a manner segregated from, but informed by those signals that 
drive myocyte contraction. Although beyond the resolution of current technologies, 
within each nuclear invagination diverse Ca2+ signalling patterns may be delivered by 
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transients separated by ~300 nm, consistent with the dimensions and distances of 
separation between punctate complexes of BAF and emerin (~500nm), and lamin A 
and H3K9me2 (~300nm). Such signal segregation may help orchestrate interactions 
between lamin A, emerin and their respective binding partners (Burke & Stewart, 
2013), informing chromatin re-organisation and ultimately transcription by modulating, 
for example, BAF and H3K9me2 attachment sites. Moreover, the sizes of the punctate 
complexes of BAF and emerin (150-600 nm), and lamin A and H3K9me2 (200-600nm) 
fit with the estimated size of the RyR1 clusters (several hundred nm). It appears 
plausible, therefore, that the activities of such nuclear envelope transmembrane 
complexes may be governed, as previously (Strelkov et al., 2004) predicted, by the 
redistribution of electrostatic charge across macromolecular complexes that span the 
ONM and INM of nuclear invaginations, and through chromatin-modifying enzymes 
(some of which are Ca2+-dependent, i.e. HDAC) targeted to the nanospaces conferred 
by each invagination (Zuleger et al., 2011). In this way, nuclear invaginations could 
provide capacity for the coordination of transcription through parallel processing of 
nano-scale Ca2+ signals that govern alterations in transcriptional potential that 
contribute to, for example, vascular remodelling in health (Gomez et al., 2002) and 
disease (Bierer et al., 2011, Suzuki et al., 2002). 
 
However, to confirm that the Ca2+ signalling can modulate gene expression by 
demarcating chromatin attachment, direct evidence must be provided. Due to the 
limitation of technology, we cannot monitor gene expression in live acutely isolated 
PASMCs upon Ca2+ signalling in the nuclear invaginations. To test the hypothesis, we 
might need to 1) induce Ca2+ signals in the nuclear invaginations alone but not the 
cytoplasm; 2) monitor the changes in chromatin attachment along the nuclear 
invaginations; 3) assess the changes in gene expression. This is one of the future 
experiment I aim to conduct. 
 
7.3.4 Proliferating PASMCs provided a model of nuclear invagination that is not 
able to generate spatially restricted Ca2+ signals, and these nuclear 
invaginations are not lined by chromatin-anchoring proteins. 
The proliferating PASMCs provided a great model for comparing with the nuclear 
invaginations in differentiated PASMCs. I show that the nuclear invaginations of the 
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differentiated PASMCs are lined by chromatin anchoring NET protein complexes, and 
I proposed that the nuclear invaginations give rise to specially restricted Ca2+ signals 
for the regulation of chromatin attachment and thus gene suppression. However, in 
proliferating PASMCs, the chromatin anchoring NET proteins are dissociated from the 
nuclear invaginations whereas the expression of RyR1 is heavily reduced or even 
eliminated. It is difficult to infer whether the rearrangement of NET proteins is induced 
by RyR1 reduction or the other way around, but the fact that the chromatin attachment 
sites and spatially restricted Ca2+ signals are either co-existing in one phenotype or 
both absent from the other phenotype further supports the argument that they are 
perhaps functionally correlated. 
In support of this view, it was observed that the distribution of BAF-emerin association 
is correlated to the Ca2+ signalling pattern. In differentiated PASMCs, the Ca2+ signal 
is restricted in the nuclear invaginations, and the BAF-emerin association is majorly 
found on the nuclear invaginations compared to the nuclear periphery. In contrast, the 
induced Ca2+ signals were propagated across the entire nucleoplasm in proliferating 
PASMCs. Correspondingly, the BAF-emerin association is enriched at the nuclear 
periphery of the proliferating PASMCs. In either phenotype, the BAF-emerin 
association is always maintained in close contact with the Ca2+ signals, indicating the 
possibility that the chromatin attachment is modulated by the Ca2+ signals. 
 
The major difference between the differentiated and proliferating PASMCs lies in the 
changes in gene expression, i.e. the expression of the contractile apparatus and 
proliferating markers (Gomez and Owens, 2012, Rensen et al., 2007). Perhaps the 
Ca2+ signals do modulate the suppression or induction of these markers in response 
to the environment, as the Ca2+ handling is altered during the smooth muscle 
phenotypic switch (Berra-Romani et al., 2008). 
 
7.4 Conclusions 
It was proposed before that the SR in smooth muscle cells form functionally 
segregated compartments underpinned by differential targeting of RyRs and SERCAs 
and that they give rise to Ca2+ signals for the regulation of smooth muscle functions 
(Figure 7.1 A). Adding pieces to the puzzle, I propose a new model (Figure 7.1B) that 
the segregated SR compartments give rise to Ca2+ signals that are segregated by and 
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restricted within the cytoplasmic nanocourses, because the RyR1, 2, 3 and SERCA2a, 
2b,1 are strategically targeted to those nanocourses. These nanocourses and the 
spatially restricted Ca2+ signals demarcate a series of smooth muscle functions, from 
smooth muscle relaxation and contraction to gene expression. 
 
Figure 7.1 Developing view on spatially restricted Ca2+ signalling for the 
regulation of smooth muscle functions 
(A) A schematic image showing the old view on functionally segregated SR 
compartments. Adapted from (Evans et al., 2016). 
(B) The new model of spatially restricted Ca2+ signalling segregated by cytoplasmic 
nanocourses and how they demarcate smooth muscle functions.  
(C) A schematic image showing the proposed new model of cytoplasmic nanocourses 





7.5 Limitations and future experiments 
Acutely isolated PASMCs are physically stretched and treated with enzyme during 
the isolation process. During imaging, they are positioned under strong laser that may 
“fry” the cells. As the result, most of the cells are hampered, and it is difficult to find a 
cell that survives the isolation, remains resistant to the strong laser and stays intact 
and viable till the end of the confocal experiment. Within these cells, there is still a 
population that is moderately damaged that they are not able to maintain the 
nanocourses and respond to stimuli. Therefore, it is extremely difficult to record a cell 
that shows the nanocourses and is able to generate Ca2+ signals within. After months 
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of experimentation, I only managed to image 3 cells as such. To overcome this 
problem, live cell imaging with intact artery can be conducted.  Cell isolation can be 
avoided by conducting whole artery issection and live tissue confocal imaging, which 
reduces damage to the cell. Moreover, it would be interesting to visualize the 
intracellular nanocourses in the intact arteries, as they would appear in nature. 
Different Ca2+ indicators should also be applied, which helps to confirm that the 
differential intensity of Fluo-4 in the nanocourses at rest is not caused by varied micro-
environments but varied basal Ca2+ concentration. For example, Mag-fura 2 staining 
or Calcium crimson staining. 
 
The amplitudes of Ca2+ fluxes and induced Ca2+ transients were only measured within 
selected nanocourses that displayed little movements, because the nanocourses are 
very dynamic, and tracing them manually would result in inaccurate and biased 
measurements. The quantitative analysis may benefit from the application of 
computer software that would trace the nanocourses automatically. As the result, 
relatively accurate measurement can be taken from all the nanocourses, which may 
reinforce my conclusion.  
 
A third future experiment I aim to conduct is to monitor the BAF-emerin association 
and lamin-A association following the induction of Ca2+ signals in live cells, and assess 
the changes in gene expression in response to the Ca2+ signals in the nuclear 
invaginations. The experiment would provide direct evidence that shows 1) whether 
the chromatin attachment is modulated by Ca2+ signals, and 2) whether the Ca2+ 
signal in the nuclear invaginations regulates gene expression. The assessment of 
gene expression can be achieved by RT-qPCR, RNA sequencing or detecting the 








Result Tables of Chapter 3 
 
Table 3.1 Distance of separation between hotspots (nm) within the 
subplasmalemmal nanocourses, extraperinuclear nanocourses, perinuclear 










 201 275 332 313 
 236 253 435 295 
 369 234 407 297 
 469 321 379 330 
 304 348 357 388 
 395 374 359 308 
 308 405 351 480 
 315 434 618 297 
 370 435 586 266 
 431 530 579 437 
 395 529 525 361 
 508 499 259 408 
 343 673 640 301 
 304 518 625 310 
 312 268 309 291 
 359 417 467 325 
 359 546  405 
 481 348  358 
 341 361  438 
 374 333  390 
 324 534   
 283 475   
 401 386   
 338 449   
  461       
Mean 359.2 414.4 451.8 349.9 








Table 3.2 Amplitude of the Ca2+ sparks at hotspots (nm) within the 
subplasmalemmal nanocourses, extraperinuclear nanocourses, perinuclear 
nanocourses and nuclear invaginations in acutely isolated PASMCs. The index 











 0.131569 0.166558 0.133988 0.150716 
 0.157402 0.197348 0.123504 0.23179 
 0.158674 0.166558 0.143178 0.269106 
 0.251254 0.097348 0.141368 0.131568 
 0.109225 0.200599 0.093909 0.160334 
 0.161402 0.099046 0.165642 0.176198 
 0.085476 0.107325 0.110269 0.21397 
 0.132508 0.131816 0.110859 0.099456 
 0.128482 0.104754 0.183797 0.209038 
 0.138959 0.128821 0.107505 0.172258 
 0.114364 0.076511 0.140358 0.131085 
 0.078533 0.098623 0.149515 0.157969 
 0.249131 0.173118 0.115201 0.160699 
 0.365298 0.109897 0.069908 0.030743 
 0.127836 0.038779 0.224009 0.016481 
 0.068025 0.169781 0.152304 0.181409 
 0.164866 0.12218 0.097652 0.139719 
 0.057768 0.193237 0.227914 0.157666 
 0.035673 0.175658 0.098241 0.091685 
 0.17801 0.14238 0.37524 0.138779 
 0.140343 0.360987 0.229389 0.141609 
 0.220683 0.35189 0.255042 0.043598 
 0.599305  0.163032 0.013197 
 0.222436  0.148229 0.426819 
 0.170442   0.102267 
 0.455819   0.207409 
  0.201754     0.096514 
Mean 0.181675 0.155146 0.156669 0.150077 









Table 3.3 Amplitude of the Ca2+ sparks at hotspots (nm) within the 
subplasmalemmal nanocourses, extraperinuclear nanocourses, perinuclear 
nanocourses and nuclear invaginations in PASMCs preincubated with 1µM of 
thapsigargin for 1 hour. The index of amplitude was converted from ΔFX/F0 of 










 0.039761 0.100028 0.069746 0.013985 
 0.061225 0.131462 0.129566 0.077648 
 0.118495 0.053462 0.069625 0.056738 
 0.108271 0.043546 0.043639 0.052314 
 0.035585 0.063761 0.058697 0.07284 
 0.057203 0.051683 0.084801 0.068332 
 0.036699 0.057695 0.070841 0.078988 
 0.061971 0.091575 0.081227 0.092324 
 0.036257 0.039423 0.049913 0.051151 
 0.034469 0.054095 0.064628 0.078962 
 0.113401 0.081476 0.030033 0.129241 
 0.034382 0.095602 0.08156 0.0257 
 0.028941 0.070349 0.025773 0.042879 
 0.036877 0.042996 0.037416 0.095547 
 0.028127 0.114912 0.080152 0.041915 
 0.030123 0.08483 0.034316 0.049397 
 0.036147 0.08391 0.068532 0.04105 
 0.067766 0.123053 0.095612 0.152836 
 0.012479 0.082725 0.152595 0.132921 
 0.061093 0.131714 0.061505 0.093162 
 0.12872  0.069185  
 0.167224  0.119188  
 0.082584    
 0.073251    
  0.154048       
Mean 0.065804 0.079915 0.071752 0.072397 










Table 3.4 Frequencies of the Ca2+ sparks at hotspots (number per second) 
within the subplasmalemmal nanocourses, extraperinuclear nanocourses, 










 0.15 0.16 0.17 0.12 
 0.16 0.13 0.15 0.14 
 0.15 0.16 0.15 0.13 
 0.125 0.15 0.15 0.15 
  0.15 0.15 0.125 0.15 
Mean 0.147 0.15 0.149 0.138 






Table 3.5 Frequencies of the Ca2+ sparks at hotspots (number per second) 
within the subplasmalemmal nanocourses, extraperinuclear nanocourses, 
perinuclear nanocourses and nuclear invaginations in PASMCs preincubated 










 0.18 0.167 0.167 0.18 
 0.16 0.2 0.183 0.15 
 0.18 0.167 0.16 0.15 
 0.125 0.15 0.15 0.15 
  0.175 0.125 0.15 0.15 
Mean 0.164 0.1618 0.162 0.156 












Table 3.6 Amplitudes and frequencies of the Ca2+ sparks at nuclear hotspots in 
PASMCs preincubated with 1mM of tetracaine for 4 hour. 
 Nuclear hotspot 
  Amplitudes Frequencies 
 0.066912 0.13 
 0.192013 0.17 
 0.120445 0.15 
 0.074545 0.175 
 0.139385 0.125 
 0.149805 0.15 
 0.086561 0.15 
 0.059116  
 0.202875  
 0.12923  
 0.083446  
 0.030853  
 0.123916  
 0.058413  
 0.019413  
 0.073691  
  0.059368   
Mean 0.098235 0.15 






Table 3.7 Peak changes of the Ca2+ transients after extracellular application of 
300 nM maurocalcine, measured at the hotpots within the subplasmalemmal 
nanocourses, extraperinuclear nanocourses, perinuclear nanocourses and 











 1.272071 0.503374 0.41125 1.291595 
 1.073014 0.485226 0.288277 1.726202 
 0.999028 0.422486 0.356511 0.70771 
        2.114983 
Mean 1.114704 0.470362 0.352013 1.460123 




Table 3.8 Peak changes of the Ca2+ transients after extracellular application of 
300 nM maurocalcine, measured within the subplasmalemmal nanocourses, 
extraperinuclear nanocourses, perinuclear nanocourses and nuclear 












 1.009831 0.349799 0.247907 0.991589 
 1.103231 0.434695 0.272455 1.429193 
 1.000755 0.335009 0.154848 0.594752 
        1.811832 
Mean 1.037939 0.373168 0.22507 1.206842 















 21.645 23.454 
 27.929 30.732 
  32.609 34.587 
Mean 27.39 29.59 












Table 3.10 Peak changes of the Ca2+ transients after extracellular application of 
30 µM angiotensin II, measured within the subplasmalemmal region, 











 0.125294 1.372749 1.112321 1.783748 
 -0.04629 0.223504 0.216356 0.676727 
 0.185156 1.27624 1.761254 2.293166 
 0.629815 1.248178 1.522193 2.590571 
 1.461936 2.009568 3.137771  
 0.962765 1.514761 1.65743 3.301197 
 0.253627 0.511072 0.522853 0.988954 
  -0.10283 0.162559 0.237438 0.567486 
Mean 0.4337 1.04 1.271 1.743 






Table 3.11 Cell area (µM2) before and after extracellular application of 30 µM 











 129.987 122.44 
 86.026 82.187 
 125.44 105.28 
 104.832 83.491 
 118.018 109.737 
 104.439 89.771 
 110.361 93.163 
  29.576 24.284 
Mean 101.1 88.79 
S.E.M 11.31 10.43 
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Table 3.13 Peak changes of the Ca2+ transients after extracellular application of 
300 nM maurocalcine, measured within the subplasmalemmal region, 
extraperinuclear region, perinuclear region and nuclear invaginations in 
PASMCs, or PASMCs preincubated with 1 µM thapsigargin for 1 hour, or 1nM 
tetracaine for 4 hours. 













 0.3337491 0.9915889 -0.21517 -0.26154 0.226776 0.464371 
 1.007933 1.429193 0.018301 0.279764 0.303385 -0.00876 
 -
0.2727373 
0.5947521 -0.02221 -0.1694 -0.22228 -0.23983 
 0.1466857 1.811832 0.222742 0.517673 0.056163 -0.20428 
 1.0500816 
       
  0.2636145           
Mean 0.4216 1.206842 0.0009158 0.09162 0.09101 0.002875 
S.E.M 0.2105 0.264014 0.08979 0.1848 0.1165 0.162 
 
  Nucleus 
Nuclear 
Invagination 
 1 1.63854 
 1 2.351686 
 1 2.455898 
 1 2.157854 
 1 2.199312 
 1 2.452488 
 1 1.926657 
 1 3.886632 
 1 1.453375 
 1 1.485226 
 1 2.861231 
 1 2.090122 
 1 2.391232 
  1 4.178297 
Mean 1 2.395 
S.E.M 0 0.2139 
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Table 3.14 Peak changes of the Ca2+ transients after extracellular application of 
30 µM angiotensin II, measured within the subplasmalemmal region, 
extraperinuclear region, perinuclear region and nuclear invaginations in 
PASMCs, or PASMCs preincubated with 1 µM thapsigargin for 1 hour, or 1nM 
tetracaine for 4 hours. 
  Control Thapsgargin preincubated 





 1.125237 1.783748 0.19 0.25 
 -0.0769 0.676727 0.19088 0.369722 
 1.132993 2.293166 0.04 0.06 
 0.197611 2.590571 0.37 0.25 
 1.23964   0.078766 0.127927 
 1.273363 3.301197    
 -0.03541 0.988954     
  -0.09747 0.567486     
Mean 0.5949 1.743 0.1739 0.2115 
S.E.M 0.2288 0.3945 0.05744 0.05382 
 
 
  Tetracaine preincubated 8-bromo cADPR preincubated 






 0.120159 0.357267 0.302956 0.67123 
 0.151981 0.203679 0.1125 0.11523 
 0.208966 0.43937 0.426545 0.842806 
  0.114616 0.106852     
Mean 0.1489 0.2768 0.2807 0.5431 









Figure 8.1 Vasoconstrictor triggers Ca2+ release in the extraperinuclear, 
perinuclear nanocourses and nuclear invaginations. 
(A) A series of confocal scans through the middle of a pulmonary arterial smooth 
muscle cell loaded (25o C) with Fluo-4 is shown in the upper panels. Pseudocolour 
was applied to indicate high Fluo-4 intensity in white-yellow and low Fluo-4 intensity 
in blue-purple. The nucleus was drawn out by a yellow box. Subplasmalemmal 
nanocourses were magnified in the white boxes aligned at top and bottom. The 
response of the cell following the extracellular addition of 30 µM angiotensin II is 
shown by displaying the images of the cell at 4 time points (i-iv). The lower panels 
show the higher magnification images of the nucleus at the 4 time points (i-iv). 
Detection threshold was modified to show clearly the nuclear invaginations without 
signal saturation. The nucleus (N) and one nuclear invagination (NI) are indicated by 
white arrow heads. 
(B) Fluo-4 fluorescence ratio (Fx/FC0) versus time for the regions of interests 
(subplasmalemmal region in white, extraperinuclear region in blue, perinuclear region 
in green, nucleus in black, nuclear invaginations in yellow) were plotted. F0 = Fluo-4 
fluorescence intensity for the region of interest at time 0; Fx = fluorescence intensity 






Results tables for Chapter 4 
 
Table 4.1 Results of the linear regression analysis comparing lamin A density 
identified structures in pulmonary arterial smooth muscle cells, including the 
total invaginations with total peripheral structures, trans-nuclear invaginations 
with blind invaginations, trans-nuclear invaginations with superficial 
invaginations, ridges with clefts 
  R Square Equation 
Total invaginations Vs  
Total peripheral structures  
0.01145 Y = -0.3499*X + 34.91 
Trans-nuclear invaginations Vs  
Blind invaginations 
0.2373 Y = 0.4112*X + 1.060 
Trans-nuclear invaginations Vs  
Superficial invaginations 
0.02343 Y = 0.05637*X + 0.3203 
Ridges Vs Clefts 0.11500 Y = 0.5658*X + 7.325 




Table 4.2 Number of structures labelled by lamin B1 per acutely isolated 





 0 11 17 
 0 10 10 
 0 13 17 
 0 22 15 
 0 10 15 
 0 14 13 
 0 20 19 
 0 12 18 
 0 15 16 
 0 10 16 
 0 16 15 
 0 14 22 
Mean 0 13.92 16.08 






Table 4.3 Number of nuclear invaginations identified in each pulmonary arterial 
smooth muscle cell studied, and the number of nuclear invaginations labelled 














0 0 0 0 
2 2 0 0 
0 0 0 0 
0 0 0 0 
1 1 0 0 
0 0 0 0 
1 0 1 0 













0 0 0 0 
0 0 2 2 
0 0 0 0 
0 0 0 0 
0 0 1 1 
0 0 0 0 
0 0 0 0 
















Table 4.4 Volume of nesprin 1 labelling colocalized with SUN2 labelling in 
pulmonary arterial smooth muscle cells, and the Pearson’s correlation 
coefficients between the two labelling 
 
Volume of Nesprin-1 
labelling 
Pearson's correlation 
 colocalised with 
SUN2 labelling 
 coefficiency 
 56.98 0.4787 
 47.31 0.2954 
  45.94 0.321 
Mean 50.08 0.365 







Table 4.5 Results of the linear regression analysis comparing emerin density 
identified structures in pulmonary arterial smooth muscle cells, including the 
total invaginations with total peripheral structures, trans-nuclear invaginations 
with blind invaginations, trans-nuclear invaginations with superficial 
invaginations, ridges with clefts 
  R Square Equation 
Total invaginations Vs  
Total peripheral 
structures  
0.05368 Y = -0.6420*X + 33.41 
Trans-nuclear 
invaginations Vs  
Blind invaginations 
0.105 Y = 0.5115*X + 1.126 
Trans-nuclear 
invaginations Vs  
Superficial invaginations 
0.005181 
Y = -0.04962*X + 
0.4542 







Table 4.6 Separations between the emerin-BAF colocalization puncta (nm) and 





 the puncta (nm) 
Diameters of the Puncta 
(nm) 
 243 600 
 212 210 
 385 450 
 1120 214 
 251 250 
 552 600 
 994 150 
 359 350 
 502 462 
 419 345 
 240 254 
 464 215 
 450 580 









 486   
Mean 495.5 361.4 















Table 4.7  Separations between the lamin A-H3K9me2 colocalization puncta (nm) 




 the puncta (nm) 
Diameters of the Puncta 
(nm) 
 340 230 
 275 350 
 183 576 
 326 583 
 152 470 
 234 370 
 363 487 
 435 587 
 918 467 









 215   
Mean 335.5 471 















Results tables for Chapter 5 
 






per cell   
 0 0 
 0 0 
 0 0 
 0 0 
 0 0 
 0 0 
 0 0 
 0 0 
 0 1 
 0 1 
 0 2 
 0 3 
   2 
Mean  0.36 

















Table 5.2. The index of basal Ca2+ concentration in the nucleoplasm and the 
cytoplasm of each cells studied, and peak changes in the nucleus and the 
cytoplasm in response to either 300 nM maorocalcine or 1µM thapsigargin 
  
Index of  
nuclear 
basal 
Index of  
cytoplasmc 
basal 























 0.509859 1 0.036358 0.020404 4.837826 3.404236 
 0.523317 1 0.016949 0.000012 2.119578 1.780076 
 0.842509 1 0.129325 0.106079 8.147806 5.117965 
 0.526272 1 0.080489 0.046115 3.824164 2.37143 
 0.588937 1 0.020045 0.038621 4.886705 3.473375 
 0.581576 1 0.047261 0.176164 5.677141 3.633987 
 0.629268 1 0.165791 0.001085 3.177792 2.075136 
 0.697754 1 0.008314 -0.08179 2.384988 1.291088 
 0.846434 1 0.59249 0.300968 2.480301 1.888536 
 0.746802 1 0.328139 0.081002 2.856905 1.974071 
 0.584531 1 0.276096 0.002665 3.2019 1.901735 
 0.985156 1 0.0000034 0.025055 5.493281 3.329096 
 0.768323 1 0.039722 0.043831 3.197432 1.880605 
 0.973094 1 0.07316 0.046898 4.679192 2.973982 
 0.928921 1 0.103943 0.324734 3.484982 2.22958 
  0.854902 1 0.469832 -0.05784 2.278085 4.034003 
Mean 0.7242 1 0.1492 0.06712 3.921 2.71 


















Table 5.3 The index of basal Ca2+ concentration in the nucleoplasm and the 
cytoplasm of each cells studied, and peak changes in the nucleus and the 














 0.5807299 1 6.94 2.755 
 0.5230062 1 7.15 3.168 
 0.6438746 1 2.89 1.452 
  0.660381 1 4.72 1.92 
Mean 0.6020 1 5.43 2.323 
























Table 5.4  The index of peak changes in the nucleus and the cytoplasm in 
response to 30 µM Angiotensin II in the cells preincubated with 1 mM tetracaine 














 1.07 1 6.94 2.755 
 1.23 1 7.15 3.168 
 0.64 1 2.89 1.452 
  0.66 1 4.72 1.92 
Mean 0.9 1 5.43 2.323 

















2.5271 1.32637 0.1471 0.02668 
2.3296 1.54149 0.07362 0.0535 
4.21057 2.46871 0 0 
1.94765 1.02404 0.00624 0 
5.62265 4.63797   
8.55002 5.40077     
4.198 2.733 0.05674 0.02005 


















0.061 0.0234 0 0 
0.0248 0.0433 0.06 0 
0.1782 0.0446 0.01 0.02 
0.0412 0.0092 0.11 0.25 
0.0763 0.0301 0.04 0.07 






Table 5.5  The number of nuclear invaginations per cell identified in the lamin A 
labelled proliferating PASMCs, and the surface to volume ratio (µM2/ µM3) in 
acutely isolated or proliferating PASMCs 
  









Surface to volume 
ratio (µM2/ µM3) 
proliferating PASMCs 
 0 4.52906 1.43659 
 0 7.13636 1.50355 
 0 5.0152 2.34272 
  0 3.41772 3.06154 
Mean 0 5.025 2.086 










Table 5.6 The percentage of volume of nesprin-1 labelling colocalized with SUN 
2 in acutely isolated cells or day 7 cultured cells, the percentage of volume of 
SUN 2 labelling colocalized with nesprin-1 in acutely isolated or day 7 cultured 
cells, The pearson's correlation coefficiency of the colocalization in acutely 
isolated cells or day 7 cultured cells Percentage of volume of SUN 2 labelling 





























with SUN 2 

























 56.98 53.24 75.56 52.34 0.4787 0.1252 
 47.31 28.59 40.6 26.79 0.2954 0.1079 
  45.94 38.19 45.49 17.42 0.321 0.1346 
Mean 50.08 40.01 53.88 32.18 0.365 0.1226 
S.E.M 3.474 7.174 10.93 10.44 0.05731 0.00782 
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Table 5.7  The percentage of volume of emerin labelling colocalized with lamin 
A in acutely isolated cells or day 7 cultured cells, the percentage of volume of 
lamin A labelling colocalized with emerin in acutely isolated or day 7 cultured 
cells, The pearson's correlation coefficiency of the colocalization in acutely 






















































 44.74 33.85 45.26 64.4 0.0835 0.0767 
 58.52 62.1 50.53 56.36 0.2893 0.03 
 56.28 69.56 47 60 0.2876 0.058 
  68.09 55.97     0.5423   
Mean 56.91 55.37 47.6 60.25 0.3007 0.0549 




















Table 5.8  The percentage of volume of emerin labelling colocalized with BAF 
in acutely isolated cells or day 7 cultured cells, the percentage of volume of 
BAF labelling colocalized with emerin in acutely isolated or day 7 cultured cells, 
The pearson's correlation coefficiency of the colocalization in acutely isolated 




































































 12.33 28.7 38.02 83.76 -0.1333 0.03 
 14.76 20.16 48.14 58.58 -0.1204 -0.0288 
 4.02 10.99 53.79 49.79 -0.0155 0.0048 
 17 49.75 31.29 44.41 -0.1491 0.0177 
 17.57 28   -0.0265  
 15.24 38   -0.0865  
 8.94 36.75   -0.0302  
 1.87 8.47   -0.0682  
 4.94 22.46   -0.1203  
  2.09 8.48     -0.1395   
Mean 9.876 25.18 42.81 59.14 -0.08895 0.005925 
S.E.M 1.98 4.364 5.038 8.712 0.01609 0.01267 
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Table 5.9 The percentage of volume of lamin A labelling colocalized with 
H3K9me2 in acutely isolated cells or day 7 cultured cells, the percentage of 
volume of H3K9me2labelling colocalized with lamin A in acutely isolated or day 
7 cultured cells, The pearson's correlation coefficiency of the colocalization in 
























































 53.2 67.8 52.38 54.42 0.2279 -0.1841 
 44.5 45.6 30.15 31.58 0.103 -0.1065 
 46.5 64.5 32.68 26.82 0.0313 -0.1916 
 
  44.99 28.2 0.2001 -0.0901 
 
    0.2927  
 
    0.025  
 
    0.1216  
          0.0894   
Mean 48.07 59.3 40.05 35.26 0.1364 -0.1431 















Result tables for chapter 6 
 
Table 6.1 Peak changes and area under curve of the Ca2+ response to 30µM 




Change Area under curve 
 1.846288 193.8208 21.2602 
 1.685022 284.1208 26.01439 
 2.4005 202.4255 121.9845 
 2.205113 59.01095 2.974608 
 1.838464 132.3247 4.286159 
 2.557419 71.28946 76.5145 
 2.0758 362.4879 150.9634 
 2.668044 442.4983 6.082609 
 0.456 6.724051 3.516479 
 0.824377 2.909037 89.59709 
 0.546373 60.75317 31.80879 
 0.736149 41.8527 8.948335 
 0.364 36.45663 19.87766 
 0.631941 22.10307 67.52199 
 0.641724 21.06999 49.35669 
 0.804339 7.452102 29.04057 
 1.064549 31.18843 26.92941 
 0.504113 32.57053 12.11392 
 0.590381 8.018969 38.35737 
 0.3525 32.51012 20.60985 
 1.9797 108.5351 12.78839 
 0.853891 86.97842 12.99878 
 3.039872 5.565264 2.011897 
 0.863074 1.659069 7.185016 
 1.717431 1.923789  
 0.5122 39.19508  
 0.369165 4.630285  
 0.839385 54.91663  
 0.872021 128.5483  
 0.885329 20.88364  
 0.95219 13.92708  
  0.562 14.48983   
Mean 1.19498 60.27825675 




Table 6.2 Peak changes and area under curve of the Ca2+ response to 2µL DMSO 
in PASMCs 
 2µL DMSO  Peak 
Change 
Area under curve 
 0.010667 0.004667 3.138071 2.764306 
 0.007333 0.006381 2.563443 1.827629 
 0.073333 0.029429 2.528163 3.238316 
 0.037714 0.002857 3.952043 2.442861 
 0.037048 0.008952 2.129717 2.196202 
 0.020571 0.038667 2.680679 3.031384 
 0.007143 0.072096 7.713808 3.704313 
 0.002 0.030571 1.96709 1.848136 
 0.035143 0.013121 5.781402 2.464735 
 0.001905 0.12149 1.773827 2.334021 
 0.031429 0.02284 2.698095 3.841661 
 0.025238 0.016523 2.255026 1.656889 
 0.035556 0.006318 6.436929 3.063363 
 0.040794 0.003401 3.716242 1.947628 
 0.016984 0.071619 3.667659 1.660012 
 0.000476 0.063111 2.011877 2.545954 
 0.00373 0.047841 3.485026  
 0.044286 0.002286 2.023573  
 0.046476 0.017079 2.773798  
  0.247143 0.458889     
Mean 0.033441422 2.967539143 
















Table 6.3 Peak changes and area under curve of the Ca2+ response to 30µM 
rapamycin in HEK293 cell stably expressing GCaMP5-hTPC2 
  
Peak change 




 233.1314 247736.7 
 364.184 311506.3 
 127.2018 361413.3 
 130.4578 100375.3 
 726.5482 100024.5 
 107.8726 642808.9 
 109.853 71837.02 
 276.2546 182774.4 
 233.7618 227307.8 
 559.169 607097.3 
  177.9142 441003.6 
Mean 276.9408 299444.1 



















Table 6.4 Peak changes and area under curve of the Ca2+ response to 2µL DMSO 
in HEK293 cell stably expressing GCaMP5-hTPC2 
 
  
Peak change in 
response to 2uL 
DMSO 
Area under curve 
 70.71577  
 13.05383 87525.34 
 78.5816 126326.5 
 25.26674 68595.44 
 3.999571 168175 
 94.0896 115109.1 
 116.6324 101637.5 
 129.2326 36273.51 
  72.83677 115521.3 
Mean 67.15654 102395.5 






Table 6.5 Peak changes and area under curve of the Ca2+ response to 30µM 
rapamycin in HEK293 cell stably expressing GCaMP5-hTPC2 preincubated with 
1µM thapsigargin for 30 minutes. 
 
  
Peak change in response to 
Rapamycin+ Thapsigargin 
preincubation 
Area under curve 
 277.0086 619393 
 184.2636 399569.7 
 214.608 242931.7 
 226.148 179133 
  246.6546 224473.4 
Mean 229.7366 333100.2 







Table 6.6 Peak changes and area under curve of the Ca2+ response to 30µM 
rapamycin in HEK293 cell stably expressing GCaMP5-hTPC2 preincubated with 
1µM Bafilomucin-A1 for 30 minutes. 
 
  
Peak change in response to 
Rapamycin+ Bafilomycin-A1 
preincubation 
Area under curve 
 86.0082  
 55.19757 132863.4 
 118.2486 88358.33 
 69.61827 161821.8 
 142.3346 210660.7 
 79.03023 250072.1 
 52.01317 173877.4 
 26.9173 161768.6 
 20.58983 206059 
  163.0524 120681.5 
Mean 81.30102 167351.4 





Table 6.7 Peak changes and area under curve of the Ca2+ response to 30µM 
rapamycin in HEK293 cell stably expressing GCaMP5-hTPC2 preincubated with 
10µM nifedipine for 30 minutes. 
 
Peak change in response to 
Rapamycin+ Nifedipine 
preincubation 
Area under curve 
  137480.9 
 67.16047 107453.4 
 77.2638 51273.71 
 80.4877 57666.22 
 65.5204 82033.56 
 98.29657 146745.7 
  39.52509 98421.2 
Mean 71.37567 97296.38 
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